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ABSTRACT 
Surface Layer Proteins as Virulence Factors in Clostridium difficile infection 
– Mark Lynch B.Sc. 
Clostridium difficile is a nosocomial pathogen possessing Surface Layer Proteins 
(SLPs), which exhibit adherent and immunostimulatory properties. Using 
bioinformatics tools, evidence of positive selection (PS) was detected in the 
SLPs of hypervirulent ribotype (RT) 027, indicating a potential correlation 
between PS and immunostimulatory properties. The SLPs were purified, and 
examined for their effect on immune cells. Up-regulation of pro-inflammatory 
cytokines was observed, however the strength of the response differed between 
strains. RT 027 induced a strong inflammatory response relative to the RT 001, 
with which it exhibits sequence similarity. An animal model of C. difficile 
infection compared severity of RT 001 and RT 027. RT 001 induced mild 
disease with full recovery by day 7, while RT 027 exhibited more severe disease 
with less clearance. Tissue damage was visualised by histology staining. Further 
staining showed macrophage and neutrophil infiltration of the tissue. qPCR 
analysis showed induction of Th17-linked pro-inflammatory cytokines at day 3 
in response to RT 001, with levels lowering by day 7. RT 027 infected animals 
showed later production of IL-10. This may contribute to suppressing clearance. 
A dendritic cell T cell co-culture was also carried out to fully determine the 
effect of SLPs on the adaptive immune response. These results strongly suggest 
the importance of SLPs in disease, and that positive selection may be playing a 
role in driving the emergence of hypervirulent strains. 
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1.1 Clostridium difficile 
Clostridium difficile is a spore-forming, anaerobic gram-positive bacteria and the 
leading cause of antibiotic-associated diarrhoea worldwide (Dawson et al. 2009). 
Infection usually occurs in hospitalised patients undergoing broad-spectrum 
antibiotic treatment, where treatment leads to a disruption of the protective 
microbiota of the gut (Rupnik et al. 2009). Therefore, this makes the intestine 
more susceptible to colonisation by pathogens (Sekirov et al. 2008; Buffie et al. 
2012). In the absence of commensal bacteria, ingested C. difficile spores can 
germinate, colonise the intestinal walls, and begin producing toxins. With the aid 
of flagella, proteases and other surface proteins, they can penetrate deep into the 
mucus layer of the intestine (Denève et al. 2009). Depending on the strain 
causing the infection, symptoms can range from mild diarrhoea to life-
threatening pseudomembranous colitis, sepsis and death (Rupnik et al. 2009).  
 
1.1.1 C. difficile Toxin Production 
C. difficile produces two main toxins; TcdA and TcdB. These cytotoxic proteins 
are secreted from the bacteria and endocytosed by host cells (Genth et al. 2008). 
They act by glycosylating small Rho GTPases in the intestinal cells, resulting in 
disorganisation of the actin cytoskeleton, apoptosis, and destruction of the 
intestinal epithelium (Kreitman & Akashi 1995). This damage can then allow the 
bacteria to access the underlying connective tissue, to which it can bind and 
invade deeper. A negative regulator, TcdC, is encoded in the same region as the 
two toxins. In total TcdA, TcdB and TcdC form the pathogenicity locus or PaLoc 
(Spigaglia & Mastrantonio 2002). It has been suggested that inactivation in the 
TcdC gene results in increased toxin production, giving rise to hypervirulent 
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strains such as ribotype (RT) 027 (Spigaglia & Mastrantonio 2002). Indeed, an 
18bp deletion has been observed in the TcdC gene of 027 strains, and it has been 
proposed that unregulated toxin production was the cause of its hypervirulence 
(Spigaglia & Mastrantonio 2002). However, there are also various deletions 
observed in non-virulent strains (which may not result in loss of function), 
overall suggesting that increased virulence is not solely due to toxin production 
(Drudy, Fanning, et al. 2007).  
 
Another hypervirulent strain, ribotype 017, was shown to produce a truncated, 
non-functional TcdA. Other TcdA-TcdB+ strains have been observed, and this 
toxin variance shows TcdB as the most important toxin in C. diff colonisation 
(Karjalainen et al. 2001). As diagnosis often relied on Toxin A assays to identify 
C. diff in stool samples, this strain may have long gone unnoticed. These toxin 
variant strains are of particular importance in Ireland. A study conducted in St. 
James Hospital determined that 81 out of 85 isolates were ribotype 017 
(Karjalainen et al. 2001).  These strains also show resistance to a wide variety of 
antibiotics, including fluoroquinolones (Karjalainen et al. 2001). While the 
toxins of C. difficile are obviously of great importance in the study of its 
pathogenesis, other virulence factors cannot be ignored.    
   
1.1.2 Clostridium difficile Spores 
Survival of C. difficile is dependent on the production of spores, and it is spore 
germination that is believed to be the first step in establishing CDI (Cohen et al. 
2010). These spores are incredibly resilient and can survive many standard 
hospital cleaning agents, persisting on surfaces for extended periods of time 
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(Riggs et al. 2007; Setlow 2007). Once these spores are ingested and reach the 
intestinal tract, they can strongly adhere to intestinal epithelial cells (Paredes-
Sabja & Sarker 2012). These spores also appear resistant to most antibiotics 
(Sarker & Paredes-Sabja 2012; Baines et al. 2009). Therefore, antibiotic 
treatment, which disrupts the protective microbiota, does nothing to target the 
spores, whilst eradicating their nutrient competitors. Specific primary bile salts, 
in the gut, such as taurocholate, promote germination of C. difficile spores, while 
chenodeoxycholate, a secondary bile salt, can inhibit spore germination as well 
as vegetative cell growth (Giel et al. 2010). The gut microbiota metabolise these 
primary bile salts into inhibitory secondary salts, providing a further protective 
function. However, upon antibiotic treatment, the disruption of the microbiota 
leads to an accumulation of primary bile salts (Hashimoto et al. 1996), promoting 
spore germination.  
 
Vegetative cells induce a host immune response, with immune cells being 
recruited to the site of infection. Macrophages have been shown to phagocytose 
C. difficile spores in vitro, yet these phagocytosed spores remain dormant, and 
are not destroyed by the macrophage (Paredes-Sabja et al. 2012).  In addition, 
proteins on the exterior of the spore directly interact with the membrane of the 
phagosome, and have the ability to induce cell death in macrophages.  While 
vegetative cells are successfully inactivated, the survival and persistence of 
spores may be a contributing factor in recurrent CDI. 
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1.1.3 Surface layer protein SlpA 
The main focus of study in C. difficile pathogenesis has been toxin production 
for some time, but there is increased interest in cell surface proteins as important 
virulence factors. Like many bacteria, C. difficile possess a surface layer, or S-
Layer. S-Layers have many proposed functions, such as adherence, molecular 
sieves and evasion of the immune system. The S-Layer of C. difficile is 
composed of two main surface layer proteins (SLPs) termed the high molecular 
weight (HMW) SLP and the low molecular weight (LMW) SLP. These SLPs are 
the predominant surface antigen in C. difficile.  
 
While many bacteria possess surface layers with multiple proteins, C. difficile is 
unique in that a single gene encodes for both major SLPs. The gene is termed 
slpA and codes for a protein precursor, consisting of three main regions, a short 
signal peptide of 26 amino acids in length, the LMW-coding region and the 
HMW-coding region. The signal peptide is thought to be responsible for 
transporting the immature SlpA protein to the cell surface, where it is then 
cleaved into the mature HMW and LMW SLPs. The structure of slpA can be 
seen in Figure 1.1. 
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Figure 1.1 
 
Figure 1.1 Structure of the slpA gene.  
The signal peptide, which directs the protein to the exterior of the bacteria before being cleaved, 
is seen in white. The coding regions for the LMW and HMW proteins can be seen in dark and 
light blue respectively. Cleavage sites are represented by a black triangle. 
 
The HMW SLP is highly conserved across strains, while the LMW SLP shows 
little sequence conservation (Calabi et al. 2002). The HMW SLP exhibits strong 
and specific binding to gastrointestinal tissues and human epithelial cells (Calabi 
et al. 2002). More recently it has been shown to be the major contributor to host 
cell adherence in vitro (Merrigan et al. 2013). Pre-coating host cells with SLP 
preparations successfully inhibited binding of C. difficile to the cells. In addition, 
adherence was also inhibited when host cells were incubated with anti-SLP 
serum prior to exposure with C. difficile (Merrigan et al. 2013). This study also 
suggested a prominent role for the LMW subunit in adherence. This is contrary 
to previously published studies (Calabi et al. 2002) which described the HMW 
protein as subunit involved in adherence. It seems likely that both SLP subunits 
play a role in adherence to the gastrointestinal tract.   
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In contrast, the LMW protein does not bind to purified extracellular matrix 
(ECM) components or mucosal connective tissues, but can weakly bind to rare 
gastrointestinal cells (Calabi et al. 2001). Therefore, the LMW protein may have 
a role other than adherence (Calabi et al. 2001). The binding of the HMW SLP to 
host epithelial cells may allow for the targeted delivery of the cytotoxins to the 
epithelial walls. This strongly suggests that when the epithelial layer has been 
damaged, the SLPs can allow the pathogen to invade deeper by binding to ECM 
components.  
 
The LMW SLP is the immunodominant antigen. Because of high sequence 
variability between strains, and the fact that different strains induce different 
immune responses, it is plausible that this protein may be involved in masking 
the bacteria from the immune system. A change in structure or specific motifs in 
the LMW protein may result in host immune cells no longer being able to 
recognise C. difficile as a pathogen. Indeed SLPs have been shown to activate 
macrophages and dendritic cells in vitro (Ausiello et al. 2006).  
 
The structure of these proteins and how they interact with each other has only 
recently been demonstrated (Fagan et al. 2009). A crystal structure was obtained 
only for a truncated form of the LMW SLP as C-terminal residues degraded at 
room temperature. The crystal structure of this LMW SLP revealed a two-
domain configuration as seen in Figure 1.2. The larger domain, Domain 2, was 
composed roughly of 10% α-helices, 30% β-sheets and 60% loops. These loops 
in Domain 2 contain many hydrogen-bonding interactions. Domain 1 contains 
both the C- and N-terminal regions of the proteins and consists of 37% α-helices, 
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36% β-strands and only 27% loops. Domain 1 is also likely responsible for 
binding to the HMW protein. Deletion of 61 residues in Domain 1 (residues 260-
321 of strain 630) resulted in a loss of binding. Despite the high variability in the 
LMW protein across strains, there are some strikingly conserved regions. For 
example, the area described above is well conserved, implying these residues are 
essential for binding to the HMW protein, and varying the sequence may result 
in a loss of binding. A common mechanism therefore must exist for the assembly 
of the mature SLP complex. The 24-peptide long signal sequence is also 
incredibly well conserved (Fagan et al. 2009).  
 
The HMW protein is well conserved, and a loss of the first 40 residues in the 
HMW sequence resulted in loss of binding the LMW protein (Fagan et al. 2009). 
The mature SLP complex was found to have an “end-to-end” orientation with a 
specific binding domain between the HMW and LMW SLPs (Fagan et al. 2009).  
The orientation of the proteins can be inferred, as the HMW SLP possesses two 
PF04122 Pfam cell wall binding motifs, which are involved with binding to 
components of the bacterial cell wall (Fagan et al. 2009). It has been shown that 
the HMW protein is most likely anchored to the cell wall, and is “displaying” the 
LMW protein as the external part of the S-Layer. As the LWM protein is the 
outermost part of the bacteria, it will be exposed to the host immune system and 
therefore its high sequence variability may be a result of evolutionary selective 
pressures exerted by the host immune response acting on the bacteria to avoid a 
host response (Fagan et al. 2009).  
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Figure 1.2  
 
 
Figure 1.2 Proposed Structure of the LMW/LMW SLP Complex 
3D model of both HMW and LMW SLPs orientated exterior to the cell wall. Taken from Fagan 
et al. 2009. 
 
The genes encoding slpA and all of the cwp genes are located on a 36.6-kb cwp 
gene cluster (Sebaihia et al. 2006). Despite slpA sequences exhibiting little 
sequence variability between serogroups (Karjalainen et al. 2002), a recent study 
has shown a potential role for recombination in slpA between different strains 
(Dingle et al. 2013). Five main clades of C. difficile, along with twelve stable 
variants of a 10-kb S-layer cassette, containing slpA, were identified. The twelve 
S-layer cassette variants unexpectedly behaved as independent components of 
the genome, associating randomly with the five clades. Dingle et al observed the 
S-layer cassette from hypervirulent RT 027 to be closely related to that of RT 
001, and concluded that, because of this, hypervirulence may not be solely 
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influenced by the S-layer. They also show that isolates sharing the same PCR-
ribotype can carry multiple distinct S-layer cassettes (Dingle et al. 2013). 
 
1.1.4 Cell Wall Proteins 
There is a family of genes (paralogs) (consisting of 29 genes in total) that code 
for cell surface proteins. All of these paralogs possess at least two copies of the 
Pfam 04122 motif, also known as “putative cell wall binding repeat 2”. Fagan et 
al have recently suggested that these be designated cell wall protein, or cwp, 
genes (Fagan et al. 2011). The majority of these genes are not well characterised, 
and the functions of many of them remain somewhat elusive. Three of the 
somewhat characterised proteins are Cwp84, Cwp66 and CwpV.    
 
Of particular interest is Cwp84, a cysteine protease whose function was initially 
hypothesised to be the degradation of the host ECM (Janoir et al. 2007). As the 
protein resides on the surface of the bacteria, it is in an optimal position to react 
with components of the ECM. It has been shown to cleave fibronectin, laminin 
and vitronectin, all of which are important components of the intestinal 
epithelium (Janoir et al. 2007). Unlike the highly variable SlpA, Cwp84 appears 
greatly conserved across strains, particularly sites in the protein active region. In 
addition, transcription of the cwp84 gene is detected only in the early exponential 
growth phase of the bacteria (Savariau-Lacomme et al. 2003). Another function 
for Cwp84 has been suggested. Dang et al have shown that Cwp84 is the 
protease that cleaves the immature slpA into its HMW and LMW components 
(Dang et al. 2010). Inhibition of this protease results in accumulation of 
immature slpA on the cell wall, which leads to a decrease in viability of the 
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bacterium. In addition to this, upregulation of slpA is seen to occur under 
inhibition of cwp84, implying a greater need for SLPs when the protease is not 
performing its function (Dang et al. 2010). It is likely that both ECM degradation 
and SLP maturation are key functions of Cwp84. The high conservation of the 
SLP cleavage site between strains and low variability of Cwp84 itself imply a 
conserved process of SLP maturation across all strains of C. difficile. It is 
therefore an extremely important component of the S-layer. 
 
Mutation of the cwp84 gene was found to result in defective localisation of other 
Cwp proteins. As Cwp84 is necessary for the maturation of slpA, it is likely that 
this delocalisation is due to a disruption of the mature S-layer complex (de la 
Riva et al. 2011). In addition to the role of Cwp84 in slpA maturation, the 
protease Cwp13 also appears to play a role in the maturation of the S-layer. This 
protein can cleave and aid the maturation of Cwp84, therefore allowing the 
formation of the mature S-layer complex. In the absence of Cwp13, both 
immature and mature forms for Cwp84 were detected, indicating Cwp13 role in 
S-layer formation. Cwp84 was still present, albeit in lower numbers. Cwp13 also 
cleaves slpA at a site distinct from Cwp84. This suggests a further role in the 
degradation of mis-folded proteins (de la Riva et al. 2011). A diagrammatic 
representation of the maturation process of SlpA can be seen in Figure 1.3. 
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Figure1.3 
 
 
 
Figure 1.3 Maturation process of SlpA.  
Cwp13 translocates to the cell membrane and processes it mature form in an autocatalytic 
fashion. The mature Cwp13 then cleaves Cwp84, which in turn cleaves SlpA into the mature 
HMW and LMW subunits. Taken from de la Riva et al. 2011. 
 
Another characterised paralog of slpA is Cwp66. Unlike Cwp84, but similar to 
the HMW SLP, it seems to function mainly in adhesion. It is transcribed during 
the exponential phase of growth, and present in much lower levels than Cwp84 
and slpA. Therefore this protein may not have the same level of importance as 
more major S-layer components. Waligora et al further demonstrated the role of 
Cwp66 in adhesion (Waligora et al. 2001). Similar to slpA, it possesses a 27 
amino acid signal sequence, most likely responsible for transporting the protein 
to the cell surface. They have also shown that the protein is evenly distributed 
across the cell wall and that the C-terminal is surface exposed. Cwp66 shows 
more variability than Cwp84, exhibiting a highly conserved N-terminal, with a 
more variable C-terminal (~58% identity). With the N-terminal region of the 
protein most likely attached to the cell wall, there will be greater pressures on the 
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C-terminal region as it may be subject to immune selection, similar to the LMW 
SLP.  Antibodies raised against the N-terminal domain of this protein resulted in 
partial loss of adherence, indicating Cwp66’s role but also showing other 
adhesions being involved (Waligora et al. 2001).   
 
1.2 Immunity in the Gastrointestinal Tract 
The small intestine, cecum, large intestine, and rectum, together constitute the 
gastrointestinal tract.  Shortly after birth, the intestine becomes colonised by vast 
amounts of non-pathogenic, commensal bacteria, with number estimating 
between 1013 – 1014 bacteria per gram of luminal content (Ley et al. 2006; Gill et 
al. 2006). In addition to these commensal bacteria, the presence of food antigens 
puts pressure on the intestinal immune system. It is of crucial importance that 
pathogens be recognised and an appropriate response mounted, while at the same 
time preventing persistent inflammation due to activation of immune cells by 
non-pathogenic antigens. Immune cells in the intestine are associated with the 
gut-associated lymphoid tissue (GALT), which comprises of Peyer’s patches in 
the small intestine, and isolated lymphoid follicles in the large intestine, or colon 
(Jung et al. 2010). These areas of tissue contain high densities of immune cells, 
which survey antigens in the gut. The underlying tissue is termed the lamina 
propria, and contains a vast array of different immune cells, such as 
macrophages, dendritic cells, mast cells and lymphocytes (Doe 1989). 
 
The first barrier pathogens face in the intestine is the intestinal epithelial cells. 
These cells form a monolayer between the lumen of the intestine and sub-
epithelial tissue, location of the immune cells. These cells provide a necessary 
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physical barrier, but also can interact with both the bacteria present in the lumen 
of the gut, and the underlying host immune cells. Through direct recognition of 
bacteria by pattern recognition receptors, epithelial cells and interact with and 
influence the immune response.  
 
1.2.1 Pattern Recognition Receptors 
Pattern recognition receptors (PRRs) on the surface of epithelial and immune 
cells are essential in detecting common microbial ligands. Many intra- and 
extracellular PRRs exist, such as Nod-like receptors and Rig-I like receptors, 
capable of recognising a plethora of common antigens, termed pattern associated 
molecular patterns (PAMPs) (Goto & Ivanov 2013). Of particular interest are the 
Toll-like receptors (TLRs), which play an important role in bacterial recognition. 
There are ten functional TLRs in humans, and thirteen in mouse, each capable of 
recognising distinct PAMPs (Akira et al. 2001). TLR1, TLR2, TLR4, TLR5 and 
TLR6 are present on the cell surface. TLR2 can form heterodimers with both 
TLR1 and TLR6 to recognise bacterial lipopeptides and lipoteichoic acid from 
gram positive cell walls (Farhat et al. 2008). TLR4 recognises lipopolysaccharide 
(LPS) on the outer layer of gram negative bacteria (Takeuchi et al. 1999). TLR5 
recognises flagellated bacteria (Hayashi et al. 2001). TLR3 and TLR9 recognise 
PAMPs from intracellular pathogens. TLR3 recognises both single and double 
stranded viral RNA (Alexopoulou et al. 2001), while TLR9 recognises 
unmethylated CpG from DNA viruses (Hemmi et al. 2000). Expression of TLR1, 
TLR2, TLR3, TLR4, TLR5 and TLR9 has been confirmed in epithelial cells of 
the small intestine (Otte et al. 2004), and have been shown to be involved in 
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maintaining homeostasis, with TLR4 and TLR2 deficient mice exhibiting 
increased susceptibility to colitis (Rakoff-Nahoum et al. 2004).  
 
The main TLR of interest in this thesis is TLR4. Despite recognising LPS of 
gram negative bacteria, TLR4 is the receptor responsible for recognising SLPs 
and mounting a response to C. difficile (Ryan et al. 2011). There are two possible 
pathways for activation downstream of TLR4, the MyD88-dependent and 
MyD88-independent pathways. The MyD88-dependent pathway results in 
downstream activation of NF-κB, proinflammatory cytokine production and 
activation of T helper cells (Akira & Takeda 2004). Initiation of the MyD88-
independent pathway, and subsequent IRF3 activation (Brikos & O’Neill 2008), 
requires the initial endocytosis of TLR4 in the presence of CD14 (Jiang et al. 
2005). This pathway leads to induction of type one interferons (Kagan et al. 
2008). In addition to this, activation of both these pathways is required for 
optimal IL-10 production in immune cells (Boonstra et al. 2006; Chang et al. 
2007). While LPS induces both pathways downstream of TLR4, we have 
previously shown that SLPs from RT 001 only activate the MyD88-dependant 
pathway (Ryan et al. 2011). The main signalling molecules involved in TLR4 
signalling can be seen in Figure 1.4. 
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Figure 1.4 
 
 
 
 
Figure 1.4 Toll-like Receptor 4 Signalling 
TLR4 signalling in response to LPS. The MyD88-dependent pathway leads to downstream 
activation of NF-κB and pro-inflammatory cytokine production, while the MyD88-independent 
pathway results in IRF3 activation and type 1 interferon production. 
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1.2.2 Dendritic Cells 
Dendritic cells (DCs) are the sentinels of the immune system and play an 
essential role in intestinal immune regulation. As the intestine possesses many 
resident inflammatory cells, an essential feature of immune cells in the 
gastrointestinal tract is to maintain homeostasis in the presence of commensal 
bacteria, while mounting a protective response against invading pathogens. 
Dendritic cells and macrophages both play important roles in immunity of the 
gastrointestinal tract, with populations of both cells residing in the lamina propria 
behind a wall of protective epithelial cells (Smith et al. 2005; Iwasaki 2007). 
Resident mucosal DCs sample the environment of the intestinal lumen in 
different ways. Specialised microfold cells, or M cells, present in the epithelium 
of Peyer’s patches can uptake antigen from the lumen, and transcytose to 
underlying DCs (Coombes & Powrie 2008). DCs can also sample antigen 
directly by forming tight junction structures with intestinal epithelial cells and 
extending dendrites into the lumen (Rescigno et al. 2001). While this process 
occurs during normal conditions, sampling of resident commensal bacteria, the 
number of these trans-epithelial dendrites is increased during infection (Niess et 
al. 2005; Chieppa et al. 2006). This process requires MyD88-dependent 
signalling through TLRs to efficiently function (Niess et al. 2005). 
 
Upon antigen uptake, intestinal DCs migrate to the mesenteric lymph nodes, 
where they can interact with naïve T and B cells. Here they can display antigens 
from commensal bacteria and apoptotic cells, helping drive tolerogenic responses 
to maintain a non-inflammatory state (Macpherson & Uhr 2004; Huang et al. 
2000). In particular, DCs isolated from the mesenteric lymph nodes were found 
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to be capable of producing high levels of TGF-β, driving naïve T cells to an 
immunosuppressive Treg phenotype, in the absence of exogenous factors 
(Coombes et al. 2007).  
 
As intestinal DCs recognise commensal bacteria without inducing an 
inflammatory response, the mechanism by which they can mount an effective 
response against pathogens is not yet fully known (Coombes & Powrie 2008). A 
distinguishing factor may be the ability of pathogens to cross the epithelial 
barrier and invade deeper into the gut. The presence of pathogenic bacteria in the 
gut may result in the recruitment of inflammatory cells by chemokine production 
by epithelial cells, where migrating DC-precursors in the blood may be recruited. 
These cells will not have the same conditioning as the resident intestinal DCs and 
therefore will mount an inflammatory response. This has been seen in response 
to pathogenic Salmonella spp., where the bacteria induced production of IL-8 
from epithelial cells, attracting neutrophils and increasing the inflammatory state 
in the gut (Rimoldi et al. 2005). This increased inflammatory state will help 
recruit non-conditioned DCs to induce a protective response. In S. typhimurium 
infection, CCR6-mediated DC recruitment to the epithelium was found to be 
required to induce a protective T cell response (Salazar-Gonzalez et al. 2006). 
Therefore, circulating non-conditioned DCs play an essential role in 
inflammatory responses against pathogens, while resident intestinal DCs ensure 
homeostasis in the gut. 
 
19 
 
1.2.3 Macrophages 
We have also previously shown that SLPs from C. difficile RT 001 activate 
macrophages and induce clearance responses (Collins et al. 2014). Macrophages, 
along with intestinal epithelial cells DCs, compose the first line of defence 
against invading pathogens, and their importance during bacterial infection has 
been previously reported (Murray & Wynn 2011; Mosser & Edwards 2008). 
Intestinal macrophages constitute the largest reservoir of macrophages in the 
body, with the highest numbers in the colon (Lee et al. 1985). Unlike 
inflammatory macrophages, they express lower levels of co-stimulatory 
molecules CD80, CD86 and CD40 (Rogler et al. 1998). While expressing TLRs 
at the mRNA and protein level, they appear unresponsive to many TLR ligands 
(Smith et al. 2005; Smith et al. 2011). Despite a general lack of cytokine 
secretion, they were found to produce high levels of TNFα, even in a steady 
state, without inducing inflammation (Bain et al. 2013). Intestinal macrophages 
are also capable of phagocytosing pathogens and exhibit bactericidal abilities 
(Smythies et al. 2005). They are also likely important in maintaining homeostasis 
in the gut, as intestinal macrophage depletion leads to inflammation (Qualls et al. 
2006). The ability of SLPs to induce cell surface molecule and cytokine 
production in inflammatory macrophages likely comes into play when non-
intestinal macrophages are recruited to the site of infection.  
 
Despite the anergic nature of intestinal macrophages, non-intestinal macrophages 
recruited to the site of infection play an essential role in bacterial clearance. 
Macrophages can reduce pathogen numbers by phagocytosing bacteria (Aderem 
& Underhill 1999) and defective phagocytosis has been shown to have a 
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detrimental role in disease (Taylor et al. 2010). Once activated, the production of 
pro-inflammatory cytokines and chemokines will recruit more inflammatory 
cells to the infected area. Macrophages are known to produce high levels of 
proinflammatory TNFα, a cytokine previously associated with Crohn’s Disease 
(Plevy et al. 1997). However, TNFα secretion from macrophages can also aid 
bacterial clearance, with TNFα knockout mice infected with mycobacteria 
recovering upon administration of recombinant TNFα (Bekker et al. 2000). 
Phagocytosis is likely the key mechanism in bacterial clearance by macrophages, 
as it physically lowers bacterial cell count by direct ingestion. As neutrophils 
have been shown to not affect bacterial cell numbers in the gut, phagocytosis by 
macrophages is likely determinate in disease resolution (Jarchum et al. 2012; 
Collins et al. 2014). 
 
1.2.4 Neutrophils 
Neutrophils are a key component in the innate immune response, and play a 
critical role in C. difficile-induced colitis (Jarchum et al. 2012). These innate 
cells have the ability to phagocytose pathogens, as well as releasing 
antimicrobial molecules such as lytic enzymes and reactive oxygen intermediates 
(ROIs) (Borregaard 2010; Nathan 2006). Neutrophils also express PRRs, 
including TLR4, this indicates their potential to directly recognise the SLPs on 
C. difficile (Hayashi et al. 2003). These cells are relatively short lived, and do not 
proliferate upon activation (Colotta et al. 1992). This short lifespan suggests that 
neutrophils only play a passive role in resolution of infection, with fewer cells 
being recruited as infection resolves, and cells dying off. They have also been 
shown to play a more direct role, with apoptotic neutrophils increasing 
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expression of CCR5, which act as decoys for the chemokines CCL3 and CCL5, 
limiting chemotaxis as the neutrophils die (Ariel et al. 2006).  
 
Cytokine production by other cell types such as macrophages can stimulate 
neutrophils to prolong their lifespan (Soehnlein & Lindbom 2010). This 
inhibition of programmed cells death is likely an important factor in clearing 
pathogens from the site of infection. Other studies have shown crosstalk between 
neutrophils and dendritic cells, with supernatant from activated neutrophils 
driving the maturation of bone marrow-derived dendritic cells in vitro (Bennouna 
& Denkers 2005). Neutrophils can also directly recruit and modulate the adaptive 
immune response, releasing chemokines specific for Th17 responses (Pelletier et 
al. 2010). These recruited Th17 cells, along with regulatory T cells, can produce 
high levels of IL-8, which can further recruit neutrophils in a positive feedback 
loop (Himmel et al. 2011). 
 
1.2.5 CD4+ T cells 
CD4+ T cells are another major population of cells involved in both homeostasis 
and protective immunity of the gut. CD4+ T cells are distributed throughout and 
around the gastrointestinal tract, and are found in the mesenteric lymph nodes 
(MLNs), gut-associated lymphoid tissue such as Peyer’s patches, as well as in 
the lamina propria and intraepithelial compartments of the colon (Mowat 2003; 
Cheroutre et al. 2011; Beagley et al. 1995). As previously stated, intestinal DCs 
can migrate to the MLNs upon antigen uptake to activate CD4+ T cells present at 
the MLN (Coombes & Powrie 2008). This occurs even in a steady state, 
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indicating the role of DCs in driving regulatory phenotypes in CD4+ T cells in 
the absence of infection (Izcue et al. 2009). 
 
Th1 cells are required for clearance of intracellular pathogens in the gut. This 
phenotype is driven by the presence of IFNγ and IL-12, and characterised by the 
expression of the transcription factor T-bet. Expression of T-bet then leads to a 
positive feedback loop, producing IL-12 and IFNγ (Zhu et al. 2012). This 
production of IFNγ was thought to drive colitis, with an IFNγ neutralising 
antibody treating disease in murine models of inflammatory bowel disease 
(Powrie et al. 1994). However, late administration of IFNγ failed to provide 
protection, and in addition, an anti-IFNγ was shown to be ineffective in treating 
Crohn’s Disease (Reinisch et al. 2010). Treatment with an anti-IL-12p40 
antibody, however was found to effectively treat established disease (Neurath et 
al. 1995). This suggests a pathogenic role for this phenotype in IBD. 
 
The protective role of the Th17 subset of CD4+ T cells in the gut has recently 
been described (Blaschitz & Raffatellu 2010). IL-23, IL-6 and TGFβ have all 
been shown to drive a Th17 phenotype (Blaschitz & Raffatellu 2010; Zúñiga et 
al. 2013). These cells are characterised by expression of the transcription factor 
retinoic acid-related orphan receptor γt (RORγt) and secretion of IL-17A, IL-
17F, IL-21, IL-22 and GM-CSF (Korn et al. 2009). These cells represent a large 
population in both infection and non-infection of the intestine (Weaver et al. 
2013). Studies have shown a link between a Th17 phenotype and increased 
disease (Feng et al. 2011), yet their persistence in the gut during a steady state 
suggests a more complex role in intestinal immunity. IL-17 promotes tight 
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junction formation, an important protective feature in preventing systemic 
inflammation (Kinugasa et al. 2000). Th17 cells are important in the clearance of 
extracellular bacteria, and have been shown to play protective roles against many 
pathogens (Khader et al. 2009; Zhang et al. 2009a; Sellge et al. 2010; Ishigame et 
al. 2009). 
 
Another important subset of T cells in both gut homeostasis and disease is the 
Foxp3+ Treg cells, and are characterised by high levels of IL-10 secretion (Fujio 
et al. 2010). These cells work in an immunosuppressive fashion, and can be 
protective during colitis, releasing IL-10 which dampens down the immune 
response (Ranatunga et al. 2012). Deficiency in IL-10 has also been shown to 
exacerbate symptoms of colitis (Kullberg et al. 1998). Despite this protective 
function of IL-10, many pathogens have the ability manipulate  its production to 
impede clearance (Redford et al. 2011; O’Leary et al. 2011; Wilson et al. 2011; 
Xavier et al. 2013). This modulation of the host immune system by pathogens is 
likely an important component of disease severity.  
 
1.2.6 Immune Responses to C. difficile  
As previously mentioned, toxin production by C. difficile results in disruption of 
tight junctions and damage to the intestinal epithelium. This induces pro-
inflammatory cytokine production and immune cell migration to the site of 
infection (Dawson et al. 2009). As SLPs are the predominant surface components 
of the bacteria, they are exposed to the host immune system. Previous studies 
have shown them to induce activation of dendritic cells (DCs), with upregulation 
of many important cell surface markers such as CD80, CD86 and MHC class II 
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(Ausiello et al. 2006). They have also been shown to upregulate pro-
inflammatory cytokine production, with elevated levels of IL-1β and IL-6 
detected (Ausiello et al. 2006). This inflammatory response to SLPs is likely to 
play an important role in CDI.  
 
Host antibody responses against SLP also appear to play a role in C. difficile 
infection (Drudy et al. 2004). Despite the fact that no difference in antibody 
levels between patients, asymptomatic carriers and controls was observed, IgM 
seems to be an important determinate for recurring infection. Patients suffering 
from recurrent cases were seem to have lower levels of IgM, relative to patients 
who only experienced an isolated case of CDI. Passive immunisation of hamsters 
with anti-SLP antibody was seen to modulate disease and delay progress of 
infection in vivo (O’Brien et al. 2005). This study detected an increase in 
phagocytosis of C. difficile in response to anti-SLP antibodies, suggesting a 
mechanism by which immunisation occurs. 
 
Our group has also shown the ability of SLPs from C. difficile RT 001 to induce 
clearance mechanisms in macrophages (Collins et al. 2014). SLPs from RT 001 
upregulated expression of proinflammatory IL-6, IL-12p40 and TNFα, in 
addition to chemokines MIP-2 and MCP. Co-stimulatory surface molecule 
expression was also increased. The rate of phagocytosis in the macrophages was 
upregulated by SLPs. This is indicative of increased clearance of the pathogens, 
as phagocytosis will decrease bacterial load. While spores can survive within 
phagosomes, the macrophages can prevent them from germinating, by isolating 
them from co-germinants (Paredes-Sabja et al. 2012). Inhibition of p38, a 
25 
 
downstream component of TLR4 signalling, resulted in the inhibition of 
proinflammatory cytokine production, and direct phosphorylation of p38 was 
observed in response to SLP. This again shows the signalling of immune cells 
through TLR4 in response to SLPs from C. difficile (Collins et al. 2014).  
 
A role for neutrophils in C. difficile infection has recently been shown, 
specifically involving MyD88-mediated neutrophil recruitment to the gut 
(Jarchum et al. 2012). As SLPs signal through TLR4 to activate MyD88, the 
proteins may have direct involvement in recruiting these cells. This study found 
that recruited neutrophils can form a protective barrier in the wake of epithelial 
cell damage during colitis, preventing dissemination of intestinal bacteria. When 
the receptor necessary for neutrophil recruitment (CCR2) was knocked out in 
mice, a 90% reduction in monocyte recruitment was detected in the gut. This 
drop did not induce increased mortality however (Jarchum et al. 2012). 
Neutrophils also did not decrease toxin concentration in the gut, or decrease 
bacterial density. Their main role in CDI is therefore to form a protective barrier 
as the epithelial layer is damaged, preventing dissemination of bacteria to the 
underlying tissues, as other cell types, such as macrophages and T cells, resolve 
infection (Jarchum et al. 2012). 
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1.3 Inflammatory Bowel Disease 
Inflammatory bowel disease (IBD) is the general term for inflammatory 
disorders of the gastrointestinal tract, and many infections, such as CDI can 
mimic the associated symptoms. It is characterized by an abnormal inflammatory 
response to antigens present in the gut, inducing a persistent inflammatory state 
(Scaldaferri & Fiocchi 2007). The two major forms of IBD are Crohn’s Disease 
and ulcerative colitis; Crohn’s Disease affects the entire gastrointestinal tract, 
causing widespread inflammation, while ulcerative colitis is normally localised 
to the colon (Podolsky 2002). In both cases, inflammation is associated with a 
breakdown of the protective epithelial barrier, resulting in activation of the 
underlying immune cells, and exacerbated inflammation.  
 
Patients with IBD exhibit increased numbers of inflammatory cells, particularly 
macrophages, in the mucosa, with the cells exhibiting increased co-stimulatory 
surface molecule and proinflammatory cytokine expression (Xavier & Podolsky 
2007; Rugtveit et al. 1997; Kamada et al. 2005). Macrophages in IBD also 
increase expression of PRRs such as TLR4, in addition to tissue-degrading 
cathepsins, all of which exacerbate inflammation in the gut (Smith et al. 2005). 
Production of TNFα by macrophages is crucial in the pathogenesis of IDB, as it 
is involved in initiation of a proinflammatory cytokine cascade, which maintains 
the damaging inflamed state of the gut (Parameswaran & Patial 2010). 
Dysregulation of DCs can also increase the inflammatory state in the gut in IBD. 
In a mouse model, depletion of DCs was seen to ameliorate dextran-sulphate 
sodium salt (DSS)-induced colitis (Berndt et al. 2007). Depletion of 
macrophages and DCs in IL-10 deficient mice was also seen to ameliorate the 
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symptoms of colitis (Watanabe et al. 2003). While the causes of IBD are not 
entirely clear, several intestinal pathogens, including C. difficile, can induce a 
colitis-like state in the gut, causing symptoms similar to that of ulcerative colitis 
or Crohn’s disease. 
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1.4 Aims and Objectives 
C. difficile has the ability to induce severe inflammation in the gut, resulting in a 
colitis-like state. The severity of disease can also vary depending on the strain 
causing infection. The Surface Layer Proteins coating the outer layer of C. 
difficile also exhibit variability between strains, and we have previously shown 
that SLPs from RT 001 induce proinflammatory cytokine production in vitro, 
indicating their ability to induce an immune response during infection. As certain 
strains are described as hypervirulent, we wanted to determine the evolutionary 
history of slpA, the gene encoding the SLPs. Using the output of this 
phylogenetic analysis, we wanted to examine if positive selection (a form of 
evolution indicative of functional shift) is present in the sequences.  We also 
hypothesised that any positive selection present may affect recognition by the 
host immune response, which in turn may affect disease severity. Our hypothesis 
suggests that the amino acid sequences of the SLPs are a crucial determinate in 
susceptibility and severity of infection, and that the SLPs of different strains have 
the ability to modulate the immune response for the benefit of the pathogen.  
 
To test this hypothesis the aims of this thesis were: 
 To determine the evolutionary history of slpA and examine for signs of 
positive selection 
 To purify SLPs from different ribotypes of C. difficile, and compare their 
effects on immune cells in vitro. 
 To investigate differences in disease severity between strains of C. 
difficile with and without positive selection in an animal model, and 
identify a potential link between disease and evolution of SLPs. 
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C. difficile is now one of the most common nosocomial pathogens in the world, 
and the emergence of new strains resulting in more severe disease highlights the 
need for a better understanding of the pathogenesis of CDI. Unravelling the role 
that SLPs play in the inflammatory response to C. difficile may potentially reveal 
therapeutic targets to help ensure the host immune system mounts an appropriate 
and effective response to clear the pathogen from the gut and resolve infection.  
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Chapter 2 
 
Materials and Methods 
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2.1 MATERIALS 
 
2.1.1 C. difficile Culture Reagents 
Material Source 
Blood Agar Plates BD 
Inoculation Loops Cruinn 
Cryovials Lennox 
Glycerol Sigma-Aldrich 
DPBS Biosciences 
Precept Tablets VWR 
DMEM Biosciences 
Anaerobic Indicator Sigma-Aldrich 
Anaerobic Gas Packs Fisher 
Sodium Thioglycolate Sigma-Aldrich 
Vitamin K Sigma-Aldrich 
Hemin Sigma-Aldrich 
Table 2.1.1 All reagents used for C. difficile culture and corresponding sources. 
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2.1.2 S-Layer Extraction Reagents 
Material Source 
50 mL unskirted centrifuge tubes Sarstedt 
BHI Broth Cruinn 
NaCl Sigma-Aldrich 
Tris Base Sigma-Aldrich 
Urea Sigma-Aldrich 
Complete Protease Inhibitor Cocktail Roche 
Slide-A-Lyzer Dialysis Cassettes Pierce 
2mL Screw Cap tubes Sarstedt 
Bis-acrylamide Sigma-Aldrich 
SDS Sigma-Aldrich 
APS Sigma-Aldrich 
TEMED Sigma-Aldrich 
Methanol Lennox 
Acetic Acid Sigma-Aldrich 
Glycine Sigma-Aldrich 
Brilliant Blue Sigma-Aldrich 
Table 2.1.2 All reagents used for Surface Layer extraction and SLP purification, 
and corresponding sources. 
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2.1.3 Cell Culture Reagents 
Material Source 
Tissue culture flasks T-75 cm2  Nunc 
Tissue culture flask T-25 cm2     Nunc 
Sterile Petri dishes Nunc 
6-, 24-, 96-well tissue culture plates  Nunc 
96-well round bottom plate Starsedt 
Trypan blue (0.4% w/v) Sigma-Aldrich 
Foetal Calf Serum Sigma-Aldrich 
RPMI-1640 Gibco 
DMEM Sigma-Aldrich 
Penicillin Streptomycin/Glutamine Life Sciences 
LPS (from E. coli) Enzo Lifesciences 
DPBS Biosciences 
Table 2.1.3 All reagents used for immune cell culture and corresponding 
sources. 
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2.1.4 ELISA Reagents 
Material Source 
96-well microtiter plate Nunc 
TMB BD 
Tween 20 Sigma-Aldrich 
Bovine serum albumin Sigma-Aldrich 
ELISA Duoset kits R&D Systems 
DPBS Biosciences 
Table 2.1.4 All reagents used for ELISA and corresponding sources. 
 
2.1.5 Flow Cytometry Reagents 
Material Source 
FACS Clean BD 
FACS Flow BD 
FACS Rinse BD 
Sodium Azide  Sigma-Aldrich 
EDTA Sigma-Aldrich 
Propidium Iodide Solution Sigma-Aldrich 
Anti-CD80 antibody BD 
Anti-CD86 antibody BD 
Anti-TLR4 antibody BD 
Anti-MHC II antibody BD 
Anti-CD40 antibody BD 
Anti-DAPI antibody BD 
Table 2.1.5 All reagents used for Flow Cytometry and corresponding sources. 
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2.1.6 RNA Isolation and cDNA Synthesis Reagents 
Material Source 
Nucleospin RNA II Columns Macherey-Nagel 
DEPC-treated dH2O Invitrogen 
cDNA Reverse Transcription kit Applied Biosystems 
Molecular grade ethanol Sigma-Aldrich 
Table 2.1.6 All reagents used for RNA isolation and cDNA synthesis, and 
corresponding sources. 
 
2.1.7 qPCR Reagents 
Material Source 
SYBR® Green Mastermix Roche 
Taqman® Gene Expression Mastermix Applied Biosystems 
MicroAmp® Optical 96-well plate Applied Biosystems 
MicroAmp® Optical Adhesive Film Applied Biosystems 
IL-6 PrimeTime qPCR Primers IDT 
IL-10 PrimeTime qPCR Primers IDT 
IL-12p40 PrimeTime qPCR Primers IDT 
IL-23 PrimeTime qPCR Primers IDT 
TNFα PrimeTime qPCR Primers IDT 
IFNɣ PrimeTime qPCR Primers IDT 
TGFβ PrimeTime qPCR Primers IDT 
RORɣ PrimeTime qPCR Primers IDT 
TLR4 PrimeTime qPCR Primers IDT 
CCL2 PrimeTime qRT-PCR Assay IDT 
36 
 
CCL3 PrimeTime qRT-PCR Assay IDT 
CCL4 PrimeTime qRT-PCR Assay IDT 
S18 PrimeTime qRT-PCR Assay IDT 
S18 PrimeTime qPCR Primers IDT 
B2M PrimeTime qRT-PCR Assay IDT 
B2M PrimeTime qPCR Primers IDT 
 
Table 2.1.7 All reagents used for quantitative PCR and corresponding sources. 
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2.1.8 Immunohistochemistry Reagents 
Material Source 
Acetone Sigma-Aldrich 
HCl Sigma-Aldrich 
Sodium Bicarbonate Sigma-Aldrich 
Ethanol Lennox 
Harris Haematoxylin Sigma-Aldrich 
Eosin Sigma-Aldrich 
Histo-clear Fisher 
OCT Solution TissueTek  
Superfrost Slides Fisher 
DPX Mountant Sigma-Aldrich 
Anti-NIMP Antibody Abcam 
Anti-CD4 Antibody eBiosciences 
Anti-F4/80 Antibody  eBiosciences 
DAB Tissue Staining Kit R&D Systems 
Table 2.1.8 All reagents used for immunohistochemical staining and 
corresponding sources. 
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2.2 BIOINFORMATICS TOOLS 
Using specific software and bioinformatics tools, it is possible to detect 
signatures of positive selection in the slpA sequences of multiple ribotypes of C. 
difficile. Sequences obtained from online databases can be used to construct a 
multiple sequence alignment (MSA) based on sequence similarity. Statistical 
tests are then performed to ensure sufficient phylogenetic signal is present before 
the phylogeny of the sequences can be resolved. Using the phylogenetic tree and 
MSA, sites of positive selection can be estimated by analysing the rate of 
synonymous mutations per synonymous site to non-synonymous mutations per 
non-synonymous site. The general workflow for the bioinformatics analysis is 
given in Figure 2.2.1. 
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Figure 2.2.1 
 
Figure 2.2.1 Workflow describing the process of biomolecular evolution analysis from sequence 
acquisition to selective pressure analysis. 
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2.2.1 Sequence Data Assembly 
slpA gene sequences were obtained from 26 different strains of C. difficile, 
representing the majority of clinically important ribotypes and serogroups. A 
literature search was first conducted for complete DNA sequences of the slpA 
gene (Eidhin et al. 2006; Karjalainen et al. 2002). GenBank and EMBL accession 
numbers were obtained and used to retrieve the sequences 
(http://www.ncbi.nlm.nih.gov/genbank/). BLAST searches were performed to 
ensure all the coding DNA sequences (CDS) for slpA had been obtained.  The 
sequences varied from 1833 to 2304 base pairs in length. The sequence data are 
given in Table 2.2.1. 
 
2.2.2 Multiple Sequence Alignment 
The nucleotide sequences were translated to amino acids using in house software 
“Translfas.c”. Multiple sequence alignments (MSAs) for the amino acid 
sequences were then obtained using two software packages, ClustalX 1.83.1 
(Jeanmougin et al. 1998) and MUSCLE 3.6 (Edgar 2004) with both alignments 
yielding the same result, the alignment produced from MUSCLE was chosen for 
all subsequent analyses. The alignment was edited by manual inspection, and 
ambiguous regions were removed, i.e. small identical regions on multiple strains 
that have been falsely misaligned, but are easily aligned by eye. The final 
alignment was then used to insert gaps into the nucleotide sequences in the 
positions corresponding from the protein alignment using in house software 
(“Putgaps.c”). The overall alignment length was 2,652 nucleotides, or 884 amino 
acids. 
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Table 2.2.1 – All slpA sequences used in bioinformatics analysis 
Ribotype Accession No. TcdA/TcdB Length of sequence Serogroup 
001 DQ060625 
DQ060626 
DQ060627 
AJ300676 
+/+ A.A: 756 
Nuc: 2,271 
G 
002 DQ060628 
DQ060629 
+/+ A.A: 726 
Nuc: 2,181 
A2 
005 DQ060630 
DQ060631 
+/+ A.A: 610 
Nuc: 1,833 
A1 
010 DQ060633 
AF478571 
-/- A.A: 767 
Nuc: 2,304 
D 
012 DQ060634 
DQ060635 
AJ291709 
+/+ A.A: 719 
Nuc: 2,160 
C 
014 DQ060638 +/+ A.A: 732 
Nuc: 2,199 
H 
016 AF478570 n/a A.A: 610 
Nuc: 1,833 
A1 
017 DQ060640 
AJ300677 
-/+ A.A: 714 
Nuc: 2,145 
F 
027 R20291 
CD196 
+/+ A.A: 758 
Nuc: 2,277 
Unknown 
031 DQ060641 -/- A.A: 739 
Nuc: 2,220 
K 
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046 DQ060636 +/+ A.A: 719 
Nuc: 2,160 
C 
054 DQ060632 +/+ A.A: 610 
Nuc: 1,833 
A1 
066 DQ060639 -/- A.A: 732 
Nuc: 2,199 
A9 
078 DQ060643 +/+ A.A: 726 
Nuc: 2,181 
Unknown 
092 DQ060637 +/+ A.A: 719 
Nuc: 2,160 
Unknown 
094 DQ060642 +/+ A.A: 739 
Nuc: 2,220 
Unknown 
 
Table 2.2.1 The table shown lists all the ribotypes used in the dataset. GenBank 
accession numbers for the slpA gene of each ribotype are given. In certain cases, 
slpA sequences from different strains within the same ribotype were included to 
allow as robust as possible analyses. Also included is information on sequence 
length, serogroup, and toxin production. 
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2.2.3 Amino Acid Composition Bias 
Composition bias may result in distantly related sequences being falsely grouped 
together due to similar amino acid compositions. The TreePuzzle 5.2 software 
(Schmidt et al. 2002) performs a chi-squared test that compares the amino acid 
composition of each sequence in the dataset to the frequency distribution 
assumed in the maximum likelihood model. This distribution assumes 
homogeneity of composition. Every sequence should ideally pass this test and 
sequences that fail should be excluded from the dataset.  
 
2.2.4 Likelihood Mapping Tests 
Likelihood mapping involves dissembling the phylogenetic tree into all possible 
quartets and assessing the support for each possible quartet (Strimmer & von 
Haeseler 1997). If the data contains no phylogenetic signal, then the likelihood of 
all three possible relationships for that quartet will be equally likely, represented 
by three tips of a triangle. If sufficient phylogenetic signal is present, the 
majority of the signal will appear in these tip regions. If little or no phylogenetic 
signal is present, the majority of the signal will be in the vertices and central 
region of the triangle, representing a network or star phylogeny respectively. An 
example of good and bad signal can be seen in Figure 2.2.2 below. 
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Figure 2.2.2  
 
Figure 2.2.2 Examples of likelihood mapping where little signal is present (A) and high signal is 
present (B). In the top row the two triangles show two different patterns of signal. Each dot in 
these triangles represents a different quartet. The numbers in the bottom triangle represent the 
percentages of quartets in each section. The fewer dots in the centre of the triangle, and the more 
at the edges, the greater the amount of phylogenetic signal.  
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2.2.5 Phylogeny Reconstruction 
To determine the most suitable model of evolution for the data, we employed 
Modelgenerator version 0.85 (Keane et al. 2006). In total, 88 models were tested 
with the data and compared with each other to see which was a better fit to the 
data.  The protein model of substitution found to be the best fit for the data was 
the WAG substitution matrix (Whelan & Goldman 2001) with a discrete gamma 
model of rate heterogeneity (G), and an amino acid frequency estimated from the 
data (F). The phylogenetic tree for the slpA sequences was estimated under 
Bayesian inference using MrBayes v3.2.1 and the amino acid alignment 
(Huelsenbeck & Ronquist 2001).  The tree was generated using the Nearest 
Neighbour Interchange (NNI) tree search algorithm and 100 bootstrap replicates 
implemented under the Akaike Information Criterion (AIC) statistic. The 
substitution model was WAG+G+F with discrete gamma model of rate 
heterogeneity. Clade supports were given as posterior probabilities. The settings 
used in MrBayes v3.2.1 are given in Table 2.2.2 below. A Shimodaira-
Hasegawa, or SH test was performed on all trees generated to test for any 
statistically significant differences between the trees. 
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Table 2.2.2 MrBayes Settings 
Parameter Setting 
Autoclose Yes 
lset applyto All 
nst 6 
rates gamma 
prset aamodelpr fixed (wag) 
mcmcp ngen 500,000 
printfreq 5,000 
samplefreq 500 
nchains 64 
sacebrlens yes 
burnin 500 
 
Table 2.2.2 Settings used for phylogenetic tree construction by MrBayes v3.2.1. 
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2.2.6 Selective Pressure Analysis 
Codon models of evolution implemented in PAML 4.3 (Yang 2007) were used in 
the analysis of the SLPs.  Site-specific and lineage-specific models were applied 
to the data, allowing for ω values across sites and along different branches. The 
models differed from each other in their complexity.  Three models were applied 
for the branch-specific analysis and seven were used for the site-specific 
analysis, these represent all currently available codon models.  
 
The first model M0 (also known as the Goldman and Yang model) (Goldman & 
Yang 1994) assumes that the rate of evolution is constant across all sites and 
lineages, and calculates a single value for ω across the entire alignment. The next 
model is known as M1 and allows for two classes of sites with ω0 =0 and ω1 =1; 
under this model purifying selection or neutral evolution are allowed, but 
positive selection is not permitted. Model M2, “the selection model”, adds more 
parameters to M1 and allows for three classes of sites. The classes of sites can 
have ω = 1, ω = 0 and ω estimated entirely from the data (and free to be >1), and 
all associated proportions of sites fitting into each of these categories is estimated 
from the data (p0 etc).  M1 and M2 can be compared with one another, as M2 is 
an extension of M1 with the addition of an extra parameter. An LRT can then be 
used to examine whether there is a statistically significant difference between the 
two models. The next model, M3, an extension of M0, contains two further 
parameters and allows ω values to be estimated entirely from the data. This 
model can allow two classes of sites to vary (k = 2) or three classes of sites to 
vary (k = 3). An LRT between M3 (k=2) and M0 can be used to determine if the 
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M3 (k=2) model better fits the data than M0. M3 (k=3) can be compared with 
M3 (k=2) (Yang & Swanson 2002).  
 
The remaining models are different from those mentioned previously as they use 
discrete approximations to continuous distributions in order to model variability 
in ω at different sites along the sequence. M7 gives variation in ω a beta 
distribution. Under this model, ten classes of sites are assumed to exist with ω 
values constrained between zero and one. M8 is a similar model to M7, but it 
allows for an additional class of site with its ω value estimated entirely from the 
data and free to be greater than 1. M8 can be compared with M7 in an LRT, a 
model that does not allow for positive selection (Yang & Nielsen 2002). A final 
model, M8a, is the null model of M8 (Yang & Nielsen 2002). It restricts the 
additional site category that is estimated from the data to be ω = 1, and therefore 
does not allow for positive selection. If M8 then gets a statistically significantly 
better likelihood score than M8a, then any positive selection observed under M8 
is more likely to be accurate (Yang & Nielsen 2002).  
 
The two lineage-specific models currently being used are Model A and Model A 
null. Model A allows ω to vary across different lineages as well as across sites. 
Model A is a lineage-specific extension of M1. Model A null does not allow for 
positive selection, it can be compared with Model A to test whether or not Model 
A is a good fit for the data. The posterior probability of any given site in the 
alignment being under positive selection can be estimated using either Naive 
Empirical Bayes (NEB) or Bayes Empirical Bayes (BEB) (Yang & Nielsen 
2002). NEB is less robust than BEB and is prone to error. In particular this 
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occurs in small datasets where ML estimates may have large sampling error and 
can result in false positives for sites under positive selection (Anisimova et al. 
2002). BEB is more robust and reduces the rate of false positives for small 
sample sets (Yang et al. 2005). 
   
A series of likelihood ratio tests (LRTs) were then carried out between models 
that are nested to determine the statistically significant model for the data for 
each branch in the tree and for the multiple sequence alignment. See Table 2.2.3 
full list of all LRTs carried out. For each model, the log likelihood (lnL) values 
were recorded, with the lnL values closest to zero representing a closer fit to the 
data. χ2 tests were then used to determine the significance of these models.   
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Table 2.2.3 Likelihood Ratio Tests 
Comparison df Δl Critical χ2 values 
M0 v M3k2 2 X2 ≥ 5.99 
M3k2 v M3k3 - X1 ≥ 1.00 
M1 v M2 2 X2 ≥ 5.99 
M7 v M8 2 X2 ≥ 5.99 
M8 v M8a* 1 X2 ≥ 2.71 (@5%) 
   ≥ 5.41 (@1%) 
M1 v model A 2 X2 ≥ 5.99 
Model A v Model A null 1 X2 ≥ 3.84 (@5%) 
 
 
Table 2.2.3 Table showing how the different models of evolution are compared to one another, 
along with the critical chi-square value that must be obtained for the particular model to pass the 
likelihood ratio test (LRT). Taken with permission from Morgan et al. 2010. 
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The difference between the lowest lnL values of models and lnL values of more 
complex models was calculated. This value, which is the difference in likelihood, 
was multiplied by the degrees of freedom given in the table below. If the 
resulting value exceeds the critical χ2 value, then the result is significant. If this 
applies for complex models, then that model of evolution is a better fit and the 
associated parameter estimates for omega and proportion of sites are taken from 
that model. 
   
Sites under positive selection were estimated using the empirical Bayes methods 
for both site and lineage-specific analyses. The methods used were naïve 
empirical Bayes (NEB) and Bayes empirical Bayes (BEB). Previously published 
knowledge on functionally important sites in the two proteins, HMW and LMW, 
were then combined with the positive selection results to determine if there is a 
correlation between positive selection and specific functions of the protein. A 3D 
structure of the LMW SLP was obtained from EMBL-EBI 
(http://www.ebi.ac.uk/). The PDB code for this structure is 3cvz. It was used to 
visualise positively selected residues on the protein. 
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2.3 C. DIFFICILE CULTURE AND SLP PURIFICATION 
2.3.1 Culture on Solid Agar 
Frozen C. difficile spore were acquired from the Central Pathology Laboratory at 
St. James’s Hospital, Dublin. Spores were streaked on to Brucella Agar plates 
with 10% Horse Blood (BD) using sterile inoculation loops, and allowed to grow 
at 37°C for 48 hours. Plates were incubated anaerobically using gas-generating 
kits in a sealed anaerobic jar.  Anaerobic indicator strips, which turn pink in the 
presence of oxygen, were used to confirm anaerobic conditions. After 48 hours, 
grey colonies, which were opaque, raised, and irregular in shape, were observed 
on the plate. A single colony was then used to streak a fresh agar plate using a 
sterile loop, which was then incubated in the same fashion as described 
previously. This was repeated for as long as colonies were required. All bacterial 
work was carried out in a class II safety cabinet.  
 
2.3.2 Stock Preparation 
To prepare fresh stocks for each new isolate, a single colony was streaked on to a 
fresh agar plate and incubated for 48 hours as described previously. One plate 
per frozen stock required was made. Two stock solutions were tested, a 
PBS/glycerol whole cell stock solution and a DMEM/glycerol spore stock 
solution. A solution of PBS with 15% glycerol was used for the whole cell stock 
solution. Two mL aliquots were added to sterile cryovials. After 48 hours, the 
plates were removed from the incubator. All the colonies from a single plate 
were collected using a sterile swab and added to the stock solution. This process 
was repeated as required. For the spore stock preparation, confluent cultures of 
each strain were grown anaerobically at 37°C for 5–7 days to generate spore 
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formation. The cultures were harvested with disposable loops into 1 mL of PBS 
in screw cap tubes. Tubes were then spun down at 8,000 rpm and the supernatant 
was removed. The cell pellet was washed in 1 mL PBS, and heat-shocked at 
56°C for 10 min to kill surviving vegetative cells. The spores were centrifuged 
and re-suspended in 1 ml DMEM with 15% glycerol. All stocks were stored at -
80°C. 
 
2.3.3 Liquid Culture 
C. difficile was also cultured in liquid Fastidious Anaerobe Broth (FAB) and 
Brain Heart Infusion (BHI) broth. BHI broth was autoclaved before use and 
supplemented with Sodium Thioglycolate, Hemin and Vitamin K. Sodium 
Thioglycolate (0.05%) was added to remove oxygen from the broth. Hemin 
(0.5%) and Vitamin K (0.1%) were added as additional nutrients for the bacteria.  
 
2.3.4 Surface Layer Extraction 
A blood agar plate was streaked as described above and C. difficile colonies were 
grown for 48 hours. BHI broth was added to 12 non-skirted 50 mL tubes and 
placed under anaerobic conditions for at least an hour to remove oxygen. One 
colony per 50 mL tube was used to inoculate the BHI broth, which was then 
incubated anaerobically for ~16 hours. As the growth characteristics for C. 
difficile varied between strains, this time needed to be adjusted and optimised for 
each strain used. When the broth appeared cloudy (with an OD of 0.8-1.0), the 
tubes were centrifuged at 3,000 rpm for 20 min to collect the cells. Supernatants 
were discarded and cell pellets were then resuspended in ice-cold 50 mM 
Tris:HCl pH 7.4. Ten mL was used per tube. The resuspended bacteria was 
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combined into 4 tubes containing 30 mL each. These tubes were again 
centrifuged at 3,000 rpm for 20 min and pellets were resuspended in ice-cold 50 
mM Tris:HCl pH 7.4. This was then combined into 2 tubes of 20 mL each and 
centrifuged at 3,000 rpm for 20 min. Cell pellets were then resuspended in 20 
mL room temperature 8 M urea/50 mM Tris:HCl pH 8.3, supplemented with 
complete protease inhibitor cocktail and incubated for 90 min at 37°C. The 
mixture was centrifuged at 12,000 rpm for 30 min and the supernatant, which 
contained the crude S-Layer, was collected. The extract was stored at -20°C until 
ready for dialysis.  
 
2.3.5 Dialysis of crude S-layer proteins 
The crude extract was dialysed against 20 mM Tris:HCl pH 8.5 to remove urea 
from the mixture. Slide-A-Lyzer® G2 Dialysis Cassettes with a Membrane 
Molecular-Weight Cut-off (MWCO) of 10 K were used, being submerged in 5 L 
of buffer. Buffer was changed every 2 hours, with a total of 4 buffer changes. 
The dialysed sample was then filtered using a Polyethersulfone (PES) Membrane 
filter with a pore size of 0.2 µm and aliquoted into 10 mL tubes. The sample was 
stored at -20°C. 
 
2.3.6 Fast Protein Liquid Chromatography (FPLC) 
Fast Protein Liquid Chromatography (FPLC) is a form of liquid chromatography 
used to separate specific proteins from a mixture by the concept of anion 
exchange. The crude protein mixture is injected into an anion exchange column, 
where the proteins bind tightly. Buffer is then run through the column with an 
increasing salt gradient, and over time the proteins are displaced from the 
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column, at a rate dependent on their affinity to the charges on the column. 
Therefore different proteins are eluted at different time points. 
 
Surface Layer Proteins (SLPs) were purified by FPLC using the MonoQ 
HR10/10 anion exchange column attached to the AKTA FPLC system. SLPs 
were eluted with a linear gradient of 0-0.3 M NaCl in 20 mM Tris HCl pH 8.5 at 
a flow rate of 4 ml/min. Fractions of 2 mL were collected. Large peaks in UV 
readings on the column related to collected fractions that contained a significant 
amount of protein. As the SLPs of each strain used varied in size, adjustment of 
the parameters in the UNICORN software were required for each strain to ensure 
optimal elution of the SLPs. The parameters are listed in Table 2.3.1 below.  
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Table 2.3.1 
Parameter Setting 
Pressure Limit 4.00 MPa 
UV Averaging Time 5.10 
Flow Rate 4.00 mL/min 
Starting Conc. Buffer B 0.00% B 
Equilibrate with 1 CV (Column Volume) 
Flowthrough Fraction Size 0.00 mL 
Start Flowthrough at NextTube 
Empty loop with 10.0 mL 
Wash Column with 5 CV 
Start Frac at 60% B 
Eluate Fraction Size 2.0 mL 
Starte Eluate Frac at FirstTube 
Peak Frac Size 0.00 mL 
Start Peak Frac At NextTube 
Peak Start Slope 100.00 mAU/min 
Peak End Slope 75.00 mAU/min 
Minimun Peak Width 0.31 min 
End Frac At 100% B 
Target ConcB 1 60% B 
Length of gradient 1 20 CV 
Target Conc B 2 100% B 
Length of Gradient 2 4 CV 
Target Conc B 3 100% B 
Length of Gradient 3 2 CV 
Conc of Eluent B 100% B 
Clean with  5 CV 
Reequilibrate with 2 CV 
 
Table 2.3.1 Table of all variable paramaters in FPLC analysis 
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2.3.7 SLP Purification – SDS-PAGE 
Polyacrylamide Gel Electrophoresis was used to visualise the presence of 
proteins in the collected fractions and determine those in which purified SLP was 
present. Protein samples were diluted in 5x Loading Buffer supplemented with 
Dithiothreitol (DTT). Samples were heated to 96°C for 5 min to denature any 
protein structures and allowed to cool to room temperature. Stacking and 
Separating Gels were made. Gels were 10% acrylamide.  APS (10%) and 
TEMED were added last with gentle swirling to induce setting. The PageRuler™ 
Plus Prestained Protein Ladder (Fermentas) was run alongside all protein 
samples as a size indicator. Two bands appearing at around 32 kDa and 44 kDa 
in the same lane indicate the presence of SLPs. Gels were submerged in 1x 
Running buffer and electrophoresis was carried out at 30 mA per gel for 
approximately one hour, until the dye front reached the base of the gel. Recipes 
for all solutions are given in the Appendix. 
 
2.2.8 Coomassie Staining 
Once electrophoresis was complete, gels were washed with dH2O and submerged 
in 10 mL of Coomassie Blue stain. The gels were then left on a rocker for 1 hour 
to stain any protein bands present, then the coomassie stain was removed and the 
gel was washed briefly with dH2O. 10 mL of destain solution was added to the 
gels. They were placed on the rocker for 10 min before replacing the buffer with 
fresh destain. This was repeated four times. The gels were then left rocking in 
destain overnight at 4°C. Gels were then examined for the presence of SLPs. 
 
 
58 
 
2.2.9 Concentration of purified SLPs 
Relevant fractions containing pure SLPs were collected and pooled together. 
They were then concentrated down to a volume of ~200 μL using Amicon Ultra-
4 filter unit centrifuge tubes. Samples were spun at 4000 rpm for 30 min to 
achieve this reduction in volume. Samples were then collected and exposed to a 
UV light for 15 min to ensure sterilisation. SLPs were then aliquoted and stored 
at -20°C until ready for use.  
 
2.2.10 Confirmation of slpA Sequences 
The strains used in this study included R13537 (RT 001) and R12885 (RT 014). 
In these strains the sequence of the slpA gene has been previously determined 
(accession numbers DQ060626 and DQ060638 respectively). To determine the 
slpA gene sequences of our clinical strains belonging to ribotypes 027 and 078, 
whole-genome sequencing was performed at Trinity College Dublin. 
 
2.3.11 LAL Endotoxin Testing of SLPs  
SLP samples were tested for the presence of endotoxin, to ensure any observed 
immune response was not due to contaminants. The ToxinSensorTM 
Chromogenic LAL Endotoxin Assay Kit from GenScript was used, as Limulus 
amebocyte lysate (LAL) reacts with bacterial endotoxin and lipopolysaccharide. 
A series of standards were made from 1 EU/mL (endotoxin unit/mL) endotoxin 
stock solution, yielding standards of 0.1, 0.05, 0.025 and 0.01 EU/mL. Standards 
and samples (100 μL) were placed in specific endotoxin-free vials in duplicate. A 
blank of LAL reagent water was also prepared. LAL (100 μL) was added to each 
vial and the samples were incubated at 37°C for 10 min. Chromogenic substrate 
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solution (500 μL) was then added, the samples were gently mixed and incubated 
for 6 min. Stop solution (500 μL) and colour stabiliser were added and samples 
were gently swirled to avoid generation of bubbles. Absorbance was read at 545 
nm and the amount of endotoxin present in the samples determined from the 
standard curve. Assays were run in duplicate and included a reagent diluent only 
well. Endotoxin testing was carried out on two representative preparations of 
SLPs and subsequent SLP preparations were carried out under the same 
conditions. 
 
2.3.12 SLP Quantification 
The concentration of SLP samples was determined using the Pierce® BCA 
(bicinchoninic acid) Protein Assay Kit. The assay uses the well-documented 
reduction of Cu+2 to Cu+1 by protein in a base, along with the colourimetric 
detection of Cu+1 using bicinchoninic acid (BCA). A purple colour is observed in 
the presence of protein, with darker colour signifing a higher concentration. A 
BSA (Bovine Serum Albumin) standard curve was prepared in 20 mM Tris:HCl 
pH 8.5 from a 2,000μg/mL BSA stock solution using serial dilutions to yield 
standards at 2,000, 1,500, 1,000, 750, 500, 250, 125, 25 and 0 μg/mL BSA. Each 
standard and sample (25 μL) were added to a 96 well plate in triplicate. BCA 
Working Reagent (200 μL) was added to each of the wells and the plate was 
placed on a shaker for 30 seconds. The plate was covered and incubated at 37°C 
for 30 min. Samples were allowed to cool to room temperature and absorbance 
was read at 562 nm on a plate reader. A standard curve was constructed using the 
blank-corrected absorbance values for each standard vs. its concentration in 
μg/mL. Unknown samples were calculated from the standard curve. 
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2.4 CELL CULTURE AND STIMULATION 
2.4.1 J774 Macrophage culture 
The J774 macrophage murine cell line were grown in T75 cell culture flasks 
using DMEM (Dulbecco's Modified Eagle Medium), supplemented with 10% 
FCS (Fetal Calf Serum) and 2% Pen/Strep (a mixture of penicillin and 
streptomycin). FCS was heat-inactivated to inactivate complement. Cells were 
grown at 37°C in 5% CO2 in a humidified incubator. When cells reached ~90% 
confluence, adherent cells were removed gently scraping the flask with a sterile 
cell scraper. Cell suspension was collect in a 50 mL centrifuge tube and 
centrifuged at 1,200 rpm for 5 min. The resulting cell pellet was resuspended in 5 
mL of fully supplemented RPMI and split into new culture flask with fresh 
media. 
 
2.4.2 Bone Marrow-derived Dendritic Cell Culture  
BALB/c mice (10-14 weeks of age) were sacrificed and hind legs were removed. 
Flesh and muscle were carefully removed from the leg bones and bones were 
stored in RPMI (Roswell Park Memorial Institute) media on ice. All flesh was 
removed from the bones, the femur was cut above the knee and below the hip to 
expose bone marrow. A syringe with a 27.5 G needle was filled with RPMI and 
used to flush the bone marrow out of the femur into a sterile petri dish. The same 
process was repeated for the tibia. All bone marrow was collected in a single 
petri dish. A fresh sterile 10 mL syringe with a 19 G needle was used to collect 
the bone marrow, which was placed in a 50 mL centrifuge tube. This was 
centrifuged at 1,200 rpm for 5 min. Cells were resuspended in 5 mL of media 
and a cell count was performed. Enough media was added to the cells to load 1 
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mL of cells per plate. RPMI supplemented with GM-CSF (Granulocyte 
macrophage colony-stimulating factor) was prepared, with 9 mL required for 
every plate used. Cells were plated and incubated at 37°C in 5% CO2 in a 
humidified incubator for 3 days. Media (7 mL) was removed from each plate and 
10mL of fresh RPMI/GM-CSF was added. Cells were incubated for 4 days. Cells 
were then removed from dishes with a sterile cell scraper, collected in a single 50 
mL centrifuge tube and centrifuged at 1,200 rpm for five min. A cell count was 
performed and cells were plated at 0.5x106 cells/mL. 
 
2.4.3 CD4+ T cell Culture 
BALB/c mice (10-14 weeks of age) were sacrificed and the spleen was removed. 
All fat was removed from the spleen, which was then placed on a 40 µm nylon 
cell strainer (BD) above a 50 mL tube. The strainer was moistened with RPMI 
media. A sterile Pasteur pipette was filled with media, and was used to apply 
pressure to the spleen, breaking apart the tissue. Media (20-30 mL) was used to 
homogenise the tissue through the cell strainer. Homogenised splenocytes were 
then decanted through a fresh 40 µm strainer to remove any excess fat or debris. 
Splenocytes were centrifuged at 1,200 rpm for 5 min at 4˚C and the supernatant 
was aspirated. Cells were resuspended in 10 mL media and a cell count was 
performed as previously described. Cells were adjusted to a concentration of 
1x108 cells/mL using recommended media (PBS/2%FBS/1 mM EDTA).  
 
The EasySep™ Mouse CD4+ isolation kit was then used to purify CD4+ cells. 
Two mL of cells were placed in a 5 mL polystyrene tube and 100 µL of Normal 
Rat Serum was added (50 µL/mL of cells). 100 µL of EasySep™ Mouse CD4+ T 
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Cell Isolation Cocktail was added and mixed well. Cells were incubated at room 
temperature for 10 min. After vigorous vortexing, EasySep™ Streptavidin 
RapidSpheres™ were added at a concentration of 75 µL/mL of cells. The 
suspension was mixed well and incubated at room temperature for 2.5 min. The 
final volume of the cell suspension was brought to 2.5 mL. The polystyrene tube 
was placed in the EasySep™ Magnet and incubated for a further 2.5 min. The 
magnet was then inverted in one continuous motion, and the cells were collected 
in a new sterile polystyrene tube. A cell count was then preformed to determine 
concentration.  
 
2.4.4 CD4+ T cell/Dendritic Cell co-culture 
Dendritic cells were grown as previously described. At Day 7 of the culture, 
Cells were plated at 1x106 cells/mL and stimulated with SLPs (20 µg/mL) and 
LPS (100 ng/mL). Cells were then activated with OVA peptide (5 µg/mL). Cells 
were then incubated for a further 24 hours at 36˚C in 5% CO2. After 24 hours, 
cells were washed in PBS/2%FBS, and irradiated (at Trinity College Dublin, 
under supervision) with 40 Gy (4000 rads) using a gamma irradiator with a 
Cesium-137 source. Cells were then resuspended at a concentration of 2x105 
cells/mL. OVA-specific CD4+ T cells were isolated from OVA transgenic 
D011.10 mice as previously described. These T cells are specific to OVA peptide 
and can be activated by dendritic cells displaying OVA. OVA-specific T cells 
were adjusted to a final concentration of 2x106 cells/mL. Dendritic cells (100 μL) 
and 100 µL of T cells were added to a 96 well plate to give a final volume of 200 
µL/well. Cells were cultured for 5 days at 37˚C in 5% CO2. At Day 5, cells were 
centrifuged and 200 µL of media was carefully removed. Cell pellets were 
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resuspended in 200 µL of fresh media, and incubated further until day seven. At 
day six, fresh dendritic cells were stimulated with LPS, SLP and OVA in the 
same manner as before, and incubated for 24 hours. At day seven, cells were 
again centrifuged and 100 µL of media was removed. The dendritic cells were 
again irradiated and 100 µL (at 2x105 cells/mL) was added to the wells for the 
second round of T cell stimulation. Cells were incubated until day 10, when 
media was removed for cytokine analysis. 
 
2.4.5 Cell Enumeration  
Cell counts and viability tests were performed using a haemocytometer and 
trypan blue dye. When a cell population is mixed with the dye, live cells with 
intact membranes can exclude the dye from the cytoplasm, while dying cells with 
permeable membranes allow the dye to enter the cell. Live cells will appear with 
a bright halo around them, while dead/dying cells appear dark blue. The number 
of viable cells, as well as cell viability can then be calculated. A moistened 
coverslip is placed over the haemocytometer. Cell suspension (100 µL) was 
added to 250 µL Trypan blue dye and 150µL PBS and incubated at room 
temperature for 2 min. The cell suspension was then applied to the BrightlineTM 
Neubauer haemocytometer (Sigma) and the cells were drawn into the chamber 
by capillary action. Cells inside the 1 mm2 grid were counted and averaged under 
10x magnification using a phase contrast microscope (Figure 2.4.1). Cell number 
was then counted using the formula: Cells/mL = N x D (x104), where N = 
average cell number and D = dilution factor.  
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Figure 2.4.1 
 
Figure 2.4.1 Haemocytometer used for cell enumeration. 
 
2.4.6 Cell Stimulation 
As previously described, cells were plated at a density of 0.5x106 cells/mL, and 
incubated until adhered to the base of the well. Cells were stimulated with SLPs 
from all available ribotypes at a concentration of 20 μg/mL for 24 hours. Cells 
were also stimulated with LPS at a concentration of 100 ng/mL as a positive 
control. Control cells were incubated in media alone. After 24 hours, supernatant 
and cells were collected. Supernatant was stored at -20°C until required. 
 
2.4.7 Enzyme Linked Immunosorbant Assay (ELISA) 
Enzyme Linked Immunosorbant Assay (ELISA) is a technique for used for the 
detection and quantification of proteins in cell supernatant. Sandwich ELISAs 
were used for all studies. Immunoassays for the detection of IL-1β, IL-2, IL-4, 
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IL-10, IL-12p40, IL-12p70, IL-23 and TNFα were carried out. R&D Systems 
DuoSet ELISA kits were used in each case, with the designated protocol being 
optimised where necessary. Capture antibody, specific for the target molecule, 
was diluted in PBS to a concentration of 2 μg/mL, and coated on a 96-well plate. 
Plates were covered and incubated overnight at room temperature. Plates were 
then washed three times with wash buffer (PBS/0.05% Tween 20) and blocked 
for two hours with 300 μL of blocking buffer per well. This ensured that any 
areas of non-specific binding on the antibody were effectively blocked. A series 
of standards for each cytokine being assayed was prepared from a stock solution, 
diluted in reagent diluent (1% BSA in PBS). Plates were washed 3 times and 
samples and standards were added to the plate in duplicate. ELISA plates were 
then incubated overnight at 4°C. Biotinylated detection antibody was diluted in 
reagent diluent to a working concentration of 50 ng/mL. The plates were washed 
three times and 50 μL of Detection Antibody was added per well. Plates were 
incubated for two hours at room temperature to ensure maximum binding of the 
detection antibody to the target molecule. Plates were again washed and a 1/200 
dilution of streptavidin-HRP was prepared. Streptavidin-HRP (50 μL) was added 
per well and plates were covered and incubated for 20 min at room temperature 
and then washed. Streptavidin has a high affinity for biotin, therefore the amount 
of HRP present after washing is proportional to the amount of target protein 
HRP-substrate (50 μL), Tetramethylbenzidine (TMB), was added per well. Plates 
were incubated in the dark at room temperature for 20 min. HRP catalyses the 
oxidation of the TMB substrate, and a blue compound is formed. The intensity of 
the colour is proportional to the concentration of the target protein. The reaction 
was stopped by addition 25 μL of 2 N H2SO4 per well to prevent further 
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oxidation. Absorbance was read at 450 nm. A standard curve was constructed 
using absorbance values for each standard vs. its concentration in μg/mL. 
Unknown samples were calculated from the standard curve. In the case of IL-1β, 
TBS instead of PBS was used. 
 
2.4.8 Flow Cytometry 
Flow cytometry is a technique that allows cells in solution to be individually 
analysed by focusing a stream of cells through a laser, one cell at a time. Cell 
size and density can be determined by the nature of the scattered light. Specific 
cell surface markers can be targeted and analysed using monoclonal antibodies 
conjugated to flurochromes, which absorb and emit light of specific wavelengths. 
Excitation of the flurochromes is caused by absorption of laser light and the 
resultant scattered light is collected in photomultiplier tubes (PMT). These PMTs 
measure fluorescence intensity and side scatter, a measure of cell granularity and 
density. Cell size is detected at a photodiode in the direct path of the laser in the 
form of forward scatter, where it detects light intensity from the laser directly. 
This process allows for the analysis of individual cells within a mixture of 
multiple populations. 
 
 Cells were plated in 6-well plates at a concentration of 0.5x106 cells/mL to a 
total volume of 2 mL per well. Cells were stimulated with SLPs as previously 
described with the addition of LPS as a positive control and media alone as a 
negative control. A cell scraper was used to gently detach cells from the well, 
and cells and media were collected in a 15 mL centrifuge tube. An equal amount 
of FCS was added, and cells were incubated at room temperature for 15 min. 
67 
 
Cells were then centrifuged at 1,200 rpm for 5 min and resuspended in FACS 
buffer (PBS/2%FCS/0.05%NaN3). One mL of buffer was used per 2 million 
cells. 200 µL of each sample were transferred to a round bottom 96-well plate. 
Plates were centrifuged at 2,000 rpm for 5 min. Relevant antibody was added to 
each well at a concentration of 0.5 µg/1x106 cells. Antibody stock was diluted in 
FACS buffer as required. Treated cells were incubated at 4˚C for 30 min. Cells 
were then washed with 200 µL FACS buffer, and centrifuged at 2,000 rpm for 5 
min. This was repeated three times. Cells were resuspended in FACS buffer and 
transferred to labelled FACS tubes for analysis.  
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2.5 IN VIVO TECHNIQUES 
2.5.1 C. difficile infection of mice  
C57BL/6J mice were infected with C. difficile using an antibiotic-induced model 
of mouse infection (Chen et al. 2008).  Mice were treated for three days with an 
antibiotic mixture of kanamycin (400 μg/ml), gentamicin (35 μg/ml), colistin 
(850 U/ml), metronidazole (215 μg/ml) and vancomycin (45 μg/ml) in the 
drinking water.  Mice were subsequently given autoclaved water. On day 5, mice 
were injected intraperitoneally with clindamycin (10 mg/kg).  Mice were infected 
with 103 C. difficile spores on day six by oral gavage. Initial studies determined 
infection with 103 spores of C. difficile R13537 caused mild transient weight loss 
and diarrhoea in wild-type C57BL/6J strain mice. Animals were weighed daily 
and monitored for overt disease, including diarrhoea. Moribund animals with 
>15% loss in body weight were humanely killed.  The cecum was harvested from 
uninfected and infected mice at days three and seven and the contents were 
removed for CFU counts.   
 
2.5.2 CFU counts 
The contents of cecum were recovered from infected and uninfected mice, 
weighed and stored frozen.  Each sample of cecum material was thawed and 
homogenised in 1 mL PBS (pH 7.4) by vortex mixing in a 1.5 mL 
microcentrifuge tube.  The suspension was serially diluted (10-1 to 10-4) and 50 
μL of each dilution was spread in duplicate onto quadrants of Brazier’s CCEY 
plates (Lab M).  Plates were incubated under anaerobic conditions at 37ºC for 30 
hours.  Colonies were counted and CFU/g determined for each sample.  
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2.5.3 Tissue preparation 
Tissue samples were collected for histological staining, as well as RNA isolation. 
Squares of tissue from the cecum and the distal colon roughly 5 mm3 were cut for 
the preparation of RNA. This tissue was stored in RA1 buffer until required. The 
remaining colon was then cut in half, and the distal colon tissue prepared for 
tissue staining. The colon was cut open along its length and cleaned in PBS. 
Using two pairs of forceps, the tissue was rolled over itself, creating a “swiss 
roll” (Moolenbeek & Ruitenberg 1981), for easily obtaining a cross-section of 
the whole length of tissue. The rolled tissue was embedded in OCT (optimal 
cooling temperature) compound and flash frozen in liquid nitrogen. The tissue 
was stored at -80°C until required for use. 
 
2.5.4 Frozen tissue section preparation 
A drop of OCT was placed on the metal mount. Frozen distal colon sample in 
OCT was carefully placed on the mount and more OCT was added around it to 
adhere it to the mount and left to dry. The mount was placed on the holder and 
set to 10µm thickness. Sample was positioned correctly with arrow buttons. The 
wheel was spun to begin cutting tissue. Once tissue was exposed, the thickness 
was set to 6 µm and samples were taken.  
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2.5.5 RNA isolation and quantification 
All nucleic acid work was carried out in an RNase-free environment, to ensure 
the quality of RNA starting product. RNase degrades RNA; therefore its removal 
from the environment is essential. A dedicated RNA area was established, with 
specific gloves and only pipettes with filter tips being used. PCR grade water 
was used at all times to ensure quality of nucleic acids. 
 
Frozen tissue samples were homogenised using a rotor-stator homogeniser in 
RA1 buffer. RNA was then isolated using the NucleoSpin® RNA II Total RNA 
Isolation Kit (Macherey-Nagel). Homogenised tissue in RA1 buffer (350 µL) 
was placed in a fresh tube and 3.5 µL of ß-mercaptoethanol (ß-ME) was added to 
the sample. The samples were vortexed vigorously. In some cases, the tissue 
remains viscous, and the sample was passed through a 20 G needle to reduce 
viscosity. The samples were placed in Nucleospin® Filters (violet ring) and 
centrifuged for 1 min at 11,000 x g. The filter was then discarded and 350 µL of 
70% ethanol was added and mixed with the samples by pipetting up and down. 
The lysate was then loaded onto a NucleoSpin® RNA II Column (light blue ring) 
and centrifuged for 30 seconds at 11,000 x g. The membrane on the filter was 
then desalted by adding 350 µL Membrane Desalting Buffer (MDB) and 
centrifuged for 11,000 x g for 1 min. Next, the DNA was digested with DNase 
reaction mixture. Ninety-five µL was added to each sample and incubated at 
room temperature for 15 min. RA2 buffer (200 µL) was added to wash the silica 
membrane, and centrifuged for 30 seconds at 11,000 x g. RA3 buffer (600 µL) 
was added to the column and was centrifuged for 30 seconds at 11,000 x g. A 
further 250 µL of RA3 buffer was again added to the column and centrifuged for 
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2 min at 11,000 x g. Finally, RNase-free H2O was pre-heated to 65ºC, and 60 µL 
was added to each sample to elute the RNA. The samples were centrifuged at 
11,000 x g for one minute and the RNA was collected in sterile 1.5 mL RNase-
free centrifuge tubes.  
 
The RNA was then quantified using a NanoDrop Spectrophotometer. The 
absorbance from 230 nm to 600 nm was read for all RNA samples. Sample (1 
µL) was loaded to give quantitative assessment and purity information. An 
A260/A280 ratio close to two is required for optimum RNA purity (due to the 
absorbance of uracil to thymidine). 
 
Examining other absorbance spectra ratios, for example the A260/A230 ratio, 
can give an indication of the presence of contaminants in the sample. For 
example, phenol absorbance will lower the samples A260/A230 ratio. An 
A260/A230 ratio of 1.8-2.2 indicates non-contaminated nucleic acid. 
 
2.5.6 Reverse Transcription-cDNA synthesis 
Synthesis of complementary DNA (cDNA) from mRNA gives a DNA template 
for qPCR. Once quantified, the RNA was then reverse transcribed into cDNA for 
use in qPCR. 1 µg of RNA was used to synthesise cDNA. The components of the 
cDNA master mix are given in the table below. A final volume of 20 µL is 
required for each reaction. A total of 5.8 µL of master mix is required, therefore 
if 1 µg of RNA equates to less than 14.2 µL, the remaining volume is made up 
with RNase-free H2O. Reactions were made up in RNase-free 0.2 mL tubes and 
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placed in the thermal cycler. The reaction is described in Table 2.5.1. cDNA was 
stored at -20˚C until required. 
 
Table 2.5.1 Parameters for cDNA synthesis from RNA. 
 Step 1 Step 2 Step 3 Step 4 
Temp (˚C) 25 37 85 4 
Time 10 min 120 min 5 min ∞ 
 
 
2.5.7 Quantitative Polymerase Chain Reaction 
RNA was isolated from colonic tissue to examine gene expression by real-time 
quantitative Polymerase Chain Reaction (qPCR). This process uses primers to 
bind to a specific region of cDNA and amplify it exponentially using a heat-
stable DNA polymerase. The sequences of all primers used are given in 
Appendix D. The amount of cDNA amplified is quantified in real time and 
allows quantification of the target gene. Quantification can be absolute (total 
copies) or relative. Relative quantification was primarily used in this study, 
where expression is normalised to a control gene. SYBR green intercalating dye 
non-specifically binds to double-stranded DNA, and when it forms a complex 
with qPCR-amplified DNA, it is excited by light of wavelength 492 nm and 
emits light of 520 nm. This allows for the detection of PCR product. The non-
specific nature of SYBR green dye can result in the fluorescence of double-
stranded contaminants, such as genomic DNA, and result in false positives or 
high background. The use of gene-specific probes can prevent this from 
happening. These probes are labelled with a reporter dye and quencher, and 
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exploit the 5’ – 3’ nuclease activity of DNA polymerase to cleave the probe and 
release the reporter dye from the quenching protein, resulting in signal. The cost 
of running a patent protected technique lessens its usability when screening large 
amounts of target genes. 
 
The synthesised cDNA was used for all proceeding PCR reactions using specific 
primers for specific genes. Before gene analysis of cDNA was carried out, 
standard curves were obtained for each set of primers to ensure their quality. A 
1:10 serial dilution of cDNA was made from neat to 10-4. Using the primer of 
interest, a reaction was carried out on the serial dilution of cDNA. The log of the 
dilution factor was plotted against the Cq value to obtain a standard curve. The 
efficiency of the PCR reaction was determined with the slope of the standard 
curve and the equation below. 
 
Efficiency = 10^(-1/Slope) – 1 x 100 
 
An efficiency of 100% means the PCR product is doubling every cycle during 
the logarithmic phase of the reaction. Slopes ranging from -3.60 to -3.20 equate 
to efficiencies of 90-110%, along with an R2 value of >0.95, were considered 
acceptable. 
 
SYBR-Green based detection was used for the majority of qPCR reactions, as an 
initial screening of colonic tissue was required. Initially, the cDNA is heated to 
95˚C to denature the DNA double helix into two separate strands. The mixture is 
then cooled to 55˚C to allow primers to anneal to the target sequences. The 
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temperature is raised to 72˚C, the optimal working temperature of Taq 
polymerase, which then copies the template sequence, forming a double stranded 
DNA sequence. This process is repeated for 40 cycles. The SYBR dye then binds 
to this newly formed double stranded product, and fluoresces at intensity directly 
proportional to the amount of new DNA generated. All samples were normalised 
to a normalisation gene, which is an endogenous control that maintains 
expression levels despite treatment. Two suitable normalisation genes were 
selected to ensure maximum accuracy of the qPCR assays. Ribosomal protein 
s18 and GusB were the normalisation genes selected. All samples were 
normalised to the geometric mean of the normalisation genes Cq values. Samples 
were compared using the comparative Cq method: 
 
  ddCq = dCq sample – dCq reference 
 
dCq sample is the normalised Cq value of the treated sample and dCq reference is 
the normalised Cq value of the control sample. Primers were added at a final 
concentration of 500 mM, and ROX reporter dye was used an internal reference 
signal to account for non-PCR fluorescence occurring in individual wells. All 
samples were run on the ABI Prism 7500 under the following conditions: 
 
Table 2.5.2 Parameters for qPCR reaction. 
 Step 1 Step 2 Step 3(a) Step 3(b) 
Temp (˚C) 50 95 95 60 
Time 2 min 10 min 15 sec* 1 min* 
   * repeat for 40 cycles 
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2.5.8 Haematoxylin & Eosin Staining 
Tissue slides were mounted on the tissue holder and fixed in 75% 
acetone/alcohol for 5 min at room temperature. Slide were then washed in PBS 
for 5 min by dipping up and down, and placed in haematoxylin for 10 min to 
stain the tissue. Excess stain was then removed by placing the tissue under 
running tap water for 5 min, before dipping the slides in 1% acid alcohol for 30 
seconds. The slides were again washed under tap water for 1 min and placed in 
0.1% Sodium bicarbonate for 1 min. Slides were washed under tap water for 5 
min and then rinsed in 95% ethanol for 10 dips. The tissue was then 
counterstained with eosin for 1 min. The sections were then dehydrated by 
dipping in 75% ethanol for 3 min, 95% ethanol for 3 min (x2), 100% ethanol for 
3 min, and then finally in Histoclear for 3 min (x2). Slides were left to dry. 2 
drops of DPX mountant (Sigma-Aldrich) were applied to coverslips and the 
slides were firmly pressed down on them. The slides were then stored at room 
temperature until ready for use.  
 
2.5.9 Neutrophil/Macrophage/CD4+ T cell tissue staining  
An HRP-DAB staining kit (R&D) was used to detect the presence of neutrophils 
in mouse colonic tissue. Tissue sections secured on slides were placed in a 
humidity chamber to prevent drying. The sample was covered in 1-3 drops of 
Peroxidase Blocking reagent for 5 min and then washed with PBS for 5 min. 
Serum Blocking Reagent was added to the tissue for 15 min. Slides were drained, 
but not rinsed, and incubated for 15 min with Avidin Blocking Reagent. Sections 
were then rinsed again with PBS and drained. Biotin blocking reagent was added 
and incubated for a further 15 min, before rinsing again in PBS. A 1/100 dilution 
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of primary antibody (Abcam, anti-NIMP-R14, 15µg/mL) was made and 100 µL 
was added to each tissue section. Samples were incubated for one hour at room 
temperature. The tissue was rinsed with PBS and washed 3 times (15 min/wash). 
Slides were then carefully drained to remove excess buffer. Biotinylated 
Secondary antibody was added to the samples and incubated for 45 min, and the 
tissue was rinsed with PBS and washed 3 times (15 min/wash) with the excess 
buffer then being removed. Samples were incubated for 30 min with Hanks Salt 
Solution with HRP (HSS-HRP), the tissue was rinsed with PBS and washed 3 
times (2 min/wash) with the excess buffer then being removed. 150 µL of DAB 
chromogen was added to each tissue section and incubated for 15 min. Samples 
were rinsed with distilled water, and washed with fresh distilled water for 5 min. 
Excess water was removed and sections were counterstained with haematoxylin 
for 30 seconds, before being rinsed and washed with water. Slides were placed 
vertically on filter paper and mounted with coverslips using DPX mountant. 
Slides were then stored at room temperature until required.  
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Analysis of sequence patterns of Surface 
Layer Proteins from different strains of 
Clostridium difficile 
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3.1 INTRODUCTION 
3.1.1 Modern Synthesis of Evolution – Molecular Evolution: 
Evolution is the change in inherited characteristics of living systems over time 
and through successive generations. The first to propose it were Darwin and 
Wallace, publishing a joint letter in 1858, detailing observed variation within 
species and a natural means of selection (Darwin & Wallace 1858). It was 
proposed that variation within a population would lead to individuals possessing 
traits better suited to the environment than others. These individuals with 
increased fitness would then be selected and not only would these individuals 
survive but they would contribute these advantageous traits to the next 
generation at a greater rate than those less fit. This idea was based on 
observations of morphological characteristics between individuals of a species. 
For example, different sub-species of finches living on the Galapagos displayed 
variation in beak morphology. In each case, the subspecies of finch possessed a 
beak that was well suited for accessing the main food source of that island. 
Darwin postulated that the finches of the Galapagos descended from a common 
ancestral species native to mainland Equador, and that the standing variation in 
the founder population provided the substrate for selection to act on individuals 
in the population of each island (Darwin 1859). This diversification into various 
ecological niches is known as an adaptive radiation event. The discovery of DNA 
as the material of inheritance in the early 20th century and the seminal work by 
Zuckerkandl and Pauling in the 1960’s (Zuckerkandl & Pauling 1965a; 
Zuckerkandl & Pauling 1965b) marked the emergence of a new field of 
evolutionary study that incorporated the use of molecular data as well as 
phenotypic/morphological characters.  
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3.1.2 Mutation Rate, Genetic Drift and Effective Population Size: 
The basis of molecular evolution lies in genetic mutations, where incorrect 
nucleotides added during DNA replication give rise to amino acid substitutions 
which can alter the 3D structure and therefore the function of the protein. 
Zuckerkandl and Pauling proposed the “Molecular Clock” to describe the steady 
accumulation of amino acid substitutions over time (as judged by the fossil 
record) (Zuckerkandl & Pauling 1965b). For the globin gene across a group of 
vertebrate species they recorded the number of amino acid substitutions and 
found a direct correlation between the number of substitutions and the amount of 
time that had elapsed since they last shared a common ancestor (Zuckerkandl & 
Pauling 1965b). The presence of a global molecular clock would have had 
distinct advantages for the modelling of protein change over time, for the 
extrapolation of divergence times in the absence of fossil data, and for the 
prediction of the trajectory of sequence change into the future (e.g. 
epidemiological implications). However, this hypothesis has since been 
disproven and there is no global molecular clock. Many recent studies show 
mutations occurring at variable rates across different species, different proteins, 
different regions of the same protein, and indeed different genomes in the same 
cell (Shuying Li, Dennis K. Pearl 2000; Gu & Li 1992; Yang & Nielsen 1998). 
 
The accumulation of mutations, in the absence of selection, is known as random 
genetic drift. Under the Neutral Theory of evolution, genetic drift is the causative 
agent of evolutionary change (Kimura 1968). The rate at which these neutral 
mutations become fixed in a population is dependent on the effective population 
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size, or Ne (Wright 1938). The probability of a mutation becoming fixed (Px) is 
given by Equation 1: 
 
Equation 1:  Px = ½(Ne) 
 
If Ne is large, then the rate of fixation of random mutations in the population will 
be small. A small Ne will increase the rate at which random mutations become 
fixed (Kimura 1968). In certain cases where population size is severely reduced, 
such as in the event of a population bottleneck, genetic variability within that 
population is reduced (Lynch & Hill 1986). Therefore any mutations that arise 
are more likely to rapidly become fixed in the population (See Figure 3.1). To 
accommodate the accumulation and acceptance of slightly deleterious mutations 
in populations, the Neutral theory was expanded to the “Nearly Neutral Theory 
of Molecular Evolution” (Ohta 1973; Ohta & Gillespie 1996), which is central to 
evolutionary theory today. 
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Figure 3.1 
 
 
Figure 3.1 Fixation of deleterious mutations based on population size 
The probability of fixation of deleterious alleles (Uf) is affected by the strength of selection 
against Uf (s) and the effective population size (Ne). The allele is initially present at frequency 
1/(2Ne). Deleterious mutations will fix more readily in smaller populations (Ne = 10) compared 
to larger populations (Ne = 1000). Taken from (Whitlock & Bürger 2004). 
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3.1.3 Natural Selection: 
Natural selection acts on individuals of a population. Any substitution that 
increases the fitness and reproductive success of an individual in a given 
environment or set of conditions - will result in increased propagation of those 
traits. Over time, and in the absence of a change in selective pressure such as 
environmental shift, the genetic mutation that gave rise to the trait will spread to 
fixation in the population.  
 
Selective pressures can be classified as positive (advantageous to the host) or 
purifying (disadvantageous). Purifying selection works to remove deleterious 
mutations from a population. It is generally held that the majority of coding 
positions are evolving under purifying selection (Hughes 1999).  The importance 
of amino acid sequence on protein structure, and therefore function, places an 
evolutionary restraint on the sequences, limiting the number of viable amino acid 
substitutions (Peterson et al. 2009). However, when Ne is low, and genetic 
variation is reduced, slightly deleterious mutations can become fixed due to 
genetic drift (Figure 3.1) (Whitlock and Bürger 2004). Positive selection occurs 
in cases where an amino acid substitution increases the fitness of an organism, by 
improving the function of the gene on which the mutation occurred. These 
mutations can only occur at specific points on a gene (Nielsen et al. 2005) This 
increased fitness will allow the individual to propagate its genes, and the 
population retains these advantageous mutations in a given set of environmental 
conditions. This has been observed in many mammalian genes to date (Kosiol et 
al. 2008).  
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There has long been debate as to the role of natural selection as the main driving 
force in molecular evolution (Nei 2005). Much of the literature describes the 
majority of amino acid substitutions as neutral or nearly neutral, and “positively 
selected” sites are, in fact, the result of the random fixation of amino acid 
altering substitutions due to population size and genetic drift (Ohta & Gillespie 
1996; Ohta 1973; Kimura 1968). King & Jukes (1969) proposed that the main 
function of natural selection was to eliminate deleterious mutations from a 
population, while advantageous mutations accumulated by the random fixation 
of neutral or nearly neutral mutations. Evidence for positive selection does exist 
however. Many examples are seen in immune-specific genes (Tanaka & Nei 
1989; Su & Nei 2001). For example, positive selection was detected in the 
peptide binding sites of the MHC Class I molecule, with purifying selection 
detected in the non-peptide binding sites (Hughes & Nei 1989). As this molecule 
is essential is distinguishing self-peptides from non-self peptides, greater 
variation in the peptide binding sites will infer an advantage by allowing immune 
cells to display a larger range of pathogenic peptides.  
 
3.1.4 Relationship between Sequence, Structure and Function of a Protein: 
Degeneracy exists in the genetic code, with multiple codons coding for each 
amino acid. Many mutations at the DNA level therefore will not result in an 
amino acid substitution, and these are known as silent mutations. When silent 
mutations occur in the protein coding sequence of a gene they are referred to as 
synonymous substitutions. Mutations that do give rise to an amino acid 
substitution are known as non-synonymous substitutions.  
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The specific 3D conformation of a protein determined by its sequence is of 
extreme importance to its function. It has been shown that certain non-
synonymous substitutions have a measurable effect on the overall structure and 
function of the protein (Peterson et al. 2009; Loughran et al. 2012). As proteins 
tend to have very specific functions, the majority of substitutions will result in a 
partial or complete loss of function (MacArthur et al. 2012). This structure-
function relationship gives rise to an evolutionary constraint where much of the 
protein sequence cannot change is the protein is to remain functional (Peterson et 
al. 2009). Therefore many non-synonymous substitutions will be under purifying 
selection and will be removed from the population. For example a non-
synonymous point mutation in the haemoglobin beta gene will result in sickle 
cell anaemia (Wishner et al. 1975).  
 
The level of positive selection in any given genome is debated and from 
comparative genomic studies in a wide range of species it has been estimated that 
between 20% and 40% of protein coding genes show signatures of positive 
selection (Smith & Eyre-Walker 2002; Kosiol et al. 2008). Recent publications 
have shown a definitive link between positive selection as predicted from protein 
sequences and protein functional shift (Moury & Simon 2011; Loughran et al. 
2012; Levasseur et al. 2006). Loughran et al clearly show positive selection 
resulting in protein functional shift through site-directed mutagenesis on 
positively selected sites in human myeloperoxidase (MPO). They show that the 
novel chlorination activity of MPO was obliterated on mutating the positively 
selected residues (Loughran et al. 2012). This study is particularly salient to this 
chapter as the models employed by Loughran et al (Loughran et al. 2012) to 
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detect selective pressure heterogeneity are identical to those used in this chapter. 
Other studies have also shown this clear link between molecular predictions of 
positive selection and protein functional shift, including the study of the fungal 
lipase/feruloyl esterase A family involving site-directed mutagenesis on sites 
under positive selection showing a loss of function phenotype (Levasseur et al. 
2006). (Moury & Simon 2011) also found a clear link between positive selection 
and functional shift in Potato Virus Y (PVY), where mutation of a specific codon 
resulted in increased virus accumulation in the host. Therefore, protein functional 
shift is synonymous with the signature for positive selection in coding DNA 
sequences (Hughes 1999; Loughran et al. 2012; Levasseur et al. 2006). 
  
3.1.5 Measuring Selective Pressure Heterogeneity: 
Selective pressure heterogeneity is estimated using the ratio of the rate of non-
synonymous substitutions per non-synonymous site (Dn) to synonymous 
substitutions per synonymous site (Ds), i.e., Dn/Ds or ω as it will be referred to 
throughout this chapter.  An ω = 1 indicates neutral evolution, ω < 1 indicates 
purifying selective pressure, and, ω > 1 indicates positive selection. This method 
of estimation of selective pressure is based on the assumption that the rate of 
synonymous substitution acts as a proxy for the rate of neutral evolution or 
genetic drift as these sites are undetectable by natural selection. The assumption 
that Ds is a proxy for genetic drift has been questioned (Du et al. 2014; 
Dimitrieva & Anisimova 2014) and evidence to the contrary has been proposed 
from a comparative genomic analysis of the BRCA1 gene (Hurst & Pál 2001) . In 
this example an elevated ω value was shown to result from purifying selection on 
silent sites (Hurst & Pál 2001). Using sliding window analysis on mouse-rat and 
86 
 
human-dog comparisons of the BRCA1 gene, a particularly low Ds was observed 
to coincide with sites where ω > 1. Therefore it is possible that an estimate of ω 
> 1 may not be indicative of true positive selection, but may result from a 
decrease in Ds as a result of purifying selection on silent sites (Hughes 2007). 
Different sequence alignment methods can give different outputs, impacting any 
reconstructed phylogeny and subsequent positive selection analysis. When 
testing for positive selection, alignment methods with a higher tendency to place 
non-homologous together were found to be error prone, resulting in false 
positives (Blackburne & Whelan 2013). When using Codeml (Yang 2007; Yang 
1998), a small dataset, high sequence similarity, low sequence length can all 
result in false positives (Anisimova et al. 2001; Anisimova et al. 2002). Methods 
of phylogeny construction, such as neighbouring-joining (Saitou & Nei 1987), 
are also much less accurate than Bayesian inference, and can therefore impact on 
positive selection results (Kuhner & Felsenstein 1994). Avoidance of such 
methods will minimise the risk of obtaining false positives. 
 
3.1.6 Methods for Assessing Selective Pressure Heterogeneity: 
Initial methods to detect positive selection included averaging methods for 
estimating Dn/Ds for an entire alignment (Nei & Gojobori 1986; Li et al. 1985) 
and sliding window approaches analysing overlapping regions of the protein 
thereby accounting for variation in mutational rates across regions of the protein. 
Both of these approaches have subsequently proven to be misleading in their 
estimates of the selective pressure at work (Schmid & Yang 2008). For example, 
the sliding window approach involves calculating Dn/Ds ratios across a small 
section, or window, of the alignment (Schmid & Yang 2008). This window then 
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advances by a predefined window shift size, and the Dn and Ds values are 
recorded in each window across the entire protein (Fares et al. 2002). While 
simple in terms of underlying concept and computational requirements, many 
analyses using these approaches have proven over simplistic averaging over all 
sites or all lineages (Endo et al. 1996; Fares et al. 2002). Indeed the issue with 
the sliding window approach is that is it inconsistent, and has been shown to 
generate artifactual trends of synonymous and non-synonymous rate variation 
(Schmid & Yang 2008).  
 
It is clear that modelling a simple Dn/Ds ratio over the entire protein, or over all 
lineages in the alignment, is not biologically realistic and can lead to 
underestimation from over simplification of the process of molecular evolution. 
Given the heterogeneity in mutational rates and selective pressures across 
proteins and lineages and given the lack of precision, accuracy and concern over 
statistical robustness provided by averaging methods and sliding window 
approaches, we have employed a suite of codon models of evolution modelled in 
a maximum likelihood framework (Yang 2007). These models allow for 
variation in selective pressure across sites and across lineages (Goldman & Yang 
1994; Yang & Nielsen 1998; Yang & Nielsen 2002). The various models 
employed are summarized below and are detailed in the materials and methods 
chapter in more detail (Chapter 2). The models are nested and as such they can 
be compared to one another (under strict guidelines) using LRTs (Anisimova et 
al. 2001; Yang 1998). These LRTs compare nested models of evolution and 
allow for variable Dn/Ds ratios among sites in a sequence (“site-specific 
models”), along branches in a phylogenetic tree (“branch models”), or a 
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combination of both (“site-branch models”). Each of the models differs in 
complexity by the addition of extra parameters. Each model allows for a number 
of classes of sites in the sequences, for example, the nearly neutral model M1a 
allows two site classes where ω = 0 and ω = 1. The model that best fits the data 
(i.e. best describes the observed pattern of substitution in the sequences) is 
identified by the LRT. In general, one model is constrained so that ω ≤ 1. 
Another model will allow at least one class of sites where ω is estimated from the 
data. Under these circumstances, if ω > 1, and following the appropriate LRT 
there is a  statistically significant increase in likelihood value relative to the 
simpler model, then the simpler model is rejected and positive selection is 
invoked (statistical significance is estimated using the chi-squared distribution). 
The significance of the difference in likelihood score between the models (Δln) 
can be tested by comparing 2 Δln with χ2υ, where υ is equal to the degrees of 
freedom (df). The df corresponds to the number of free parameters between the 
models being compared.  
 
3.1.7 Positive selective pressure as a predictor of functional change between 
C. difficile subtypes.   
In the case of C. difficile infection (CDI), the severity of disease, and observed 
symptoms, can vary greatly, depending on the strain causing the infection 
(Dawson et al. 2009). Particular strains, such as ribotypes 027 and 078, have 
been associated with more severe disease, and as a result have been dubbed 
‘hypervirulent’ (Goorhuis et al. 2008; Marsh et al. 2012; Clements et al. 2010). 
These strains have also been associated with higher rates of recurrent infection 
(Marsh et al. 2012). The SLPs, encoded by the slpA gene, exhibit variability 
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between strains (McCoubrey & Poxton 2001) We have previously shown the 
ability of SLPs from RT 001 to induce an inflammatory response in vitro (Ryan 
et al. 2011; Collins et al. 2014). We set out to elucidate if patterns of substitution 
within the SLPs contributed to the fitness of the pathogen as measured by 
disease/infection profile of the strain.  
 
In patients infected with C. difficile, recovery usually occurs within seven days, 
with the host immune response successfully clearing the pathogen 
(Kachrimanidou & Malisiovas 2011). An efficient host response relies on 
recognition of the pathogen, and this may be achieved through specific pathogen 
recognition signatures on the SLP sequence. We know from a previous study of 
C. difficile RT 001 that SLPs activate the immune system through TLR4 (Ryan 
et al. 2011). Given the variability observed in the SLP coding sequence between 
ribotypes it is possible that the TLR4 affinity for SLP may also vary across 
ribotypes. A similar relationship between SLP sequence and immune recognition 
has been observed by Thompson (2002). If the host response is initiated through 
recognition of a specific protein signature on the bacterial SLP, then altering the 
sequence of this protein may impact upon recognition of the pathogen. By 
determining if the genes coding for SLPs from different strains are undergoing 
positive selection, we may gain further insight into the pathogenic role of SLPs 
in infection. 
 
By identifying specific proteins, or regions within proteins, under positive 
selection in C. difficile we are pinpointing the specific amino acid adaptations 
that enable the organism to better survive its environment. Our hypothesis is that 
90 
 
the variation in the SLPs from C. difficile is not solely due to genetic drift, and 
that this variation is increasing the fitness of the organism. As we know SLPs 
activate the immune system to induce an inflammatory response, we propose that 
positive selection of SLPs from specific strains will modulate the recognition and 
response to the pathogen. Therefore SLP sequence will play a role in disease 
severity. To test this, we first compile a dataset of slpA sequences from different 
strains of C. difficile, align these sequences and construct a phylogenetic gene 
tree, after which we test from signatures of positive selection in the slpA genes. If 
our hypothesis is true, we will expect to detect positive selection in the more 
virulent strains of C. difficile, suggesting a role for slpA sequence in disease 
severity. If it is false, we would not expect to detect positive selection in these 
strains, with sequence variation being a product of random genetic drift. 
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3.2 RESULTS 
3.2.1 SlpA Multiple Sequence Alignment  
Sequences used in the analysis are detailed previously in Table 2.2.1. In some 
cases, there are multiple identical representatives for the same ribotype. The 
multiple sequence alignment of the slpA gene resulted in 2652 aligned nucleotide 
positions (884 codon positions). The first 24 residues in the alignment appear 
highly conserved, representing the signal peptide involved in transport of the 
SLPs to the surface of the cell, as seen in Figure 3.1. The next 300 residues 
represent the LMW protein, and a high level of variability is seen, with many 
indel events. In comparison, positions 350 to 430 in the alignment are more 
highly conserved and represent the HMW SLP-binding domain. Region 450 – 
650 represents a highly conserved region of the HMW subunit, while region 750 
– 800 displays a more variable region of the HMW SLP. Position 27 to 430 
represents the LMW portion of slpA and 431 to 883 represent the HMW SLP, 
Figure 3.1 displays the full alignment.  
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Figure 3.1 
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Figure 3.1 Multiple Sequence Alignment of SlpA The complete amino acid sequences for the 
slpA protein from 26 different strains of C. difficile aligned using MUSCLE 3.6 (Edgar 2004). 
Sequences from ribotypes 001, 002, 005, 010, 012, 014, 016, 017, 027, 031, 046, 054, 066, 092 
and 094 are present. The first 24 peptides represent the conserved signal peptide. Residues 25 – 
430 represent the variable LMW SLP, while positions 430 – 883 represent the HMW SLP. 
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3.2.2 slpA Likelihood Mapping 
Likelihood mapping tests were performed using TreePuzzle v5.2 (Schmidt et al. 
2002) to determine if there was sufficient phylogenetic signal present. This 
software breaks the phylogenetic tree into all possible quartets and assesses the 
support for each quartet (Strimmer & von Haeseler 1997). If the data contains no 
phylogenetic signal, then the likelihood of all three possible relationships for that 
quartet will be equally likely, represented by populations of the three tips of a 
triangle, seen in Figure 3.2. If sufficient phylogenetic signal is present, the 
majority of the signal will appear in these tip regions. If little or no phylogenetic 
signal is present, the majority of the signal will be in the vertices and central 
region of the triangle, representing a network or star phylogeny respectively. 
96.8% of signal appeared in the corners of the triangle, indicating sufficient 
signal for phylogenetic analysis to be carried out on the sequences. The results 
can be seen in Figure 3.2. 
 
Analysis of amino acid composition bias was also carried out on the sequences. 
This was to determine if sequences were being falsely grouped together on the 
phylogeny due to similar amino acid frequencies rather than recent shared 
history. There is much evidence for this problem in the literature (Loomis & 
Smith 1990; Penny et al. 1990; Hasegawa & Hashimoto 1993). The composition 
of each sequence was compared to the frequency distribution assumed in the 
model of evolution (Schmidt et al. 2002). All sequences passed this test, 
indicating that there was no composition bias to negatively impact the 
phylogeny. The results of the amino acid composition bias tests can be seen in 
Table 3.1.  
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Figure 3.2 
 
 
Figure 3.2 Likelihood Mapping Results for SlpA 
Results of the likelihood mapping tests for the level of phylogenetic signal in the dataset.  The 
vast majority of the signal (> 96%) appears in the corners of the triangle, and are evenly 
distributed across all three corners, indicating there is sufficient phylogenetic signal within the 
dataset for the analysis to be carried out. 
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Table 3.1 
Sequence 5% Chi-Squared Test p-value 
DQ060633 Passed 99.99% 
AF478571 Passed 100.00% 
DQ060628 Passed 92.86% 
DQ060629 Passed 92.86% 
AF478570 Passed 95.22% 
DQ060630 Passed 95.22% 
DQ060631 Passed 95.22% 
DQ060632 Passed 96.48% 
DQ060638 Passed 99.95% 
DQ060639 Passed 99.95% 
DQ060625 Passed 99.99% 
DQ060626 Passed 99.99% 
DQ060627 Passed 99.99% 
AJ300676 Passed 99.99% 
R20291 Passed 99.92% 
CD196 Passed 99.92% 
DQ060641 Passed 99.99% 
DQ060642 Passed 99.99% 
DQ060643 Passed 100.00% 
DQ060634 Passed 100.00% 
DQ060635 Passed 100.00% 
AJ291709 Passed 100.00% 
DQ060636 Passed 100.00% 
DQ060637 Passed 100.00% 
DQ060640 Passed 99.95% 
AJ300677 Passed 99.95% 
 
Table 3.1 Results of test for compositional heterogeneity. The amino acid composition of all 
sequences was calculated and compared with the frequency distribution assumed in the maximum 
likelihood model.  
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3.2.3 Phylogenetic Trees 
The dataset consisted of slpA genes from 29 isolates of C. difficile representing 
16 ribotypes and 886 aligned amino acid positions. The Bayesian phylogenetic 
trees of the gene were constructed using both MrBayes v3.1.2 (Huelsenbeck & 
Ronquist 2001) and PhyloBayes v3 (Lartillot et al. 2009). Both programs 
produced statistically identical trees (See Appendix for statistical analysis). A 
radial phylogram was produced using the Dendroscope software (Huson et al. 
2007) and is shown in Figure 3.3 below. Ribotypes with very short branch 
lengths since divergence from their common ancestor are given as clusters at the 
tips of branches. Branch lengths are proportional to amount of evolutionary 
change. Support values for each branch are given as posterior probabilities (PP), 
and were found to be the maximum possible value (i.e. 1.00), except where 
otherwise specified on the tree. The phylogeny shows that the hypervirulent RT 
027 is closely related to RT 001, with RT 001 being a particularly common strain 
in Ireland. 
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Figure 3.3 
 
 
Figure 3.3 Phylogenetic tree of SlpA  
Phylogenetic tree of the SlpA protein from 16 major ribotypes of C. difficile, reconstructed using 
MrBayes (Huelsenbeck & Ronquist 2001). The ribotypes are labelled using conventional 
numbering system. Ribotypes with very short branch lengths since divergence from their 
common ancestor are given as clusters at the tips of branches. Branch lengths are proportional to 
amount of evolutionary change. All but three nodes had the maximum posterior probability value 
(PP) = 1.00: two of these values are shown in red italics on the tree - 0.99 and 0.89. The final 
exception was the node joining 046 and 092, where * denotes PP of 0.82.  
 
 
 
 
 
0.99 
0.89 
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3.2.4 Selective Pressure Analysis 
Both the alignment and phylogenetic tree were used to determine selective 
pressure variation along the alignment. Dn/Ds ratios were estimated using 
maximum likelihood at both site-specific and lineage-specific levels. The site-
specific analysis used 8 models. M1 gave a InL value of -16,292.610. Model M2, 
had an InL = -16,242.808. When an LRT was carried out between M1 and M2, 
M2 was found to be a significantly better fit for that data then M1 (2Δl = 99.604, 
P<0.05). As M2 predicted sites of positive selection on slpA, this shows that a 
model allowing for, and predicting, positive selection (M2) fit the data better 
than neutral models (M1). M0 had an InL value = -16,877.369 and an ω = 
0.1440, meaning that under this model purifying selection is invoked. Both M3 
(k=2) and M3 (k=3) gave better likelihood scores than the previous models, InL 
= -16,210.101 for M3 (k=2) and InL = -16,098.846 for M3 (k=3). The difference 
in likelihood between M3 (k=2) and M0 was statistically significant (2 Δl = 
1334.535, P<0.05), as was the difference in likelihood values between M3 (k=3) 
and M3 (k=2) (Δl = 111.254). Model M8 gave the lowest InL value of all the 
models at InL = -16,052.155. M8 was compared with both M7 and the null 
model M8a with two independent LRTs, and proved statistically more significant 
than either of the rested models. A 2Δl = 106.64 for M7 v M8, and a 2Δl = 87.17 
for M8a v M8 was calculated. Therefore, M8 is the site-specific model that best 
fits the data and gives the highest likelihood.  Under this model, 44 amino acid 
sites in total were estimated to be undergoing positive selection (ω = 0.5). A 
summary of all LRTs is given in Table 3.2. A summary of the models used along 
with estimated sites under positive selection are given in Table 3.3 for site-
specific models and in Table 3.5 for lineage-specific. A 3-D model of the LMW 
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SLP was obtained from PDB (accession number: 3cvz) to visualise the spatial 
positioning of positively selected amino acid residues (Figure 3.4) (Fagan et al. 
2009).  
 
The portion of the alignment representing the LMW protein-coding region was 
highly variable between strains. Site-specific analysis showed that residues 
estimated to be positively selected were largely located within a loop-rich region 
in domain 2 of the LMW portion of the gene. 
 
The lineage-specific analyses yielded a more complex story. All lineages under 
selection can be seen in Figure 3.5. On a number of branches, positive selection 
was seen to be occurring in the HMW protein-coding region, an area of the gene 
that is well conserved across the strains in the dataset, see alignment (Figure 3.1). 
The vast majority of branches with evidence of positive selection have their 
positively sites restricted to the HMW protein, however 4 branches (branch 
numbers 7, 9, 11 and 12) exhibited positive selection in the LMW protein. 
Branches 9, 11 and 12 all estimate a small number of sites in the LMW SLP to 
be under selection, with branches 11 and 12 leading to hypervirulent RT 017 and 
078 (Table 3.4 and Figure 3.5). Branch 3 (RT 002) estimated 11 sites under 
positive selection in the LMW and 41 sites in the HMW of the SLP (slpA).  
 
Of particular importance here are the results for branch 7, leading to RT 027 
(Table 3.4). RT027 is of clinical importance due to the fact that it is 
hypervirulent (Marsh et al. 2012), and positive selective pressure (and 
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subsequent protein functional shift) may be a contributing factor to its 
pathogenesis.  
 
In total, eight branches show positive selection occurring in the HMW protein, 
including branches leading directly to RTs 010, 002, 005, 031 and 094. This 
indicates that these RTs have been under selective pressure to adapt, and given 
the function of the HMW protein the pressure may have been for improved 
adhesion to the host epithelium (Calabi et al. 2002; Merrigan et al. 2013). There 
are relatively few sites in the LMW region under positive selection for these 
branches. There was no evidence of positive selection in either LMW or HMW 
regions in the common RT 001. 
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Table 3.2 
Branch 
Numbered 
as per 
Fig.3.5 
LRT Null 
Model 
lnL 
Alt Model 
lnL 
ΔInL Critical 
Value 
Null 
Rejected
? 
- m0 vs 
m3Discrtk2 
-16877.36 -16210.10 1334.5 5.99 Yes 
- m1Neutral 
vs 
m2Selection 
-16292.61 -16242.80 99.60 5.99 Yes 
- m3Discrtk2 
vs 
m3Discrtk3 
-16210.10 -16098.84 111.25 1 Yes 
- m7 vs m8 -16105.47 -16052.15 106.64 5.99 Yes 
 m8a vs m8 -16095.74 -16052.15 87.17 2.71 Yes 
1 m1Neutral 
vs modelA 
-16292.61 -16283.29 18.64 5.99 Yes 
1 modelAnull 
vs modelA 
-16287.47 -16283.29 8.36 3.84 Yes 
2 m1Neutral 
vs modelA 
-16292.61 -16287.40 10.40 5.99 Yes 
2 modelAnull 
vs modelA 
-16291.58 -16287.40 8.35 3.84 Yes 
3 m1Neutral 
vs modelA 
-16292.61 -16273.15 38.90 5.99 Yes 
3 modelAnull 
vs modelA 
-16280.23 -16273.15 14.14 3.84 Yes 
4 m1Neutral 
vs modelA 
-16292.61 -16254.53 76.14 5.99 Yes 
4 modelAnull 
vs modelA 
-16271.07 -16254.53 33.07 3.84 Yes 
5 m1Neutral 
vs modelA 
-16292.61 -16279.22 26.76 5.99 Yes 
5 modelAnull 
vs modelA 
-16279.95 -16279.22 1.45 3.84 No 
6 m1Neutral 
vs modelA 
-16292.61 -16292.61 0 5.99 No 
6 modelAnull 
vs modelA 
-16292.61 -16292.61 2x10-6 3.84 No 
7 m1Neutral 
vs modelA 
-16292.61 -16267.49 50.235 5.99 Yes 
7 modelAnull 
vs modelA 
-16292.69 -16267.49 50.40 3.84 Yes 
8 m1Neutral 
vs modelA 
-16292.61 -16286.51 12.18 5.99 Yes 
8 modelAnull 
vs modelA 
-16289.93 -16286.51 6.84 3.84 Yes 
9 m1Neutral 
vs modelA 
-16292.61 -16280.18 24.84 5.99 Yes 
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Branch LRT Null 
Model 
lnL 
Alt Model 
lnL 
ΔInL Critical 
Value 
Null 
Rejected
? 
9 modelAnull 
vs modelA 
-16290.96 -16280.18 21.55 3.84 Yes 
10 m1Neutral 
vs modelA 
-16292.61 -16292.61 0 5.99 No 
10 modelAnull 
vs modelA 
-16292.61 -16292.61 2x10-6 3.84 No 
11 m1Neutral 
vs modelA 
-16292.61 -16289.17 6.88 5.99 Yes 
11 modelAnull 
vs modelA 
-16292.61 -16289.17 6.88 3.84 Yes 
12 m1Neutral 
vs modelA 
-16292.61 -16288.18 8.84 5.99 Yes 
12 modelAnull 
vs modelA 
-16291.48 -16288.18 6.59 3.84 Yes 
13 m1Neutral 
vs modelA 
-16292.61 -16280.74 23.73 5.99 Yes 
13 modelAnull 
vs modelA 
-16289.44 -16280.74 17.39 3.84 Yes 
14 m1Neutral 
vs modelA 
-16292.61 -16287.18 10.84 5.99 Yes 
14 modelAnull 
vs modelA 
-16289.57 -16287.18 4.78 3.84 Yes 
15 m1Neutral 
vs modelA 
-16292.61 -16278.29 28.62 5.99 Yes 
15 modelAnull 
vs modelA 
-16283.81 -16278.29 11.02 3.84 Yes 
16 m1Neutral 
vs modelA 
-16292.61 -16246.06 93.09 5.99 Yes 
16 modelAnull 
vs modelA 
-16269.49 -16246.06 46.86 3.84 Yes 
17 m1Neutral 
vs modelA 
-16292.61 -16291.19 2.83 5.99 No 
17 modelAnull 
vs modelA 
-16291.19 -16291.19 0 3.84 No 
18 m1Neutral 
vs modelA 
-16292.61 -16277.20 30.81 5.99 Yes 
18 modelAnull 
vs modelA 
-16282.83 -16277.20 11.26 3.84 Yes 
 
Table 3.2 Table of Likelihood Ratio test (LRT) results for site-specific and lineage-specific 
models for each branch on the tree. Likelihood values are given for each null and alternative 
model. 
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Table 3.3 
Model P L Estimates of parameters PS sites 
M0 : one ratio 1 -16877.369 ω = 0.144 None 
M1:Neutral 1 -16292.610 p0= 0.617 p1=0.382 
ω0=0.082, ω1= 1.000 
Not allowed 
M2:Selection 4 -16242.808 p0= 0.593 p1= 0.327 
(p2= 0.078) 
ω0= 0.086 ω1= 1.00 
ω2 = 68.753 
BEB 
46 > 0.50 
12 > 0.95 
4 > 0.99 
M3:Discrete(K = 2) 3 -16210.101 p0= 0.460 p1= 0.539 
ω0= 0.031 ω1= 0.355 
 
None 
M3:Discrete(K = 3) 5 -16098.846 p0=  0.382 p1= 0.515 
p2= 0.101 
ω0= 0.018 ω1= 0.245 
ω2= 20.897 
 
None 
M7: Beta 2 -16105.477 p=0.418 q=1.298 Not allowed 
M8: Beta&Omega 
> 1 
4 -16052.155 p0= 0.920 p=0.476 
q=1.960 
p1=0.079  
ω = 29.209 
BEB 
44 > 0.50 
11 > 0.95 
4 > 0.99 
M8a: Beta&Omega 
= 1 
3 -16095.794 p0=  0.871 p = 0.523 
q =  2.949 
p1= 0.128, ω = 1.000 
Not allowed 
 
Table 3.3 Results of Site-specific analysis. All models tested are displayed, along with number of 
parameters, log likelihood scores, estimates of parameters, and number of positively selected 
sites.  
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Table 3.4 
Branch Model P lnL Estimation of parameters PS Sites 
1 A 3 -16283.290 p0 = 0.612 p1= 0.379 
p2 = 0.004 p3 = 0.002 
Background: 
ω0 = 0.081 ω1= 1.000 ω2=1.000 
Foreground: 
ω0 = 0.081 ω1 = 1.000 ω2 = 999.0 
BEB 
3>0.99 
2 A 3 -16287.406 p0=0.613 p1=0.379 
p2=0.004 p3=0.002 
Background: 
ω0=0.081 ω1=1.000 ω2=1.000 
Foreground: 
ω0=0.081 ω1=1.000 ω2=999.0 
BEB 
3>0.99 
3 A 3 -16273.156 p0=0.546 p1=0.325 
p2=0.080 p3=0.047 
Background: 
ω0=0.077 ω1=1.000 ω2=1.000 
Foreground: 
ω0=0.078 ω1=1.000 ω2=305.086 
BEB 
52>0.50 
11>0.95 
1>0.99 
4 A 3 -16254.536 p0=0.534 p1=0.326 
p2=0.086 p3=0.052 
Background: 
ω0=0.076 ω1=1.000 ω2=1.000 
Foreground: 
ω0=0.078 ω1=1.000 ω2=49.513 
BEB 
51>0.50 
21>0.95 
8>0.99 
7 A 3 -16267.493 p0=0.577 p1=0.364 
p2=0.035 p3=0.022 
Background: 
ω0=0.082 ω1=1.000 ω2=1.000 
Foreground: 
ω0=0.082 ω1=1.000 ω2=999.000 
BEB 
15>0.50 
 
8 A 3 -16286.517 p0=0.599 p1=0.369 
p2=0.019 p3=0.012 
Background: 
ω0=0.080 ω1=1.000 ω2=1.000 
Foreground: 
ω0=0.080 ω1=1.000 ω2=65.618 
BEB 
9>0.50 
1>0.95 
9 A 3 -16280.189 p0=0.585 p1=0.366  
p2=0.029 p3=0.018 
Background: 
ω0=0.080 ω1=1.000 ω2=1.000 
Foreground: 
ω0=0.081 ω1=1.000 ω2=998.998 
BEB 
11>0.50 
1>0.95 
 
11 A 3 -16289.170 p0=0.593 p1=0.372  
p2=0.020 p3=0.013 
Background: 
ω0=0.082 ω1=1.000 ω2=1.000 
Foreground: 
ω0=0.081 ω1=1.000 ω2=998.975 
BEB 
3>0.50 
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Branch Model P lnL Estimation of parameters PS Sites 
12 A 3 -16288.187 p0=0.604 p1=0.367  
p2=0.017 p3=0.010 
Background: 
ω0=0.080 ω1=1.000 ω2=1.000 
Foreground: 
ω0=0.080 ω1=1.000 ω2=998.952 
BEB 
6>0.50 
1>0.95 
13 A 3 -16280.744 p0=0.601 p1=0.341  
p2=0.036 p3=0.020 
Background: 
ω0=0.079 ω1=1.000 ω2=1.000 
Foreground: 
ω0=0.079 ω1=1.000 ω2=32.021 
BEB 
18>0.50 
1>0.99 
14 A 3 -16287.185 p0=0.606 p1=0.376  
p2=0.010 p3=0.006 
Background: 
ω0=0.079 ω1=1.000 ω2=1.000 
Foreground: 
ω0=0.081 ω1=1.000 ω2=67.858 
BEB 
3>0.50 
2>0.95 
15 A 3 -16278.296 p0=0.598 p1=0.354  
p2=0.029 p3=0.017 
Background: 
ω0=0.077 ω1=1.000 ω2=1.000 
Foreground: 
ω0=0.078 ω1=1.000 ω2=8.993 
BEB 
12>0.50 
4>0.95 
1>0.99 
18 A 3 -16277.205 p0=0.560 p1=0.337  
p2=0.063 p3=0.038 
Background: 
ω0=0.078 ω1=1.000 ω2=1.000 
Foreground: 
ω0=0.077 ω1=1.000 ω2=94.127 
BEB 
45>0.50 
7>0.95 
2>0.99 
 
Table 3.4 Results of the lineage-specific analysis. All models tested, log likelihood, estimates of 
parameters and sites under positive selection are given for each branch.  
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Figure 3.4 
 
 
 
Figure 3.4. Positively selected residues highlighted on the 3D structure of the LMW SLP. 
The LMW SLP crystal structure was obtained from the EMBL database and positively selected 
sites highlighted. α-helices and β-sheets can clearly be seen along with loop regions. Specific 
amino acids under positive selection are labelled in gold. The majority of sites under positive 
selection can be seen in Domain 2, which is rich in loops. Red asterisks indicate residues with 
probability of greater than 0.9 being under positive selection.  
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Figure 3.5 
 
 
Figure 3.5. The phylogenetic tree of the SLPs analysed and summary of lineages under 
positive selection. Branches in blue correspond to positively selected sites detected in the High 
Molecular Weight (HMW) protein, those highlighted in red correspond to positively selected 
sites in the Low Molecular Weight (LMW) protein. Positive selection was estimated on branches 
leading to ribotypes 012, 017, 027 and 078 for the LMW SLP, while selection in the HMW SLP 
was detected in branches leading to 002, 005, 010, 031 and 094. In all cases the parameters for 
selective pressure analysis were chosen from the codon substitution model that fitted the data best 
following likelihood ratio tests. 
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3.3 DISCUSSION 
C. difficile is an increasingly problematic nosocomial pathogen and the main 
focus of research into its pathogenesis has been cytotoxic protein production. 
Deletions in the toxin regulator TcdC were thought to account for the increased 
disease severity in patients infected with RT 027 (Carter et al. 2011), yet this 
same deletion has been observed to result in a functional TcdC (Dupuy et al. 
2008). Therefore toxin production alone cannot account for such a wide range of 
symptoms observed in different hospitals. We have previously shown that SLPs 
from RT 001 can induce an inflammatory response, specifically through TLR4 
(Ryan et al. 2011). While we know that these proteins do indeed have the 
capacity to induce inflammation, to date no comparative studies have been 
performed on the SLPs of different strains. Little is known of how this sequence 
variability affects the ability of the immune system to recognise and respond to 
C. difficile. The results of this study indicate that the observed sequence variation 
in the SLPs of C. difficile is not entirely random, and many of the observed 
variable sites along the slpA gene are under positive selection. 
 
The 26 isolates in our dataset exhibit vastly different sequences in the slpA gene, 
particularly in the area encoding the LMW protein. The HMW protein was much 
more conserved (Karjalainen et al. 2001) suggesting the importance of structure 
in its role in adherence (Calabi et al. 2002; Merrigan et al. 2013). As the LMW 
subunit is the outermost component of the SLP complex (Fagan et al. 2009), it is 
likely the first part of the bacteria with which immune cells will come into 
contact. Sequence variation between strains suggests that the immune system 
may not be able to recognise SLPs from different strains to the same extent, and 
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this sequence variation may play a role in the vast spectrum of symptoms 
observed in C. difficile Infection. Here we propose that SLP sequence is an 
essential determinant of susceptibility and severity of infection.  
 
Signatures of positive selection were indeed detected in the SLP sequences in our 
dataset, strongly suggesting this variation was not random, and inferred a 
survival benefit to the pathogen. The site-specific analysis showed positive 
selection occurring in the LMW-coding region of the gene. The majority of sites 
estimated with the highest probability (PP>0.95) occur on the outermost region 
of the protein, Domain 2. While the exact residues that interact with TLR4 are 
not known, the position of these positively selected sites make them a potential 
candidate. This region of the protein is likely the most accessible to immune 
cells, as the S-Layer lattice may make other regions inaccessible for recognition 
(Fagan et al. 2009). Amino acid substitutions, particularly at important regions 
involved in recognition, may affect the ability of the host to detect the bacteria 
through SLP-TLR4 interaction. Variation in sequence will likely perturb 
recognition motifs, thereby affecting the recognition and interaction of immune 
cells.  The SLPs can therefore be thought of as a molecular “cloak” to mask the 
bacteria from the pattern recognition receptors (PRRs) of the host. S-Layers of 
bacteria have previously been reported to play a role in immune evasion 
(Thompson 2002; Kern & Schneewind 2010; Bahl et al. 1997; Sara et al. 2000; 
Sleytr 1997), and the SLPs of C. difficile may be acting in a similar fashion. 
Conversely, mutations at these sites may result in stronger activation of an 
inflammatory response. In the case of a gut pathogen like C. difficile, this may be 
beneficial. Increased inflammation will result in a breakdown of the epithelial 
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lining, and as SLPs bind to extracellular matrix components (Calabi et al. 2002), 
may allow the pathogen to gain a stronger foothold.  
 
As we were interested in comparing the SLPs from different strains of C. 
difficile, we performed lineage specific analysis for selective pressure 
heterogeneity. The results indicate that many branches along the tree exhibit 
evidence of positive selection. Unexpectedly, positive selection was detected in 
the relatively conserved HMW subunit of many ribotypes on the tree. The HMW 
SLP is mainly involved in adherence to gastrointestinal tissues and ECM 
components (Calabi et al. 2002); the results suggest that SLPs from ribotypes 
010, 002, 005, 031 and 094 may be evolving to alter adherence properties of the 
protein. Improved adherence will allow for deeper penetration into the tissues 
and may contribute to persistent disease. Further experimentation would be 
required to test this hypothesis however. Positive selection is also detected in the 
LMW region of the gene for RT 002, 031 and 094, mainly in the area necessary 
for HMW-binding. This may suggest a co-evolution of the two proteins. A 
possible scenario is that as the HMW protein changes its sequence, its 
confirmation may change. As a result, the area of the LMW protein involved in 
binding to the HMW protein may have to modify its sequence to account for the 
conformational change in the HMW SLP.  
 
Only four branches of the tree estimated positive selection in the LMW subunit. 
Two of these branches led to the “hypervirulent” 027 and 078 ribotypes. Of 
particular interest is the close relationship between RT 001 and 027. RT 001 is 
not associated with severe disease, and we have previously shown SLPs from 
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this ribotype induce clearance responses in macrophage to help moderate and 
clear infection (Collins et al. 2014). The SLP sequence from RT 001 is closely 
related to that of RT 027, yet the sequence differences between the two ribotypes 
are under positive selection. In total, 15 amino acid resides were estimated to be 
under positive selective pressure in RT 027 SLPs. Many studies describe 027 as 
being associated with more severe and persistent disease, and toxin production 
alone cannot account for this (Carter et al. 2011; Clements et al. 2010; Valiente 
et al. 2014; Marsh et al. 2012). As the SLPs in RT 027 have undergone a 
predicted functional shift, they may now be modulating the immune response to 
ensure the pathogen is not cleared, while also increasing inflammation to cause 
tissue damage and allow the bacteria to strongly adhere and give rise to persistent 
and recurrent infection. 
 
When the pattern of positive selection was mapped on to the phylogenetic tree of 
the 26 slpA sequences, two distinct clades can be seen. Hypervirulent strains 027 
and 078 appeared on one side of the tree, with the epidemic RT 027 most closely 
related to RT 001 (Figure 3.5). If the SLPs in this group are evolving in a unique 
way to avoid recognition by the host immune system, then this would prevent, or 
at least slow down, clearance of this strain in the host. The bacteria can remain 
producing toxins undisturbed and so lead to increased pathogenesis. While it 
cannot be denied that the toxins play a major role in virulence, the SLPs are 
likely making a significant contribution to pathogenesis. 
 
The existence of horizontal gene transfer (HGT) in prokaryotic cells has recently 
questioned the validity of phylogenetic trees when examining the evolutionary 
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history of bacteria (Doolittle 2000). By exchanging genes between species and 
strains, bacterial genomes can become a mosaic over time, strongly suggesting 
that linear evolution of individual species does not occur.  Indeed, a recent study 
has shown that recombinational switching can occur in the S-Layer cassette of C. 
difficile (Dingle et al. 2013), and that a single PCR ribotype can carry multiple S-
Layer cassettes. For our analysis however, the slpA sequences for each isolate in 
a specific ribotype were identical, and all ribotypes displayed unique sequences. 
Because of this, we make an initial assumption that the SLPs of C. difficile are 
not undergoing horizontal gene transfer, and therefore are evolving in a linear 
manner. In addition, while HGT may still be occurring in the genome of C. 
difficile, specifically in the region coding for SLPs, HGT has no bearing on this 
analysis. As this study is examining only a single gene from C. difficile, we are 
resolving the phylogenetic relationships between slpA sequences alone, 
regardless of any HGT that is occurring. As a result however, we cannot assume 
that the slpA sequences in this dataset are globally universal for each given 
ribotype. For the proceeding chapters, slpA sequences were confirmed by whole 
genome sequencing where required, and were found to be identical to those in 
this analysis. 
 
In conclusion, we have resolved the phylogeny of the slpA gene from 26 strains 
of C. difficile, and detected signatures of positive selection in multiple sequences, 
most notably in ‘hypervirulent’ strains 027 and 078. Variations in these 
sequences that are undergoing positive selection are inferring a survival benefit 
on the pathogen, and may play a role in the increased disease severity associated 
with RT 027 and 078. While the molecular evolutionary analysis of these 
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sequences gives some intriguing insights into their role in severity of infection 
and the inflammatory response, further in vitro and in vivo analyses will be 
needed to directly confirm the role these proteins have in modulating the immune 
system. By isolating SLPs from different strains of C. difficile, and examining 
the response of immune cells to the proteins, it will be possible to determine how 
this positive selection and sequence variation plays a role in the response to the 
pathogen and clearance of disease. 
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Chapter 4 
 
Purification and Immune 
Characterisation of SLPs from different 
ribotypes of Clostridium difficile 
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4.1 INTRODUCTION 
In recent years, the emergence of hypervirulent C. difficile strains has elicited a 
renewed interest in this pathogen. Many previous studies have suggested a role 
for the SLPs as important virulence factors in infection (Ryan et al. 2011; Vohra 
& Poxton 2012; Ausiello et al. 2006; Collins et al. 2014; Madan & Jr 2012). For 
example, human monocytes and human monocyte-derived dendritic cells 
(MDDCs) have been shown to become activated in the presence of SLPs, 
resulting in the upregulation of pro-inflammatory cytokines IL-1β and IL-6, as 
well as cell surface molecules CD80, CD83 and MHC class II (Ausiello et al. 
2006). 
 
We have previously shown that SLP activates immune cells through TLR4 (Ryan 
et al. 2011). Bone marrow-derived dendritic cells (BMDCs), from C3H/HeN 
mice, stimulated with SLP from RT 001 showed upregulation of IL-12p70, IL-
23, TNFα and IL-10, and increased expression of CD40, MHCII, CD80 and 
CD86. We showed that BMDCs isolated from C3H/HeJ mice, a strain naturally 
defective in TLR4 signalling, did not become activated by SLP and had no 
induced cytokine secretion or cell surface marker expression (Ryan et al. 2011; 
Eidhin et al. 2006). In vivo studies further corroborated these findings, and 
demonstrated that TLR4-/- and MyD88-/- mice were more susceptible to infection, 
and displayed greater weight loss and greater CFU counts than wild type, TLR2-/- 
and TRIF-/- mice. TLR4-/- mice were also unable to mount an antibody response 
to SLP four days post-infection, with low levels of IgG antibody present in the 
circulation relative to wild type. 
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Another indicator of the importance of SLPs is demonstrated by studies showing 
that immunisation of hamsters with anti-SLP antibody significantly decreases the 
rate of infection, increasing rates of phagocytosis and lowering bacterial load in 
the gut. As SLPs are the main surface antigen of C. difficile, antibody binding 
may also affect the bacteria’s ability to bind to the gastrointestinal tract (O’Brien 
et al. 2005).  
 
In the previous chapter, we show that evidence of positive selection was detected 
in the SLPs of certain strains. Sequence differences between SLPs of other C. 
difficile strains were also observed, with some of these sequence differences 
being positively selected for. To further examine this, and to determine if these 
observed sequence differences affect the immune response, we sought to purify 
SLPs from a variety of C. difficile ribotypes, and examine the ability of these 
SLPs to elicit an immune response. 
 
Given that we wanted to isolate, purify and quantify SLPs from a range of 
different strains, we need to consider that the varying size of SLPs (Eidhin et al. 
2006) requires unique parameters for SLP purification by FPLC. Therefore, this 
study first aimed to fully optimise C. difficile growth, and SLP purification 
protocols for a variety of C. difficile ribotypes. This would then allow us to then 
compare SLPs between ribotypes, for their effect on the immune response. 
Furthermore, it will enable us to compare ribotypes undergoing positive selection 
with all other ribotypes, thus helping to determine if positive selection plays a 
role in modulating the immune response. To this end, we choose to purify 
ribotypes 027 and 078, which displayed evidence of positive selection, and 
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ribotypes 001 and 014, which did not, for comparison. This will greatly increase 
our understanding of how C. difficile modulates the immune response, 
specifically through its outer layer of SLPs.  
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4.2 RESULTS 
4.2.1 C. difficile growth times on blood agar and liquid broth 
For each ribotype stock used, plates were examined after 24 hours incubation for 
the presence of C. difficile colonies. C. difficile appeared as circular cream/grey 
colonies with irregular or jagged edges on the blood agar. In each case, sparse 
colonies were visible after 24 hours. After 48 hours colonies appeared larger and 
more confluent. 
 
The growth of C. difficile in liquid broth required optimisation. Colonies were 
grown and incubated in BHI (Brain Heart Infusion) broth until an OD value of 
0.8~1.0 was achieved. An incubation time of 16 hours yielded satisfactory results 
for RT 001, with broth appearing cloudy. A 16-hour incubation time for RT 078 
resulted in the formation of pellets in the bottom of the tubes, which were easily 
re-suspended upon agitation. This build-up of cellular material indicated a 
shortened incubation time was required. Incubation for 8 hours yielded the 
necessary OD value of one for RT 078. RT 027 behaved in a similar manner to 
RT 001, with the bacteria growing in BHI after 16 hours of incubation with no 
problems. The incubation time for each SLP ribotype is given in Table 4.1. 
 
Table 4.1 
C. difficile Ribotype Incubation Time 
001 16 Hours 
027 16 Hours 
078 8 Hours 
014 16 Hours 
Table 4.1 Required growth times for C. difficile in BHI broth. RT 078 grew at a much more 
rapid rate than RT 001, 014 or 027. 
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4.2.2 Purification Optimisation of SLPs  
Crude S-Layer extract was collected from each ribotype and dialysed before 
being run through the FPLC machine. For ribotype 001 a gradient of 0-0.3M 
NaCl in 20mM Tris-HCl pH 8.5 at a flow rate of 4 ml/min was used. The 
increase in NaCl concentration occurred over 20 column volumes (CV). The 
gradient was visualised on a graph alongside UV peaks, which represented 
proteins detaching from the column and eluting into 2mL fractions. Fractions 
collected on or near high UV peaks on the graph were chosen to run on gels as 
they likely contained protein (Figures 4.1 and 4.8). 
 
The initial parameters resulted in purified SLPs collected across many fractions, 
however the initial 30 fractions contained no protein. This was due to heavy 
binding to the column, and an insufficient concentration of salt to remove the 
bound proteins. When the length of the gradient was lessened to 10 CV (Figures 
4.2 and 4.8), pure SLPs were produced, but with fewer empty fractions. Further 
shortening of the gradient to 8 CV eluted fractions from A1-B10 and gave rise to 
extra bands visualised with the SLPs (Figures 4.3 and 4.9). This indicated the 
slope of the gradient was too high, and many proteins were eluting from the 
column at once. The dark SLP bands were visible from A5 – A11 with other 
protein bands. A gradient of 10 CV was used as standard for all further RT 001 
purifications. The SLPs were eluted in the later fractions B14 – C11. Various 
other bands were detected in later fractions, representing lesser proteins of the 
surface layer. 
 
124 
 
SLPs from RT 014 were also eluted at a gradient of 10CV (Figure 4.4 and Figure 
4.10). Fractions were collected later in the run for this ribotype, therefore no 
other proteins were eluted during the purification, and only a single UV peak was 
observed on the graph. When crude S-Layer extract from RT 078 was run with a 
10 CV gradient of 0-0.3M NaCl, many fractions contained no protein. For this 
ribotype, as well as 027, shortening the length to 8 CV improved the run time 
(Figures 4.5 and 4.12 for 027, 4.6 and 4.13 for 078). FPLC graphs for the four 
different ribotypes are shown in Figures 4.1-4.6.  
 
Table 4.2 
 
Ribotype Gradient used 
001 10 CV 
014 10 CV 
027 8 CV 
078 8 CV 
 
Table 4.2 Salt gradients (in Column Volumes) required to elute purified SLPs. 
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Figure 4.1 – Ribotype 001 Eluted at 20CV 
 
 
Figure 4.1 FPLC graph from crude S-Layer of ribotype 001 eluted at 20CV.  
Peaks represent light absorption by displaced proteins in mili-absorption units (mAU), quantified 
on the y-axis. Time in minutes is given on the x-axis. The largest peak on the graph at 50 mins 
represents the purified SLPs, while other peaks represent various surface proteins. The green 
slope represents increasing concentration of salt, while the red vertical lines represent individual 
fractions collected. 
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Figure 4.2 – Ribotype 001 Eluted at 10CV 
 
 
 
 
 
Figure 4.2 FPLC graph from crude S-Layer of ribotype 001 eluted at 10CV.  
Peaks represent light absorption by displaced proteins in mili absorption units (mAU), quantified 
on the y-axis. Time in minutes is given on the x-axis. The largest peak on the graph at 50 mins 
represents the purified SLPs, while other peaks represent various surface proteins. Fewer peaks 
are observed under these conditions, as the shorter gradient elutes proteins at a faster rate. The 
green slope represents increasing concentration of salt, while the red vertical lines represent 
individual fractions collected. 
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Figure 4.3 – Ribotype 001 Eluted at 8CV 
 
 
 
Figure 4.3 FPLC graph from crude S-Layer of ribotype 001 eluted at 8CV.  
Peaks represent light absorption by displaced proteins in mili absorption units (mAU), quantified 
on the y-axis. Time in minutes is given on the x-axis. The largest peak on the graph at 35 mins 
represents the SLPs. Due to the increased salt gradient; several proteins are eluted at this point. 
Other peaks represent various surface proteins. Fewer peaks are observed under these conditions, 
as the shorter gradient elutes proteins at a faster rate. The green slope represents increasing 
concentration of salt, while the red vertical lines represent individual fractions collected. 
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Figure 4.4 – Ribotype 014 Eluted at 10CV 
 
 
Figure 4.4 FPLC graph from crude S-Layer of ribotype 014 eluted at 10CV.  
Peaks represent light absorption by displaced proteins in mili absorption units (mAU), quantified 
on the y-axis. Time in minutes is given on the x-axis. The largest peak on the graph at 55 mins 
represents the purified SLPs, while other peaks represent various surface proteins. The green 
slope represents increasing concentration of salt, while the red vertical lines represent individual 
fractions collected. 
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Figure 4.5 – Ribotype 027 Eluted at 8CV 
 
 
 
Figure 4.5 FPLC graph from crude S-Layer of ribotype 027 eluted at 8CV.  
Peaks represent light absorption by displaced proteins in mili absorption units (mAU), quantified 
on the y-axis. Time in minutes is given on the x-axis. The largest peak on the graph at 30 mins 
represents the SLPs. Other peaks represent various surface proteins. The green slope represents 
increasing concentration of salt, while the red vertical lines represent individual fractions 
collected. 
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Figure 4.6 – Ribotype 078 Eluted at 8CV 
 
 
 
Figure 4.6 FPLC graph from crude S-Layer of ribotype 078 eluted at 8CV.  
Peaks represent light absorption by displaced proteins in mili-absorption units (mAU), quantified 
on the y-axis. Time in minutes is given on the x-axis. The largest peak on the graph at 55 mins 
represents the purified SLPs, while other peaks represent various surface proteins. The green 
slope represents increasing concentration of salt, while the red vertical lines represent individual 
fractions collected. 
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4.2.3 SDS-PAGE  
Fractions (2 mL) were collected during FPLC. The fractions were labelled A1-
A15, B1-B15, and C1-C15 etc. Of these, 100µL aliquots of every second sample 
were taken to run on polyacrylamide gels. Gels were stained as described in 
Materials and Methods. Any SLPs present were visualised as two bands 
appearing at roughly 32kDa and 44kDa. Figure 4.7 shows bands present in an 
undialysed crude S-Layer extract, a dialysed extract and purified SLPs 
respectively. The figures below show purified SLPs for RT 001 (Figures 4.8 and 
4.9), 014 (Figure 4.10), 027 (Figure 4.11) and 078 (Figure 4.12). 
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Figure 4.7  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.7 SDS-PAGE gels of eluted crude undialysed, dialysed and purified SLP.  
Many bands are present in the undialysed crude extract (Lane 1), representing other components 
of the S-Layer that exist in much lower concentrations. Once dialysed, the same proteins are 
present, possibly due to small spore sizes in the dialysis cassettes, whose main purpose is to 
remove urea from the sample (Lane 2). Purified samples appear in Lane 3 as two bands 
representing the HMW and LMW SLPs, appearing at 32kDa and 44kDa. The molecular weight 
ladder is given on the left in kDa. 
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Figure 4.8 
 
 
Figure 4.8 SDS-PAGE gels of eluted S-Layer from RT 001 at gradients of 20 and 10 CV.  
The SLPs were eluted into fewer fractions at 10CV, but at higher concentrations. The time frame 
of the FPLC run was also reduced. The HMW and LMW SLPs are identified by two dark bands 
appearing around 32kDa and 44kDa respectively. The molecular weight ladder is given on the 
left in kDa. 
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Figure 4.9 
 
 
Figure 4.9 SDS-PAGE gels of eluted S-Layer from RT001 eluted at 8 and 10 CV.  
Fractions are labelled A1-E3. Run 3, with a salt gradient of 8CV was found to be ineffective, 
with multiple bands appearing in the same fraction as the SLPs. Fractions A3 and A5 clearly 
show multiple bands with the darker SLPs. A gradient of 10CV was therefore used for all further 
RT 001 extractions. SLPs were then observed in fractions A15 to B3.The HMW and LMW SLPs 
are identified by two dark bands appearing around 32kDa and 44kDa respectively. The molecular 
weight ladder is given on the left in kDa. 
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Figure 4.10 
 
 
Figure 4.10 SDS-PAGE gels of eluted S-Layer from RT 014 at 10CV.  
Fractions are labelled A1 – B8. Elution of RT 014 was carried out with an 8 CV gradient, both 0-
0.3M NaCl in 20 mM Tris HCl pH 8.5. Two dark bands appearing around 32kDa and 44kDa 
respectively identify the HMW and LMW SLPs. SLP bands can be clearly seen at A7 – A11. 
Similar to RT 002 and 010, no other surface proteins were observed on these gels. The molecular 
weight ladder is given on the left in kDa. 
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Figure 4.11 
 
 
 
Figure 4.11 SDS-PAGE gels of eluted S-Layer from RT 027 at 8CV 
SDS-PAGE gel images showing eluted fractions of crude S-Layer from RT 027. Fractions are 
labelled A1 – D5. Two dark bands appearing around 32kDa and 44kDa respectively identify the 
HMW and LMW SLPs. Similar to 002, 010 and 014 no other surface proteins were observed on 
these gels.  Purified SLPs were observed in fractions B5 – C1. RT 027 SLPs were eluted in high 
amounts as observed by the many fractions displaying the double bands. The molecular weight 
ladder is given on the left in kDa. 
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Figure 4.12 
 
 
Figure 4.12 SDS-PAGE gels of eluted S-Layer from RT 078 at 10CV and 8CV. 
SDS-PAGE gel images showing eluted fractions of crude S-Layer from RT 078. Fractions are 
labelled A1 – c3. Two dark bands appearing around 32kDa and 44kDa respectively identify the 
HMW and LMW SLPs. Adjusting the salt gradient to 8 CV resulted in purified SLPs being 
eluted. SLP bands were observed in fractions B1 – B5 at a gradient of 10 CV, and A11 – B5 at a 
gradient of 8 CV. The molecular weight ladder is given on the left in kDa. 
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4.2.4 SLPs from Ribotype 001 induce cell surface marker upregulation. 
 
To confirm the immunostimulatory activity of the proteins, SLPs from RT 001 
were used to stimulate BMDCs, with LPS acting as a positive control. Cells were 
collected and analysed for expression of important cell surface markers. Levels 
of CD80, CD86 and CD40 were all highly upregulated by SLPs from RT 001 
(Figure 4.13). This confirmed what we had previously published for RT 001 
(Ryan et al. 2011). LPS, a positive control, also highly upregulated these surface 
markers. TLR4 was more highly upregulated by LPS, with only a small increase 
observed for SLP stimulation. The results from Flow Cytometry analysis can be 
seen in Figure 4.13. 
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Figure 4.13 
 
 
 
Figure 4.13 Cell surface marker expression by BMDC.  
Cells were incubated with either LPS or SLP for 24 hours and were then washed and stained with 
antibodies specific for cell surface markers shown above. Histograms indicate fluorescence 
intensity, with a shift to the right indicative of upregulation. Shaded histogram represents control 
cells, dark line histograms represents cells stimulated by LPS/SLP. Results are indicative of three 
independent experiments. 
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4.2.5 SLPs from Ribotype 001 induce proinflammatory cytokine production. 
BMDCs were stimulated with either LPS or SLP in order to detect cytokines 
induced by ELISA. In this experiment, irrelevant Surface proteins, eluted during 
FPLC, were also added to the cells, as a negative control. LPS and SLP were also 
added together in the same well, to examine whether the presence of both 
antigens compounded activation. Figure 4.14 shows that, as expected, IL-12p40, 
IL-6, IL-1β and anti-inflammatory IL-10 were all found to be upregulated in 
dendritic cells stimulated with SLP. Proteins eluted during FPLC, which were 
not SLPs (UN), did not induce any cytokine response from DCs, suggesting the 
SLPs are the immunodominant surface antigen. In addition, there were no 
synergistic or additive effects observed when SLP and LPS were added together. 
The results can be seen in Figure 4.14. 
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Figure 4.14 
 
Figure 4.14 Cytokine production by BMDCs.  
BMDC were stimulated with LPS (100ng/mL), SLP (20µg/mL) or irrelevant unknown proteins 
(UN) (20µg/mL). Supernatants were collected and cytokine levels were analysed by ELISA. SLP 
from RT 001 stimulated cytokine production, albeit to a lesser extent to LPS. Alternate cell wall 
proteins eluted during FPLC did not stimulate immune cells, nor did LPS and SLP together have 
a greater effect. The results show the mean (±SEM) for n = 3. *** p<0.001, ** p<0.01, * p<0.05, 
determined by one-way ANOVA, followed by Newman-Keuls analysis comparing all groups. 
Results are indicative of three independent experiments. 
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4.2.6 SLPs from different ribotypes of C. difficile have differential effects on 
expression of cell surface markers on macrophages. 
With the immunostimulatory properties of SLP confirmed by activation of 
dendritic cells in vitro, a comparative analysis of all available SLPs was 
preformed to determine if sequence variation resulted in different immune 
responses. Of all ribotypes in our dataset we chose four to represent each area of 
the phylogenetic tree. RT 001 was previously well characterised by our group, 
and others. From Chapter 3, we detected evidence of positive selection on the 
SLPs of RT 027, as well as RT 078, both being linked with hypervirulence. We 
also choose SLPs from RT 014, a strain not associated with hypervirulence, and 
on which we detected no evidence of positive selection. SLPs from these 
ribotypes were used for all further analysis. J774 murine macrophages were used 
for this initial screening, due to their low cost, ease of use and lack of need for 
animals. Furthermore, we have already detected the effect of RT 001 on 
macrophages (Collins et al. 2014). The macrophages were stimulated with SLP 
of various ribotypes, with LPS being used as a positive control. For each 
ribotype, SLPs were added at a concentration of 20µg/mL, and LPS at a 
concentration of 100ng/mL.  
 
We examined the effects of the SLPs on the expression of cell surface markers 
important in antigen presentation and interaction with other immune cells.  There 
was a strong upregulation of CD40, CD80 and MHC II expression on 
macrophages in response to LPS. SLPs from RT 027 and 078 all strongly 
upregulated these surface markers at levels comparable to LPS (Figures 4.15 – 
4.18). RT 001 and 014 SLPs also increased expression of CD40, CD80 and 
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MHC II on macrophages, but to a lesser extent than LPS. Cells stimulated with 
SLPs from RT 027 and 078 induced a higher expression of CD40, CD80 and 
MHC II than either RT 001 or 014.  
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Figure 4.15  
CD40 
 
 
Figure 4.15 Surface marker CD40 expression on macrophages in response to SLPs and LPS 
J774 macrophages were stimulated with SLP from ribotypes 001, 014, 027 and 078 (20µg/mL) 
for 24 hours. LPS (100ng/mL) was used as a positive control. Results show expression of the cell 
surface marker CD40. Histograms indicate fluorescence intensity, with a shift to the right 
indicative of upregulation. Control cells are shaded in grey, SLP-stimulated cells are labelled in 
blue, and LPS-stimulated cells are labelled in red. All SLPs induced induction of CD40, with 
SLPs from RT 027 and 078 being most potent. Results are indicative of three independent 
experiments. 
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Figure 4.16 
CD80 
 
Figure 4.16 Surface marker CD80 expression on macrophages in response to SLPs and LPS 
J774 macrophages were stimulated with SLP from ribotypes 001, 014, 027 and 078 (20µg/mL) 
for 24 hours. LPS (100ng/mL) was used as a positive control. Results show expression of the cell 
surface marker CD80. Histograms indicate fluorescence intensity, with a shift to the right 
indicative of upregulation. Control cells are shaded in grey, SLP-stimulated cells are labelled in 
blue, and LPS-stimulated cells are labelled in red. All SLPs induced induction of CD80, with 
SLPs from RT 027 and 078 being most potent. Results are indicative of three independent 
experiments. 
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Figure 4.17 
CD86 
 
Figure 4.17 Surface marker CD86 expression on macrophages in response to SLPs and LPS 
J774 macrophages were stimulated with SLP from ribotypes 001, 014, 027 and 078 (20µg/mL) 
for 24 hours. LPS (100ng/mL) was used as a positive control. Results show expression of the cell 
surface marker CD86. Histograms indicate fluorescence intensity, with a shift to the right 
indicative of upregulation. Control cells are shaded in grey, SLP-stimulated cells are labelled in 
blue, and LPS-stimulated cells are labelled in red. All SLPs induced marginal induction of CD80, 
with SLPs from RT 027 and 078 being most potent. Results are indicative of three independent 
experiments. 
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Figure 4.18 
MHC Class II 
 
Figure 4.18 Surface marker MHC Class II expression on macrophages in response to SLPs 
and LPS  
J774 macrophages were stimulated with SLP from ribotypes 001, 014, 027 and 078 (20µg/mL) 
for 24 hours. LPS (100ng/mL) was used as a positive control. Results show expression of the cell 
surface marker MHC Class II. Histograms indicate fluorescence intensity, with a shift to the right 
indicative of upregulation. Control cells are shaded in grey, SLP-stimulated cells are labelled in 
blue, and LPS-stimulated cells are labelled in red. All SLPs induced induction of MHC Class II, 
with SLPs from RT 027 and 078 being most potent. Results are indicative of three independent 
experiments. 
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4.2.7 SLPs from different ribotypes of C. difficile have differential effects on 
the production of cytokines by macrophages. 
Our four ribotypes, 001, 014, 027 and 078, were used to stimulate J774 
macrophages and the cytokine profile of these cells was analysed. J774 
macrophages were stimulated with SLP and LPS (positive control) for 24hrs, and 
ELISA was used to measure the levels of IL-6, IL-10, IL-12p40, IL-23, IL-27 
and TNFα. SLPs from each ribotype induced cytokine production at higher levels 
than control cells. SLPs from RT 001 and 014 consistently induced the lowest 
levels of cytokines relative to other ribotypes, with no significant difference 
being observed between the cytokine levels in response to either ribotype (Figure 
4.19). SLPs from both ribotypes produced higher levels of TNFα (p<0.001), IL-
12p40 (p<0.05), IL-6 (p<0.001), and IL-27 (p<0.01) relative to control cells. 
 
Activation of macrophages with RT 027 SLPs consistently induced higher 
cytokine levels, with two-fold increases in of IL-12p40, TNFα, IL-6 IL-23, IL-27 
and IL-10 observed relative to RT 001 (Figure 4.19; p<0.001). As previously 
stated, RT 027 has been dubbed a “hypervirulent” strain, and is associated with 
more severe disease progression and recurrence. SLPs from RT 078 also induced 
a strong inflammatory response, in the case of TNFα, producing higher levels 
than SLPs from 027 (p<0.05). Relative to RT 027, SLPs from RT 078 induced 
lower levels of IL-12p40 (p<0.01), IL-6 (p<0.001) and IL-10 (p<0.001) (Figure 
4.19). These results show SLPs from RT 027 to be extremely potent activators of 
the inflammatory response. This increased potency may play a role in the 
observed severity of disease caused by RT 027.  
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Figure 4.19 
 
Figure 4.19 Cytokine production by macrophages in response to SLP and LPS. 
J774 macrophages were stimulated with LPS (100ng/mL) and SLP (20µg/mL) from ribotypes 
001, 027, 014 and 078 for a period of 24 hours. Supernatants were collected and cytokine levels 
were analysed by ELISA. SLPs from RT 027 and 078 consistently induce higher levels of 
cytokine production relative to RT 001 and 014. The results show the mean (±SEM) for n = 3. 
*** p<0.001, ** p<0.01, * p<0.05, determined by one-way ANOVA, followed by Newman-
Keuls analysis comparing all groups. Results are indicative of three independent experiments. 
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4.2.8 SLPs from different ribotypes of C. difficile have differential effects on 
the production of chemokines by macrophages. 
The production of chemokines in response to SLPs from different ribotypes was 
also analysed. Levels of MIP-1α, MIP-2, MCP and RANTES were analysed in 
response to RT 001, 014, 027 and 078 SLPs (Figure 4.20). SLPs from RT 001 
and RT 014 induced the lower chemokine levels, yet MIP-1α (p<0.01), MIP-2 
(p<0.001), MCP (p<0.01) levels were significantly higher than control cells. 
RANTES levels were not significantly upregulated in response to SLPs from 
these ribotypes. SLPs from 027 and 078 consistently produced the highest levels 
of chemokines, comparable to LPS-stimulation. RT 027 induced significantly 
higher levels of MIP-1α (p<0.001), MIP-2 (p<0.001), MCP (p<0.05) and 
RANTES (p<0.001) compared to RT 001-stimulation. In the case of MIP-1α, 
MIP-2 and MCP, SLPs from RT 078 induced higher levels than 027 (p<0.05, 
p<0.001 and p<0.001 respectively). Conversely, SLPs from RT 014 were weak 
chemokine stimulators, with the exception of MIP-1α, where levels were similar 
to that of LPS. These results once again show the strong potency of SLPs from 
RT 027 and 078 to induce high levels of inflammatory molecules. 
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Figure 4.20 
 
Figure 4.20 Chemokine production by macrophages in response to SLP and LPS. 
J774 macrophages were stimulated with LPS (100ng/mL) and SLP (20µg/mL) from ribotypes 
001, 027, 010, 014 and 078 for a period of 24 hours. Supernatants were collected and chemokine 
levels were analysed by ELISA. SLPs from RT 027 and 078 consistently induce higher levels of 
chemokine production relative to RT 001 and 014. The results show the mean (±SEM) for n = 3. 
*** p<0.001, ** p<0.01, * p<0.05, determined by one-way ANOVA, followed by Newman-
Keuls analysis comparing all groups. Results are indicative of three independent experiments. 
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4.2.9 SLPs from different ribotypes of C. difficile have differential effects on 
the production of cytokines by dendritic cells. 
Given the importance of dendritic cells in the immune response, we next 
examined whether the differences we observed between ribotypes in 
macrophages also we evident in dendritic cells. Similar to the trend of the 
previous experiments, SLPs from RT 027 and 078 generally induced higher 
levels of proinflammatory cytokines than RT 001 and 014 (Figure 4.21). Two 
exceptions to this were IL-6 and IL-23. No significant difference was observed in 
IL-6 levels between RT 001 and 027, yet both were significantly higher than 
control (p<0.001). Levels of IL-23 were higher in SLP RT 001-stimulated cells 
compared to 027- and 078 SLP stimulation (p<0.001). This is the only instance 
of RT 001 inducing the highest response relative to SLPs from the other 
ribotypes. 027 SLPs induced high levels of the immunosuppressive IL-10 in 
addition to proinflammatory cytokines (p<0.001). Chemokine levels also 
followed a similar trend. There is an almost two-fold increase in levels of MIP-
1α, MIP-2 and MCP in 027-stimulated cells relative to RT 001 (p<0.05 for MIP-
1α, MIP-2, p<0.01 for MCP). Both RT 027 and 078 induced the highest levels of 
chemokine production, at levels higher or equal to LPS stimulation. RT 001 and 
014 induced levels higher than control cells, but lower than LPS (MIP-1α 
p<0.01, MIP-2 p<0.05 and MCP p<0.001). The results can be seen in Figure 
4.21. 
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Figure 4.21 
 
Figure 4.21 Differential effects of SLPs on BMDCs  
BMDCs taken from BALB/c mice were stimulated with LPS (100ng/mL) and SLP (20µg/mL) 
from ribotypes 001, 027, 014 and 078 for a period of 24 hours. Supernatants were collected and 
cytokine levels were analysed by ELISA. The results show the mean (±SEM) for n = 3. *** 
p<0.001, ** p<0.01, * p<0.05, determined by one-way ANOVA, followed by Newman-Keuls 
analysis comparing all groups. Results are indicative of three independent experiments. 
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4.2.10 SLPs from different ribotypes induce variable levels of phagocytosis 
in macrophages. 
A key difference in the infection caused by different ribotypes of C. difficile is 
the effective clearance of the infection. We therefore next examined the ability of 
the SLPs from RT 001, 014, 027 and 078 to induce phagocytosis in 
macrophages. FITC-labelled polystyrene beads were added to cells that were 
stimulated with SLPs for 24hrs. Cells stimulated with LPS were used as a 
positive control. Cells were analysed at 30 minutes, 1 hour and 2 hours by flow 
cytometry to determine the rate of phagocytosis of the beads in the presence of 
SLPs. Cells positive for FITC indicated phagocytosing cells. Cells not stimulated 
with SLPs but exposed to the polystyrene beads were used as a negative control. 
 
Control cells had a low level of phagocytosis at 30 minutes; less than 5% of the 
population contained beads (Figure 4.22 and 4.23). After 1 hour, this had 
increased marginally to 7% and by 2 hours, 25% of the population of cells had 
phagocytosed the beads. Phagocytosis was significantly increased for LPS-
stimulated cells, with 17%, 25% and 53% of the population phagocytosing beads 
at the 30 minute, 1 hour and 2 hour time points respectively. SLPs from RT 001 
induced phagocytosis, but at a decreased level when compared to LPS-stimulated 
cells at each time point, and RT 014 SLPs resulted in an even poorer response 
with only 22% of cells phagocytosing at 2 hours. RT 027 and 078 SLP-treated 
cells displayed a similar level of phagocytosis to the LPS controls at 30mins but 
phagocytosis was slightly lower in these groups when compared to LPS at 1 hour 
and 2 hours. RT 078 induces higher levels of phagocytosis than RT 027 at one 
hour, but this is reversed at two hours, with the phagocytosing population at 
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almost 39% for RT 027 SLPs and 34% for RT 078. At one hour it has a higher 
level than RT 027 SLPs, but again at two hours, phagocytosis levels are lower 
than that on RT 001 and 027. These results did not follow the previous trend of a 
RT 001/014 versus RT 027/078 axis. RT 001 and 027 were the strongest 
initiators of phagocytosis, with RT 078 less potent and RT 014 the weakest. The 
results of the phagocytosis can be seen in Figures 4.22 and 4.23. 
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Figure 4.22 
 
Figure 4.22 SLPs from ribotypes 001 and 014 induce phagocytosis in macrophages.  
Phagocytosis of FITC-labelled fluorescent beads by J774 macrophages in the presence of LPS 
and SLP ribotypes 001, and 014. Cells were stimulated for 24hrs with SLP (20µg/mL) or LPS 
(100ng/mL), and beads were then added (10 beads/cell) for 30 minutes, 1 hour, and 2 hours. 
Percentage of the cell population was measured by the quantity of FITC signal from the cells 
using flow cytometry. SLPs from RT 001 induced higher levels of phagocytosis that those of RT 
014. Results are indicative of three independent experiments. 
 
 
157 
 
Figure 4.23 
 
 
Figure 4.23 SLPs from ribotypes 027 and 078 induce phagocytosis in macrophages.  
Phagocytosis of FITC-labelled fluorescent beads by J774 macrophages in the presence of LPS 
and SLP ribotypes 027, and 078. Cells were stimulated for 24hrs with SLP (20µg/mL) or LPS 
(100ng/mL), and beads were then added (10 beads/cell) for 30 minutes, 1 hour, and 2 hours. 
Percentage of the cell population was measured by the quantity of FITC signal from the cells 
using flow cytometry. SLPs from RT 027 induced similar levels of phagocytosis that those of RT 
001. SLPs from RT 078 induced lower levels. Results are indicative of three independent 
experiments.  
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4.2.11 SLPs from ribotype 027 induce a more potent inflammatory response 
relative to RT 001. 
We next wanted to more closely compare the SLPs of RT 001 and 027. They 
share phylogenetically similar sequences, yet positive selection was predicted on 
the SLPs of RT 027 and not RT 001. BMDCs were isolated from the bone 
marrow of BALB/C mice and culured for seven days in the presence of GMCSF. 
Cells were stimulated with SLPs from RT 001 and 027, with LPS being used as a 
positive control. Cytokine levels in response to the SLPs or LPS were analysed 
by ELISA. SLPs from 001 induced higher levels of IL-23 compared to RT 027 
SLPs (Figure 4.24, p<0.01). This cytokine, along with IL-6, is known to be 
important for Th17 responses, involved in clearing extracellular pathogens. 
Proinflammatory cytokines IL-6 (P<0.05), IL-12p40 (p<0.001), TNFα (p<0.001) 
and IL-1β (p<0.05) were all secreted at higher levels in response to RT 027 SLPs 
relative to RT 001, indicating a more severe inflammatory response to this 
ribotype. High levels of IL-10 were again detected in response to SLPs from RT 
027 (p<0.001). IL-27 is known to augment IL-10 production in T cells, and its 
increased levels in response to RT 027 SLPs (p<0.001) suggests an important 
role for IL-10 in infection with this ribotype. 
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Figure 4.24 
 
Figure 4.24 Comparisons of SLP responses from RT 001 and 027 on BMDCs. 
BMDCs taken from BALB/c mice were stimulated with LPS (100ng/mL) and SLP (20µg/mL) 
from ribotypes 001, 027, 014 and 078 for a period of 24 hours. Supernatants were collected and 
cytokine levels were analysed by ELISA. With the exception of IL-23, SLPs from RT 027 
induced higher cytokine levels than RT 001. The results show the mean (±SEM) for n = 3. *** 
p<0.001, ** p<0.01, * p<0.05, determined by one-way ANOVA, followed by Newman-Kuels 
analysis comparing all groups. Results are indicative of three independent experiments. 
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4.3 DISCUSSION 
The focus of this chapter was to determine if positive selection on the SLPs of C. 
difficile had an impact on their ability to activate an immune response. Evidence 
of positive selection was detected in several strains, and of particular interest 
were RT 078 and 027. These ribotypes have previously been described as 
hypervirulent (Marsh et al. 2012; Goorhuis et al. 2008), and the presence of 
positive selection on the SLPs of these strains indicates a potential role for these 
proteins in hypervirulence and severe disease. For comparison, we also choose 
two strains that did not show evidence of positive selection. RT 001 has been 
previously characterised by our group and others (Ryan et al. 2011; Collins et al. 
2014; Eidhin et al. 2006), and was known to induce an inflammatory response. 
We also choose RT 014 as there was also no evidence for positive selection on 
this strain, but has previously been reported to be common in humans (Janezic et 
al. 2012). A European study also determined ribotypes 001, 014, 027 and 078 as 
the most prevalent in a hospital-based survey (Bauer et al. 2011). 
 
The ability of SLPs to induce macrophages to produce cytokines and chemokines 
is an important indicator of how potently they activate the immune system. Our 
group has previously shown that SLPs from RT 001 activate the immune 
response, specifically through TLR4, and induce clearance responses in 
macrophages (Ryan et al. 2011; Collins et al. 2014). A comparative study of 
SLPs based of positive selection has not previously been performed. We found 
that SLPs from four ribotypes in our dataset activated macrophages and DCs to 
produce proinflammatory cytokines. The profile of cytokine production was 
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variable across ribotypes, with SLPs from some strains proving more potent than 
LPS, a positive control for TLR4 activation. 
 
We observed up-regulation of cell surface molecules such as CD80, CD86, MHC 
II, and CD40 in macrophages in response to SLP from RT 001, 014, 027 and 
078. Cells stimulated with SLPs from RT 027 and 078 expressed higher levels of 
CD80, CD40 and MHC II than those induced by RT 001 and 014. These 
molecules are critical in recruiting and interacting with cells of the adaptive 
immune system. CD80/86 acting as co-stimulatory molecules for T cell receptor 
(TCR) activation, inducing stimulating proliferation and cytokine production 
(Lanier et al. 1995). CD40 interacts with CD40L on T helper cells to further 
activate APCs and increase co-stimulatory signals (Grewal & Flavell 1996), and 
MHC Class II is responsible for displaying antigen to cells of the adaptive 
immune system (König et al. 1992). Higher levels of these molecules in response 
to RT 027 and 078 suggest that these strains induce a more potent inflammatory 
response relative to SLPs from RT 001 and 014. These results suggest that SLPs 
undergoing positive selection induce higher levels of surface molecule 
expression for the proliferation and activation of T cells. This was not expected, 
as our hypothesis for positive selection on the SLPs of C. difficile was to act as a 
molecular cloak, shielding itself from an inflammatory response and causing 
more persistent and severe disease. Therefore we expected a weaker response, 
however, we see a weaker response to SLPs on which no positive selection was 
detected. Perhaps this weaker response is sufficient for clearance without 
exacerbating inflammation. In the case of the positively selected SLPs, it is 
possible that increased inflammatory response benefits the bacteria, inducing 
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more tissue damage to allow greater binding to the gut, if the pathogen can avoid 
clearance by the host immune system.  
 
While upregulation of cell surface molecules are important in inducing an 
adaptive immune response, the local cytokine environment can influence the 
nature of that adaptive response. SLPs from RT 001, 014, 027 and 078 all 
activate immune cells to produce proinflammatory cytokines. Variation in the 
response of macrophages and DCs to SLP was observed depending on the 
ribotype from which the SLP were purified. RT 001 has been frequently used in 
the past to show immune reactivity, and this was observed in this study. However 
it proved to induce one of the weakest responses relative to other ribotypes. SLPs 
from RT 027 consistently induced high levels of proinflammatory cytokine 
secretion in macrophages, exhibiting up to twofold increases in cytokine 
production in response to proteins from this ribotype.  
 
High levels of proinflammatory cytokines TNFα, IL-12p40, IL-6 and IL-23 were 
all observed in response to SLPs from RT 027 and 078. TNFα is a particularly 
important cytokine in inflammatory bowel disease, with increased levels having 
previously been associated with ulcerative colitis (UC), and TNFα exhibiting a 
pathogenic effect (Neurath et al. 1997; Braegger et al. 1992). In addition many 
anti-TNF therapies are being explored for the treatment of UC and Crohn’s 
disease (Lv et al. 2014). IL-12p40 is also associated with diseases such as UC 
(Kullberg et al. 1998). While IL-6 and IL-23 are associated with induction of a 
protective Th17 response (discussed below), the presence of high levels of IL-10 
may negate the protective effects.  
163 
 
SLPs from RT 001 and 014 induced lower levels TNFα, IL-12p40, IL-6 and IL-
23 relative to SLPs from RT 027 and 078. Once again, we see SLPs under 
positive selection inducing high levels of inflammation. This inflammatory state 
must be beneficial for the pathogen, as increased tissue damage may allow the 
bacteria to invade deeper into the gut, resulting in persistent disease. The 
positively selected SLPs of hypervirulent strains also induce high levels of 
chemokines, necessary for recruiting neutrophils and cells of the adaptive 
immune system. RT 027 and 078 SLPs induced up to two-fold higher levels of 
MIP-1, MIP-2, MCP and RANTES in macrophages. These chemokines are 
essential in recruiting inflammatory cells to the site of infection, and can directly 
affect the nature of the immune response. These SLPs may recruit many 
inflammatory cells to the site of infection by stimulating these chemokines, 
exacerbating inflammation. Decreased chemokine levels have previously been 
linked to aggravated disease (Kurihara et al. 1997), yet high levels are detected in 
response to the SLPs under positive selection. It is possible that these ribotypes 
are recruiting inflammatory cells to the site of infection, but the cytokine 
environment blocks an effective response, resulting in more severe disease 
symptoms. 
 
Dendritic cells play an essential role in recognising pathogens and stimulating an 
adaptive immune response, and when stimulated with SLPs, showed a similar 
response to that of macrophages. Interestingly levels of IL-23 were higher in RT 
001 SLP-stimulated DCs compared to 027 SLP-stimulated cells. Levels of IL-6 
were also similar to that of 027 SLP-stimulation. Both IL-6 and IL-23 are 
required to drive a Th17 response. This T cell phenotype plays an important role 
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in the clearance of extracellular pathogens in the gut (Khader et al. 2009; Zhang 
et al. 2009b; Blaschitz & Raffatellu 2010) and their high levels is response to RT 
001 SLPs may hint at a role for Th17 cells in C. difficile clearance. Th17 cells 
have not previously been associated with C. difficile clearance, and suggests a 
novel mechanism by which the immune system can clear the pathogen. If the 
positive selection in the SLPs of 027 and 078 results in decreased Th17 
differentiation, these strains may be able to avoid clearance while inducing 
higher levels of inflammation. SLPs from RT 027 and 078 induced high levels of 
TNFα and IL-10. Again we see strong induction of damage-inducing TNFα and 
immune-suppressive IL-10 by SLPs undergoing positive selection. This suggests 
evolution of the SLPs to induce an inflammatory state, while suppressing the 
immune systems attempt to clear the bacteria with IL-10.  
 
High levels of IL-10 were also observed in macrophages in response to SLPs 
from 027 and 078. This cytokine exhibits immunosuppressive effects, so high 
levels in response to strains inducing severe inflammation was not expected. As 
high levels of IL-10 were produced by SLPs under positive selection, it is 
possible that C. difficile is modulating the immune response to dampen any 
clearance mechanisms and evade destruction. We have previously shown RT 001 
SLPs to effectively induce clearance responses to resolve infection, and these 
SLPs produce low levels of IL-10 relative to the other ribotypes. IL-10 has been 
shown to block Th17, Th1 and Th2 development (O’Garra & Vieira 2007; 
Maynard & Weaver 2008), and other organisms have been shown utilise IL-10 to 
avoid clearance (Xavier et al. 2013; Redford et al. 2011), and it is possible that 
positive selection on the SLPs modulates immune cells to obtain a similar result. 
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RT 027 SLPs also induce high levels of IL-27. Together with IL-6, this cytokine 
has been shown to promote IL-10 production in T helper cells (Stumhofer et al. 
2007). These cytokines, along with high levels of T cell-activating surface 
molecules, may drive an adaptive response producing large amounts of IL-10, 
increasing inflammation and tissue damage, while impairing clearance.  
 
The ability of macrophages to phagocytose pathogens is an important 
determinant in clearance of disease (Taylor et al. 2010), and SLPs from our four 
ribotypes induced phagocytosis in macrophages. Once again, the rate at which 
cells phagocytosed varied between ribotypes. SLPs from RT 001, 027 and 078 
induced high levels of phagocytosis, with 014 being less potent. SLPs from RT 
001 and 027 induced similar levels, with RT 078 being less potent. This suggests 
an impaired ability of RT 014 to activate the immune response through its SLPs. 
RT 078 and 027 have been well documented as hypervirulent strains (Stabler et 
al. 2009; Goorhuis et al. 2008), and we have detected positive selection on the 
SLPs of both 027 and 078. As selection infers greater survival benefit on the 
organism, it might be expected that SLPs under positive selection induce lower 
levels of phagocytosis. The observed increase was therefore not expected. It has 
previously been shown that phagocytosed C. difficile spores can readily survive 
inside the phagosomes of macrophages (Paredes-Sabja et al. 2012). This 
increased phagocytosis may be due to an increased inflammatory state, but as 
SLPs from RT 001 also strongly induce phagocytosis, this does not explain the 
lack of clearance in response to RT 027 and 078. It is likely that phagocytosis is 
not as important a determinate in disease severity as other factors, such as 
cytokine secretion. 
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The SLPs of C. difficile are only one component in the mechanisms inducing 
disease in the gut, and care must be taken in interpreting the response of isolated 
cell populations in vitro to purified SLPs. To fully understand the significance of 
the differences observed in immune response between C. difficile of different 
ribotypes, infection models using the whole bacteria are required. Animal models 
will help determine if the results in this chapter translate to C. difficile infection. 
This study clearly highlights the SLPs ability to induce an immune response, and 
that variations in the immune response exist between strains. In particular, there 
appears to be a role for positive selection of the SLPs in modulating the host 
immune system. It seems the ability of C. difficile to induce a Th17 promoting 
response through the SLPs, aids clearance, while positive selection seems to 
result in SLPs producing higher amounts of IL-10, thus suppressing the immune 
system and inhibiting an effective T cell response. Due to the observed strong 
inflammatory response to SLPs from RT 027, the presence of positively selected 
sites on its slpA gene, and its close phylogenetic relationship with the SLPs from 
RT 001, further exploration of the comparison between these two ribotypes may 
give further information on the nature of this hypervirulence, and its relation to 
positive selection. 
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Chapter 5 
 
A comparison of Clostridium difficile 
ribotypes 001 and 027 in vivo. 
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5.1 INTRODUCTION 
Recent years have seen an increase in the incidence of C. difficile infection 
(CDI), as well as in its severity and recurrence (Rupnik et al. 2009). It has been 
previously reported that the strain of C. difficile causing the infection can be an 
important determinate in predicting severity (Goorhuis et al. 2008; Ghose 2013; 
Marsh et al. 2012). Infection with certain strains may result in asymptomatic 
conditions, while others cause more severe conditions, such as colitis, sepsis, and 
even death.  The recent emergence of ‘hypervirulent’ strains, such as ribotypes 
027 and 078 (Goorhuis et al. 2008; Marsh et al. 2012), has renewed interest in 
CDI, with a number of these strains exhibiting increased toxin production 
(Warny et al. 2005). RT 027 in particular has been associated with more severe 
and recurrent disease. There has been debate as to whether ribotypes can be 
indicative of disease severity. Recently a study (Walk et al. 2012) has argued that 
ribotype does not predict severity of infection when results were adjusted for 
covariates. This idea has been challenged, and resulted in much discussion in the 
literature (A S Walker, Eyre, Crook, et al. 2013a; A Sarah Walker, Eyre, Crook, 
et al. 2013; Walk et al. 2013a). Walkers group have conducted the largest 
population study of genotype and CDI, who show that RT 027 is consistently 
associated with more severe disease (A Sarah Walker, Eyre, Wyllie, et al. 2013). 
The exact molecular mechanisms of this increased virulence are not fully known.  
 
Many studies have examined the importance of SLPs as virulence factors 
(Ausiello et al. 2006; Cerquetti et al. 2000; Drudy et al. 2004; Merrigan et al. 
2013). SLPs can vary greatly in sequence between strains, and this sequence 
variation may play a role in disease severity (McCoubrey & Poxton 2001; Eidhin 
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et al. 2006). We have previously shown that SLPs from RT 001 activate an 
immune response, specifically through TLR4, inducing proinflammatory 
cytokine production (Ryan et al. 2011). We have also shown the ability of SLPs 
from RT 001 to induce clearance responses in macrophages in vitro, essential for 
resolution of infection (Collins et al. 2014). As SLP sequences vary between 
strains, this sequence variability may be playing a role in disease severity. We 
have previously shown the SLPs from C. difficile RT 001 to signal through the 
MyD88-depenent pathway alone, activating NF-κB (Ryan et al. 2011), but not 
IRF3. It is not yet known if the sequence differences that exist between the SLPs 
of C. difficile have the potential to induce variable signalling pathways 
downstream of TLR4. 
  
The type of immune response that is mounted in the gut against invading 
pathogens can greatly influence disease outcome. For example, Th17 cells have 
been shown to be essential in the clearance of extracellular pathogens in the gut 
(Blaschitz & Raffatellu 2010). This T cell subset also plays a role in neutrophil 
recruitment, as Th17-deficiency results in impaired recruitment of the cells to the 
mucosa in S. typhimurium infection (Raffatellu et al. 2008). A neutrophil 
response is also important in C. difficile infection (Jarchum et al. 2012), further 
implying a role for Th17 cells in CDI. Cytokines IL-6 and IL-23 are important in 
driving Th17 adaptive response, and these cytokines have previously been 
observed to be upregulated in response to SLPs from RT 001 (Ryan et al. 2011; 
Ausiello et al. 2006). Inhibition of such a response may result in impaired 
clearance and exacerbated disease. 
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A variety of animal models exist for the study of CDI, utilising animals ranging 
from rodents such as mice and guinea pigs, to larger animals such as Rhesus 
monkeys and foals (Lawley & Young 2013; Best et al. 2011). Each model has 
unique advantages, and all have been used to greatly improve our understanding 
of the pathogen. As the host responses to C. difficile has been reported to vary 
between animals (Keel & Songer 2006), the choice of animal model is critical, 
especially in respect to comparing observations to human disease. One of the 
first animal models utilised hamsters, administering the cecal contents from 
antibiotic-treated, diseased animals to the cecum of healthy animals (Bartlett et 
al. 1977). This model proved very successful, linking the role of toxins to CDI 
(Bartlett et al. 1978; Libby et al. 1982), and demonstrating disease 
transmissibility (Bartlett et al. 1977). There are drawbacks for this model 
however, infection occurs in the cecum of hamsters, but in the colon of humans 
(Price et al. 1979). In addition, relative to mice, there is a lack of immunological 
reagents available to study the host response to infection. 
Mouse models for CDI have been continuously refined. The location of infection 
in the colon, similar to humans, and the wide availability of mouse-specific 
antibodies, make it a very suitable animal in which to study CDI. Like humans, 
healthy mice are resistant to C. difficile due to the protective nature of the 
microbiota (Lawley et al. 2009), therefore susceptibility needs to be induced by 
the administration of antibiotics. The antibiotic cocktail mouse model of CDI 
(Chen et al. 2008) mirrors the majority of disease factors observed in humans by 
disrupting the commensal bacteria of the gut, and for this reason we chose this 
model for the study. 
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 The aim of this study was to confirm variable immune responses to different C. 
difficile ribotypes in vivo and to examine whether these responses induced 
different disease states. By using the mouse antibiotic model of C. difficile 
infection and examining progress of infection, along with cytokine analysis of 
RNA from the colon, we hope to elucidate the mechanisms of disease severity in 
CDI. 
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5.2 Results 
5.2.1 Mice infected with C. difficile exhibit weight loss not observed in 
control animals 
The experimental groups for the C. difficile animal model are given in Table 5.1. 
All observed weight changes were plotted as percentage weight change. No 
weight loss was observed in control mice administered with antibiotics alone. 
Animals infected with ribotypes 001 and 027 exhibit similar weights as control 
animals one day after infection. At Day 2, a decrease in weight is observed in 
both groups indicating progression of infection (P<0.001). This can be seen in 
Figure 5.1. After Day 2, both groups begin to recover weight. RT 001-infected 
animals seem to recover at a more rapid rate, and by Day 6, their weight is 
indistinguishable from the Control group. RT 027-infected animals, however, 
appear to recover more slowly (p<0.05 at Day 5), implying a more persistent 
infection, not being cleared by the immune system. 
 
Table 5.1 
Group Day 3 Day 7 
Control 4 4 
001 6 6 
027 6 6 
Total 16 16 32 
 
Table 5.1. The table above indicates the animal numbers per group in the experiment. Four 
animals were present in each control group, and 6 for each infection group. A total of 32 mice 
were used in the study. 
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5.2.2 Ribotype 027-infected mice possess a higher bacterial load than RT 
001-infected mice. 
The contents of the cecum were collected from mice in each group at Days 3 and 
7 and used to determine the number of colony forming units (CFU), a measure of 
CFUs indicative of bacterial load in the gut. At Day 3, RT 001-infected animals 
had an average of 1x106 CFU/g, while 027-infected animals had 5 times this 
amount, averaging at 5x106 CFU/g (p<0.001). As both infected groups were 
initially treated with 103 C. difficile spores, this suggests increased virulence in 
RT 027, with a higher bacterial load three days after infection. At Day 7, 
numbers were lowered for both groups, but 027-infected animals still contained a 
large amount of bacteria in the gut (over 3x106 CFU/g, p<0.01). This is a further 
indication of RT 027s increased virulence, and suggests an inability in the host to 
effectively clear the pathogen. The CFU counts can be seen in Figure 5.1. 
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Figure 5.1 
 
Figure 5.1 Clostridium difficile infection appears more severe in 027-infected mice relative 
to RT 001 infection. Weight change and CFU counts of mice infected with 103 C. difficile 
spores, showing the progression of disease. The control group is labelled black, RT 001-infected 
group blue and RT 027-infected red. Weight-loss is observed in both 001- and 027-infected 
animals, with greater recovery in RT 001. RT 027-infected animals also exhibit higher bacterial 
load at both time points. Statistical significance between the groups was determined by one-way 
ANOVA * p<0.05; ** p<0.01, *** p<0.001. 
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5.2.3 Clostridium difficile ribotype 027 causes more severe tissue damage 
than 001, with less recovery by Day 7.  
H&E staining of colonic tissue from RT 001- and 027-infected animals revealed 
the extent of tissue damage caused by C. difficile infection. Tissue from control 
mice clearly showed the structure of the intestinal wall. Increased oedema and 
disruption of villi structure is seen in mice infected with RT 001 (Figure 5.2). 
This damage is largely repaired at Day 7. These data suggest that the animal can 
effectively mount a response against C. difficile RT 001, and reverse tissue 
damage within seven days. Tissue damage was also observed in RT 027-infected 
animals. The extent of this damage appeared similar to that of RT 001 at day 3, 
but clearance had not occurred by day 7. More severe damage to the mucosa was 
observed at this time point, indicating an inability of the animals to effectively 
clear the pathogen, indicating that C. difficile RT 027 causes more severe disease 
than RT 001. Histology images can be seen in Figure 5.2. 
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Figure 5.2 
 
 
Figure 5.2. Histology reveals increased tissue damage in mice infected with ribotype 027. 
Cross-sections of distal colon are shown for antibiotic-treated control mice, as well as RT 001- 
and 027-infected mice at day three and day seven post-infection. Nuclei are stained dark purple, 
while cytoplasm and muscle fibre are stained pink. Damage to intestinal structure can clearly be 
seen for both infected groups, with 001-infected animals recovering by day seven. As disease 
progresses in 027-infected animals, damage appears more severe, indicating a lack of clearance. 
Shown are representative images from four sampled mice per group. 
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5.2.4 Clostridium difficile ribotypes 001 and 027 induces recruitment of 
neutrophils in vivo, with neutrophils persisting in ribotype 027-induced 
infection. 
Tissue sections of the distal colon were stained with a neutrophil-specific 
antibody and DAB staining kit, with the neutrophils being visible as brown spots. 
The brown colour of the DAB staining was converted to red using ImageJ 
software, for ease of visualisation. Surrounding tissue was counterstained with 
haematoxylin to also allow for visualisation of surrounding gut tissue. No 
positive staining was observed in the tissue from control animals, indicating no 
neutrophils present in a non-infected state (Figure 5.3). A high infiltration of 
neutrophils was observed in RT 001-infected animals at Day 3, with brown spots 
being observed in the lamina propria and near the lumen. Neutrophil infiltration 
has been previously reported in CDI, so this was not surprising. At Day 7, no 
recruited neutrophils were detected in the colon. For 027-infected animals, 
neutrophils were observed at both days 3 and 7 post-infection. The presence of 
neutrophils at the later time-point suggests persistent inflammation, which is in 
line with the observed tissue damage. Representative images of neutrophil 
infiltration can be seen in Figure 5.3. 
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Figure 5.3 
 
 
Figure 5.3 C. difficile infection induces neutrophil recruitment to the gut.  
Neutrophils targeted with anti-NIMP-R14 antibody and visualised with DAB chromogen 
substrate were detected in the colon of mice infected with both ribotypes 001 and 027. For 001 
infection, neutrophils are recruited and present at day three, but had cleared by day seven. This 
clearance was not observed in 027-infection, with neutrophils persisting at day seven, possibility 
contributing to continued inflammation. Shown are representative images from four sampled 
mice per group. 
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5.2.5 Macrophages were detected in colonic tissue of both 001- and 027-
infected animals. 
Anti-F4/80 antibody was used to stain for the presence of macrophages in the 
colonic tissue of infected mice. The brown colour of the DAB staining was 
converted to red using ImageJ software, for ease of visualisation. Small numbers 
of macrophages were observed in the lamina propria of non-infected control 
tissue (Figure 5.4). This was expected as intestinal macrophages are resident in 
the gut (Doe 1989). A much higher population of macrophages were observed in 
001-infected mice at day 3, suggesting increased recruitment due to the 
inflammatory environment of the infected gut. Fewer numbers were present at 
Day 7, again suggesting that the host immune response is successfully 
controlling and resolving infection at this time point. Tissue damage was evident 
at both days 3 and 7 in 027-infected animals. Macrophage numbers appeared in 
lower numbers than 001-infected tissue, suggesting impaired clearance in 
response to this strain. At Day 7, macrophage numbers remained high, with no 
recovery in tissue structure. This is consistent with the observed late 
inflammation and more severe disease observed in RT 027-infection. 
Representative images of macrophage staining can be seen in Figure 5.4. 
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 Figure 5.4 
 
 
Figure 5.4 C. difficile infection induces macrophage recruitment to the gut.  
Macrophages stained with anti-F4/80 antibody and visualised with DAB chromogen substrate 
were detected in the colon of control mice, as well as those infected with both ribotypes 001 and 
027. Macrophages were detected in control tissue, due to the presence of resident intestinal 
macrophages. C. difficile RT 001 induced recruitment of a large amount of macrophages to the 
gut, can be seen by their higher numbers at day three. By day seven, this number had decreased. 
Macrophage numbers were also increased in RT 027-infection, with higher numbers at day seven 
relative to day three. Shown are representative images from four sampled mice per group. 
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5.2.6 Clostridium difficile ribotypes 001 and 027 induces recruitment of 
CD4+ T cells in vivo. 
Anti-CD4 antibody was used to stain for the presence of CD4+ T cells in the 
colonic tissue of infected mice. The brown colour of the DAB staining was 
converted to red using ImageJ software, for ease of visualisation. No T cells are 
detected in control tissue at either Day 3 or Day 7 after infection, suggesting a 
lack of resident T helper cells in the gut (Figure 5.5). CD4+ cells were detected 
in the colonic tissue from 001-infected mice at Day 3, albeit in lower numbers 
than either neutrophils or macrophages. At Day 7, similar numbers of CD4+ cells 
were observed, as would be expected for a successful adaptive immune response. 
Fewer CD4+ cells were detected at Day 3 of 027-infected mice. As adaptive 
responses can take longer to be induced, this was not unexpected. By Day 7, 
numbers of CD4+ cells had dramatically increased, corresponding to an 
increased inflammatory state. Representative images of macrophage staining can 
be seen in Figure 5.5. 
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Figure 5.5 
 
 
 
Figure 5.5 C. difficile infection induces CD4+ T helper cells recruitment to the gut.  
T helper cells stained with anti-CD4 antibody and visualised with DAB chromogen substrate 
were detected in the colon of mice infected with both ribotypes 001 and 027. CD4+ cells were 
not detected in control tissue. C. difficile RT 001 induced recruitment of CD4+ cells to the gut, 
with positive staining observed at both days three and seven post infection. CD4+ cell levels were 
lower in 027-infected tissue at day three, relative to RT 001-infection. This number had increased 
by day seven. Shown are representative images from four sampled mice per group.  
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5.2.7 Clostridium difficile ribotype 001 induces early production of 
proinflammatory cytokines, including those necessary for a Th17 response 
in the colon. 
qPCR analysis of homogenised colonic tissue revealed the cytokine environment 
of the gut during infection. At Day 3, IL-23, TGF-β and IL-6 were all strongly 
induced by RT 001, with a 10-fold increase in both IL-23 (p<0.01) and TGF-β 
(p<0.001), and an 8-fold increase in IL-6 (p<0.05). This can be seen in Figure 
5.6. There was no statistically significant increase of IL-23 or TGF-β in response 
to RT 027. At day 7 the expression of these cytokines had dropped to control 
levels in RT 001-infected animals. An exception to this is was an increase in 
RORγ expression in RT 001-infected animals at Day 7 (p<0.05). IL-23, TGF-β 
and IL-6 are essential in the development of an adaptive Th17 response, which 
has been previously been shown to play an important role in the clearance of 
extracellular bacterial infections. RORγ is the master regulator of Th17 response, 
and its presence in RT 001-infected animals suggests an important role for Th17 
responses in C. difficile infection. Additionally, a ~13-fold increase in IL-17 
expression was detected at Day 3 for 001-infection (p<0.001), again indicative of 
a Th17 response. At Day 7, IL-17 expression remained high in 001-infected 
animals, producing 5 times more than control mice (p<0.05). At this time point, 
027-infected animals produced higher levels of IL-17 (8-fold higher relative to 
control, p<0.01), but no statistically significant difference was found between RT 
001 and 027. RT 027 did not induce increased expression of IL-23 or TGF-β, yet 
a 4-fold increase in IL-6 was observed in response to this ribotype at Day 3 
(p<0.01). The results can be seen in Figure 5.6. 
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Figure 5.6 
 
Figure 5.6. Clostridium difficile ribotype 001 induces early production of proinflammatory 
cytokines, including those necessary for a Th17 response. qPCR analysis of colonic tissue 
isolated from all animals in control, RT 001 and RT 027 groups at Day 3 and Day 7 post-
infection. Expression of IL-6, IL-23, TGFβ, IL-17 and RORγ is upregulated by RT 001 at day 
three. This is not seen for RT 027. Cytokine production given in fold change relative to control. 
Student t tests were carried out on ΔCq values, * p<0.05; ** p<0.01, *** p<0.001. 
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5.2.8 Clostridium difficile ribotype 027 exhibits late induction of 
proinflammatory cytokines, with high levels of IL-10 in the colon.  
Three days after infection, we observed no significant increase in expression of 
pro-inflammatory cytokines IL-12p40, TNFα or IFNγ in either 001- or 027 
infected mice relative to control animals. Observed tissue damage is likely due to 
production of toxins that act on the cytoskeleton of host cells. Anti-inflammatory 
IL-10 expression was significantly upregulated by RT 027 at both Day 3 and Day 
7 post-infection; a ~2.5-fold increase in IL-10 levels was seen in 027-infected 
animals at Day 3 (p<0.01), and a ~1.5-fold increase was seen at Day 7 (p<0.05). 
IL-12p40 was upregulated by both RT 001 and 027 at Day 7, with a 2-fold 
increase in response to RT 001 (p<0.05) and 3-fold increase in response to 027 
(p<0.001). No significant up regulation of TNFα was detected in response to RT 
001, but RT 027 induced ~4-fold increase in the levels of this cytokine at Day 7 
(p<0.05). IFNγ remained consistent between the three experimental groups at 
Day 3, with a non-significant decrease caused by RT 027. At Day 7, levels of 
IFNγ were comparable between control and 001-infected animals, but a decrease 
was seen in response to RT 027 (p<0.05). The results can be seen in Figure 5.7 
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Figure 5.7 
 
Figure 5.7. Clostridium difficile ribotype 027 exhibits late induction of proinflammatory 
cytokines, with high levels of IL-10. qPCR analysis of colonic tissue isolated from all animals 
in control, RT 001 and RT 027 groups at Day 3 and Day 7 post-infection. Expression of IL-10, 
IL-12p40, TNFα, and IFNγ is modulated by RT 027. Cytokine production is given in fold change 
relative to control animals. Student t tests were carried out on ΔCq values, * p<0.05; ** p<0.01, 
*** p<0.001. 
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5.2.9 Chemokine levels are similarly up regulated in both 001- and 027-
infected mice, with TLR4 being downregulated by 027.  
TLR4 expression is responsible for recognising the SLPs of C. difficile (Ryan et 
al. 2011), so increased expression of this receptor may playing a role in initiating 
an immune response and clearing the pathogen. High levels of TLR4 (2-fold 
increase compared to control, p<0.01) were detected in 001-infected mice at Day 
3. This increase was not observed in 027-infected mice; there was a small, but 
statistically significant, decrease relative to RT 001 (p<0.05), indicating there 
may be an altered response to this ribotype. Expression of chemokines MIP-1α 
and MIP-1β and MCP were all upregulated in response to C. difficile. There was 
an almost 3-fold increase in MCP-1 expression in response to RT 001 at Day 3 
relative to control mice (p<0.01); no statistically significant increase was seen in 
027-infected animals at either time point. MIP-1α expression was not 
upregulated by either RT 001 or 027 at Day 3. Increased levels 1α were seen, 
however, at Day 7 in response to both RT 001 and 027, with 2.5-fold (p<0.001) 
and 3-fold increases (p<0.001) being observed respectively. Both RT 001 and 
027 induced a ~3-fold upregulation of MIP-1β at Day 3 relative to control 
animals (p<0.01), and at Day 7 these levels were statistically similar to control 
levels. The results can be seen in Figure 5.8. 
 
 
 
 
 
 
188 
 
Figure 5.8 
 
Figure 5.8. Clostridium difficile induces chemokine production and modulates TLR4 
expression. qPCR analysis of colonic tissue isolated from all animals in control, RT 001 and RT 
027 groups at Day 3 and Day 7 post-infection. Expression of TLR4, MCP-1, MIP-1α and MIP-1β 
is shown. Cytokine production is given in fold change relative to control animals. Student t tests 
were carried out on ΔCq values, * p<0.05; ** p<0.01, *** p<0.001. 
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5.2.10 Clostridium difficile ribotype 001 induces early production of 
proinflammatory cytokines, including those necessary for a Th17 response 
in the cecum. 
cDNA was also synthesised from RNA isolated from the cecum of control and 
infected animals. A similar trend of cytokine expression was observed in the 
cecum relative to the colon. Expression of IL-6, IL-23 and TGF-β was all 
increased in response to RT 001, but not RT 027, at Day 3. A two-fold increase 
in both IL-23 (p<0.05) and TGF-β (p<0.01) expression was detected in 001-
infected animals relative to control. There was also a three-fold increase in IL-6 
(p<0.05). No significant increase for these cytokines was detected in response to 
RT 027 at either time point. In addition, IL-17 expression was not increased by 
either ribotype at Day 3 in the cecum. An increase in IL-17 was seen at Day 7 in 
001-infected mice, but this increase was found to be statistically insignificant. No 
RORγ was detected in the cecum. For each of these cytokines, expression was 
comparable to control animals at Day 7. Cytokine expression in the cecum can 
be seen in Figure 5.9. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
190 
 
Figure 5.9 
 
Figure 5.9. Clostridium difficile ribotype 001 modulates Th17-specific cytokines in the 
cecum. qPCR analysis of cecum tissue isolated from all animals in control, RT 001 and RT 027 
groups at Day 3 and Day 7 post-infection.. Expression of IL-23, TGFβ, IL-6 and IL-17 is 
upregulated by RT 001. Cytokine production is given in fold change relative to control animals. 
Student t tests were carried out on ΔCq values, * p<0.05; ** p<0.01, *** p<0.001. 
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5.2.11 Clostridium difficile ribotype 027 exhibits late induction of 
proinflammatory cytokines, with increased levels of IL-10 in the cecum.  
cDNA was synthesised from RNA isolated from the cecum of control and 
infected animals. At Day 3, no significant increase in IL-10 was detected in 
response to either RT 001 or 027. RT 027 induced a 1.5-fold increase in IL-10 
production at Day 7 (p<0.001). There was also no statistically significant 
increase in levels of IL-12p40 for both infection groups at either time points. 
TNFα was not upregulated by either ribotype in the cecum at Day 3. At Day 7, 
however, RT 027 induced a ~4-fold increase in TNFα levels relative to control 
(p<0.01). The results can be seen in Figure 5.10. 
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Figure 5.10 
 
Figure 5.10. Clostridium difficile ribotype 027 exhibits late induction of proinflammatory 
cytokine TNFα, with increased levels of IL-10. qPCR analysis of cecum tissue isolated from all 
animals in control, RT 001 and RT 027 groups at Day 3 and Day 7 post-infection.. Expression of 
IL-10, IL-12p40 and TNFα is shown. Cytokine production is given in fold change relative to 
control animals. Student t tests were carried out on ΔCq values, * p<0.05; ** p<0.01, *** 
p<0.001. 
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5.2.12 SLPs isolated from Clostridium difficile ribotypes 001 and 027 
differentially drive high levels of IL-17 and IL-10, respectively, in vitro. 
IL-10 production is upregulated by SLPs from RT 027, while IL-17 is 
upregulated by RT 001 SLPs, in vitro. Our group has recently shown the 
importance in surface layer proteins (SLPs) in the immune response to C. 
difficile, activating immune cells through TLR4. As we have detected high levels 
of IL-10 in 027-infected mice, correlating to impaired bacterial clearance, 
determining if SLPs play a role in this response is crucial. In order to do this, we 
employed a DC/T cell co-culture model. BMDCs activated with SLPs of RT 001 
and 027, in the presence of OVA peptide, were grown in culture with CD4+ T 
cells isolated from OVA-transgenic mice. Dendritic cells were irradiated before 
co-culture, ensuring all cytokine production originated from the BMDC-activated 
T cells. Cytokine analysis revealed high levels of IL-17 in response to BMDCs 
stimulated with SLPs from RT 001 (p<0.001). This correlates with observations 
from the animal model showing Th17-linked cytokine production in response to 
this ribotype. Also correlating with the infection study was high levels of IL-10 
from T cells in response to 027 SLP-stimulated BMDCs. CD4+ T cells showed a 
two-fold increase in IL-10 production in response to 027 SLP-activated DCs 
relative to RT 001 (p<0.001). This high IL-10 production in response to 027 
SLPs is also observed in dendritic cells isolated from BALB/c mice, as well as in 
the J774 macrophage cell line. 
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Figure 5.10 
 
Figure 5.10 IL-10 production is upregulated by SLPs from ribotype 027, while IL-17 is 
upregulated by RT 001 SLPs in vitro. 
SLPs isolated from C. difficile can specifically induce cytokine profiles similar to those observed 
in vivo. Specifically, SLPs from RT 027 induced high levels of IL-10, while SLPs from 001 
induced high levels of IL-17. Statistical significance between the groups was determined by one-
way ANOVA * p<0.05; ** p<0.01, *** p<0.001. Results are representative of three independent 
experiments. 
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5.2.13 SLPs from ribotype 027, but not 001, initiate both MyD88-dependent 
and -independent pathways downstream of TLR4. 
In order to address how the different immune responses to RT 001 and 027 SLPs 
were being mediated, we examined whether they both activated similar 
signalling pathways downstream of TLR4. SLPs from RT 001 and 027 both 
activated NF-κB downstream of TLR4 (Figure 5.11), and subsequently, NF-κB-
dependent IL-8 production. IRF3 is a transcription factor associated with the 
MyD88-independent pathway, and simultaneous activation of both these 
pathways has been associated with high IL-10 production. As previously 
observed, we did not see IRF3 activation with SLPs from RT 001, but RT 027 
SLPs induce high levels of IRF3, and subsequently RANTES. A five-fold 
increase in IRF3 expression was detected relative to control cells (p<0.001), with  
RANTES also significantly increased by SLPs from 027 (p<0.001). The 
activation of both NF-κB and IRF3 by SLPs from RT 027 may explain the higher 
levels of IL-10 induced by RT 027.  
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Figure 5.11 
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Figure 5.11 SLPs from ribotype 027 induce high levels of IRF3, indicating activation of the 
MyD88-independent pathway. 
HEK-293 cells transfected with TLR4 were stimulated with SLPs from ribotypes 001 and 027. 
Levels of NF-kB and IRF3 were detected by luciferase assay, while IL-8 and RANTES levels 
were detected by ELISA. SLPs from both ribotypes stimulated production of NF-kB and IL-8. 
High levels of IRF3 and RANTES were observed in response to SLPs from 027, not 001. 
Statistical significance between the groups was determined by one-way ANOVA * p<0.05; ** 
p<0.01, *** p<0.001. Results are representative of three independent experiments. 
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5.3 DISCUSSION 
In this chapter we set out to confirm our hypothesis that C. difficile RT 027 
causes more severe disease than RT 001, by inducing higher levels of 
inflammation, and blocking the necessary clearance mechanisms required for 
resolving infection. To do this we used the antibiotic cocktail mouse model of 
CDI, which successfully mimics many of the symptoms associated with the 
disease (Chen et al. 2008).  
 
Despite some controversy in the literature regarding ribotype and prediction of 
disease severity (Walk et al. 2012; A Sarah Walker, Eyre, Wyllie, et al. 2013; A 
S Walker, Eyre, Crook, et al. 2013b; A Sarah Walker, Eyre, Crook, et al. 2013), 
this study shows a strong link between C. difficile RT 027 and severe disease. 
Animals infected with this ribotype showed greater weight loss, more tissue 
damage, and higher bacterial load relative to control and 001-infected mice. 
These observations suggest that C. difficile RT 027 cannot be effectively cleared 
by the host immune system, and as a result, causes persistent disease. There is 
evidence in the literature that RT 001 results in less severe infection than 027 
(Saxton et al. 2009), and mice infected with this ribotype were able to effectively 
recover after seven days, with lowered CFU counts and weights comparable to 
control mice. Histology of colonic tissue supported this analysis, revealing 001-
infected animals with healthy gut morphology seven days after infection, while 
RT 027 induced more severe, persistent damage.  
 
Induction of proinflammatory cytokines is likely a critical determinate in 
effectively clearing C. difficile. Upregulation of cytokines necessary for a Th17 
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response, specifically IL-6, IL-23 and TGF-β, was observed in RT 001-infected 
animals, but not in 027-infection. Increased levels of IL-17 were also detected at 
both Days 3 and 7 in 001-infected animals. Later induction of RORγ in this 
group is indicative of a Th17-driven adaptive immune response necessary for 
clearance. It has previously been established that Th17 responses play a crucial 
role in the clearance of extracellular pathogens (Khader et al. 2009; Sellge et al. 
2010; Zhang et al. 2009a). Th17 cells have been shown to play a role in tight 
junction formation, so their accumulation in the gut may aid in reversing tissue 
damage (Kinugasa et al. 2000). Reversal of tissue damage, lower CFU counts, 
and lower proinflammatory cytokine levels at Day 7 all strongly suggest that RT 
001 induces a Th17 response, which efficiently clears the pathogen from the gut. 
The lack of Th17-specific cytokines in 027-infected mice may contribute to 
persistent infection and lack of clearance.  Indeed, impaired Th17 responses have 
been associated with disease in both mice and humans. IL-17A is associated with 
increased neutrophil recruitment, which is necessary for sufficient clearance of 
C. difficile (Roussel et al. 2010). Previous studies in a Cytrobacter rodentium 
model of intestinal infection showed IL-17 exhibit protective effects (Ishigame et 
al. 2009). However, Th17 cells have also been associated with pathology of 
inflammatory bowel disease, particularly seen to have detrimental effects for 
DSS colitis models (Feng et al. 2011). From our observations, it seems likely that 
the lack of a Th17 response in RT 027 infection is a contributing factor in its 
severe infection. 
 
RT 027 induces few proinflammatory cytokines three days after infection. At this 
time point, bacterial load (CFU/g) in the gut is at its highest and histological 
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analysis reveals tissue damage induced by the infection. This observed tissue 
damage is likely due to toxin production by the bacteria, acting on the actin 
cytoskeleton of intestinal cells and destroying their structure. High levels of 
TNFα levels are associated with increased colitis in UC patients (Murch et al. 
1991), and blocking of TNFα has been shown to alleviate symptoms of UC (Lv 
et al. 2014). IL-12p40 is also associated with more severe UC (Kullberg et al. 
1998). High levels of proinflammatory TNFα, IL-12p40, and IL-6, are all 
observed in 027-infected animals at day 7. Interestingly, high levels of anti-
inflammatory IL-10 are also observed. These cytokines will induce more damage 
may play a role in persistent infection by increasing local inflammation, while 
IL-10 may supress surrounding immune cell activity, impeding clearance.  
 
IL-10 is an anti-inflammatory cytokine produced by many cells of the immune 
system. It is known to induce many anti-inflammatory actions, such as blocking 
phagosome maturation and proinflammatory cytokine production, and blocking 
antigen presentation in innate cells. It has been associated with inhibition of Th1, 
Th2, and Th17 differentiation, as well as protection against UC (O’Garra & 
Vieira 2007; Maynard & Weaver 2008; Ranatunga et al. 2012).  In contrast, 
many recent infection studies have shown that an absence of IL-10 can lead to 
increased bacterial clearance (Redford et al. 2011). This suggests that IL-10 
production results in different outcomes from different infections. IL-10 is found 
to play a deleterious role in M. tuberculosis infection, specifically by blocking 
IFNγ-mediated phagosome maturation, allowing phagocytosed bacteria to 
survive (O’Leary et al. 2011). The intracellular bacteria Brucella abortus has 
also been shown to utilise IL-10 to evade an immune response. It was found that 
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B. abortus induced early IL-10 production by CD25+CD4+ T cells to inhibit 
macrophage function, causing a balance in pro-inflammatory and anti-
inflammatory cytokines which benefited the bacteria, and caused persistent 
infection (Xavier et al. 2013). Parasites have also been seen to recruit IL-10, with 
Leishmania major also inducing early IL-10 production by T cells, making 
BALB/c mice more susceptible to infection (Schwarz et al. 2013). Blocking of 
IL-10 was also found to increase immunity to Schistosoma mansoni, again 
indicating this pathogen was using the anti-inflammatory effects of IL-10 to its 
advantage (Wilson et al. 2011). Taken together, there is a strong possibility that 
C. difficile RT 027 is modulate cells T cells to produce high levels of IL-10, 
suppressing clearance of the pathogen. 
 
IFNγ production was downregulated by RT 027. High levels of IFNγ are 
associated with UC, with anti-IFNγ antibodies alleviating disease in scid mice 
(Powrie et al. 1994). The down-regulation of IFNγ by RT 027 was therefore not 
expected. However, as anti-IFNγ antibodies have been shown to be ineffective in 
conditions such as Crohn’s disease, it is likely this cytokine in not required for 
colitis to occur. IFNγ levels have previously been associated with chemokine 
production and neutrophil recruitment (McLoughlin et al. 2008), and low levels 
which may contribute to decreased cell migration and lack of clearance. IFNγ 
can also inhibit IL-10 production (Hu et al. 2006), so low levels in RT 027-
infection correlate with increased IL-10. 
 
PCRs carried out on RNA isolated from the cecum showed a similar trend in 
cytokine production in response to the two ribotypes. The fold changes of each 
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of these cytokines were much lower than those observed in the colon. This may 
be due to the main infection occurring in the distal colon of the animals, while 
the cecum likely contains many ungerminated spores. There is however, 
statistically significant increases in IL-23, TGF-β and IL-6 in response to RT 
001, along with increased IL-10 in response to 027, suggesting that any 
vegetative cells present in the cecum are inducing a similar immune response to 
that of the colon. 
 
Cellular infiltration into the gut is indicative of an inflammatory, colitis-like 
state. We observed infiltration of neutrophils, macrophages and CD4+ T helper 
cells into the gut at different time points for both RT 001 and 027 infections. 
Neutrophil recruitment has previously been described as a necessary step in the 
clearance of C. difficile, specifically being mediated through MyD88 (Jarchum et 
al. 2012). No neutrophils were detected in the colon of control mice that were 
administered antibiotics. We detected neutrophil infiltration at Day 3 in both 
001- and 027-infected animals, showing an immune response to the pathogen. By 
day 7, neutrophil numbers had lowered in RT 001-infected animals but not in 
027-infection. It is possible that the persistent levels of neutrophils in the gut in 
response to RT 027 are contributing to an increased inflammatory state, and 
therefore playing a role disease severity. Levels of MCP were higher in 001-
infected animals relative to control at Day 3. This cytokine is responsible for 
recruiting neutrophils, and its expression explains the observed recruitment. This 
upregulation was not observed in response to RT 027 however. IFNγ has 
previously been shown to be involved in neutrophil recruitment, and is 
downregulated in response to RT 027. These observations suggest that RT 027 
202 
 
should decrease neutrophil recruitment to the gut by decreasing IFNγ expression 
and not inducing MCP production. This was not observed however, indicating a 
more complex mechanism for neutrophil recruitment. 
 
We have previously shown a role for macrophages in vitro, specifically 
responding to the SLPs of C. difficile RT 001 and inducing clearance 
mechanisms (Collins et al. 2014). In this study we detected macrophages in the 
colon of each of the animal groups. Their detection in control groups is likely 
due to the presence of resident intestinal macrophages. An increase in 
macrophage numbers in both infection groups is expected and likely contributing 
to the inflammatory environment. At Day 3, larger numbers are seen in mice 
infected with RT 001. This correlates with increased expression of chemokines 
MCP and MIP-1β in the colon at Day 3. Combined with the observed cytokine 
profile in response to RT 001, it is likely these macrophages are inducing an 
environment favouring a Th17 adaptive response, and as the SLPs activate 
clearance responses in macrophages, their early recruitment may be an 
explanation for the less severe disease associated with this ribotype. RT 027 
induces later recruitment, with macrophage numbers much higher at Day 7. 
Levels of MIP-1α are increased at both time points, but there is no increased 
expression of MCP or MIP-1β, which may explain impaired/delayed recruitment. 
The lack of proinflammatory cytokine production at Day 3 may result in a 
beneficial environment for the pathogen, causing the cells to produce IL-10 and 
therefore suppressing any clearance responses, resulting in more severe 
inflammation and disease. 
 
203 
 
CD4+ T cells were also recruited to the site of infection. No positive staining was 
observed in the colons of control animals at either time point, indicating a lack of 
CD4+ cells in the non-infected/susceptible state of the gut. Infiltration of these 
cells was observed in response to RT 001 at Day 3 and Day 7. Given the 
cytokine environment of the colon at Day 3, as determined by PCR analysis, it is 
likely that these CD4+ T helper cells are being driven to a Th17 phenotype, a 
phenotype previously shown to be necessary in bacterial clearance. The presence 
of increased levels of RORγ, the master regulator of Th17 cells, further 
corroborates this. Lower numbers of these cells at Day 7 also indicate the 
infection is being resolved. CD4+ cell infiltration is also observed in animals 
infected with RT 027, but with very low numbers at Day 3. This had increased 
by Day 7. The cytokines present in the gut during 027-infection do not promote a 
Th17 response, and this may be an indication as to why RT 027 induces more 
severe disease. Further to this, high levels of IL-10 in the colon of 027-infected 
mice suggest T cells may be acquiring a Treg phenotype. While these cells can 
play important roles in dampening down an immune response during clearance, 
they may also be recruited by C. difficile to inadvertently supress the immune 
response to the pathogen and inhibit clearance. As clearance is inhibited, the high 
levels of TNFα and IL-12p40 may be contributing to the inflammation induced 
by toxin production. This will further break down the epithelial lining of the 
intestine, resulting in the bacteria gaining a greater foothold, invading deeper into 
the gut. 
 
While the responses to C. difficile in vivo are intriguing, and give insight into the 
mechanisms by which RT 027 induces more severe and persistent disease, we 
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must be careful in correlating this data with human disease. The common 
ancestor of humans and mice existed between 65 and 75 million years ago, 
which means there is ~150 million years of independent evolution between the 
two organisms (Waterston et al. 2002; Madsen et al. 2001). Due to this, it is not 
surprising that many differences exist between the immune systems of mouse 
and human (Mestas & Hughes 2004). These differences may mean that the 
responses observed in mice to not hold true for human disease. However, as a 
model for CDI, all the observations in this chapter correlate to expected findings 
for CDI, and consistently show RT 027 inducing more severe disease. More 
severe disease is consistently observed for C. difficile RT 027, while RT 001 has 
been associated with more mild disease. The recent debates in the literature (A 
Sarah Walker, Eyre, Wyllie, et al. 2013; Walk et al. 2012; A S Walker, Eyre, 
Crook, et al. 2013a; Walk et al. 2013b) suggest that ribotype alone cannot predict 
disease severity when other factors are taken into account. In this study, the 
animal groups were treated with the same antibiotics before being administered 
103 C. difficile spores. They were kept in the same conditions for seven days. We 
observed a clear difference in severity between mice infected with RT 001 and 
027.   
 
Experiments conducted on purified SLPs in vitro also corroborated with the 
results from the animal study. Specifically, dendritic cells displaying OVA 
peptide, and activated with SLPs from RT 001 and 027 were grown in co-culture 
with OVA-specific T cells. As the dendritic cells were irradiated before the 
addition of T cells, all cytokines produced were from the T cells alone. BMDCs 
exposed to SLPs from RT 001 induced production of IL-17 in the T cells. This is 
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in line with what we observed in the animal model with high levels of IL-17 in 
the colon of 001-infected mice. This suggests that the SLPs may be playing a 
direct role in inducing this response in vivo. This IL-17 production was not 
observed in response to SLPs from 027, with high levels of IL-10 being 
observed. Again, this correlates to the findings in the animal model study. It 
appears that dendritic cells activated with SLPs from RT 001 drive T cells to 
produce IL-17, while 027 SLP-activated dendritic cells induce production of IL-
10 in T cells. These SLPs may therefore be playing an important role in disease 
severity.  
 
The mechanism for the increased levels of IL-10 we have associated with RT 
027 may lie in the downstream signalling of TLR4. As a common pattern 
recognition receptor, TLR4 signalling is well understood and results in 
downstream activation of the transcription factor NF-κB. We have previously 
shown the SLPs from RT 001 to activate the MyD88-dependant pathway 
downstream of TLR4, inducing NF-κB transcription. It has previously been 
shown that optimal IL-10 production is induced when both MyD88-dependent 
and –independent pathways are activated, and expression of IRF3 would be 
indicative of the MyD88-independent pathway being active (Boonstra et al. 
2006; Chang et al. 2007). We observed high expression of IRF3 in response to 
SLPs from 027, but not RT 001. SLPs from this ribotype also induced high levels 
of RANTES, a chemokine downstream of this arm of the pathway. Therefore, it 
appears that the SLPs from 027 are directly inducing immune cells to produce 
higher levels of IL-10 through TLR4 activation of the MyD88-independent 
pathway, which is not seen with SLPs from RT 001. 
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In conclusion, we have seen that C. difficile RT 027 induces more severe 
infection than RT 001. This ribotype caused more severe tissue damage, 
increased cellular infiltration, late induction of proinflammatory cytokines, and 
high levels of immune-suppressing IL-10. These factors act together to inhibit an 
appropriate immune response and clearance of the pathogen, while causing 
severe inflammation and tissue damage. RT 001 also induced tissue damage 
during the early stages of infection, yet generated a cytokine environment in the 
colon beneficial for the derivation of Th17 cells, an important T cell subset for 
the clearing of intestinal pathogens.  
 
We have also seen that the SLPs from C. difficile have the potential to directly 
induce these environments. Purified SLPs from RT 001 induce high levels of IL-
23, IL-6 and IL-17 in vitro (see previous chapter), while SLPs from 027 induce 
high levels of IL-10, in addition to many proinflammatory cytokines. Dendritic 
cells activated with SLPs also induce T cells to produce IL-17 in response to RT 
001, and IL-10 in response to 027. It also appears that the SLPs from 027 drive 
the MyD88-independent pathway downstream of TLR4, which is associated with 
high IL-10 production. Therefore, the SLPs from C. difficile may be directly 
modulating the immune response, in the case of RT 027, by inducing IL-10 
production and suppressing clearance mechanisms, while toxin production 
causes further tissue damage and disease. 
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Chapter 6 
 
General Discussion 
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6.1 GENERAL DISCUSSION 
Many studies have reported that the symptoms and severity of CDI can vary 
greatly depending on the strain causing infection (Kato et al. 2009; Drudy, 
Harnedy, et al. 2007; Drudy, Fanning, et al. 2007; Arvand et al. 2009; Bauer et 
al. 2011; Dawson et al. 2009; Warny et al. 2005). Some strains may induce mild 
disease, others cases may be asymptomatic, while certain strains can induce 
severe colitis, leading to sepsis and even death. Various virulence factors have 
been studied over the years, with a particular interest in toxin production. Toxins 
produced by C. difficile interact and damage the actin cytoskeleton of the 
epithelial cells of the intestine, causing infiltration of inflammatory cells into the 
gut (Libby et al. 1982). Therefore the ability of a particular strain to produce 
higher levels of toxins may explain the vast spectrum of infections observed. 
While the role of toxins in CDI has been heavily studied (Young & Hanna 2014; 
Carter et al. 2011; Steele et al. 2012; Warny et al. 2005), less is known about the 
role of the SLPs coating the outer layer of the pathogen. SLPs, consisting of low 
molecular weight (LMW) and high molecular weight (HMW) subunits cover the 
vast majority of the outer S-Layer of C. difficile. Our hypothesis states that 
different ribotypes of C. difficile cause variable disease, and that the sequences of 
the SLPs are a crucial determinate in severity of infection. The sequence of these 
proteins will determine how well the host immune system recognises the 
pathogen, and the type of immune response initiated. 
 
SLPs exhibit vast sequence variability between strains (Calabi et al. 2001; Eidhin 
et al. 2006), and have been shown to induce an inflammatory response (Ausiello 
et al. 2006). We have reported that the proteins signal specifically through TLR4 
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to induce inflammation (Ryan et al. 2011). This receptor is normally associated 
with recognising LPS on the surface of gram-negative bacteria, so the ability of 
TLR4 to also recognise proteins from a gram-positive pathogen shows the 
robustness of the innate immune response. Our group have shown that the SLPs 
from ribotype 001 activate immune cells in vitro, and induce clearance responses 
in macrophages (Collins et al. 2014). The sequence variability of the SLPs 
between strains, along with the importance of sequence in recognition by TLR4, 
suggests that proteins from different ribotypes may not activate immune cells in 
the same way, and large sequence differences may even result in a loss of 
recognition of the SLPs by the immune system.  
 
To determine if a link exists between sequence variation of SLPs and disease, we 
performed bioinformatics analysis of the gene that codes for SLPs, slpA. S-
Layers are present on the surface of many bacterial species, and sequence 
variation of surface proteins has been reported to result in immune evasion for 
many pathogens (Higgins & Carrington 2014; van der Woude & Bäumler 2004). 
The low sequence similarity between the SLPs of different ribotypes suggests C. 
difficile may have evolved a similar method for survival. Analysis of the slpA 
gene from the 16 distinct ribotypes revealed many amino acid residues 
undergoing positive selection, giving a fitness advantage to that particular 
ribotype.  
 
We detected evidence of positive selection in both the LMW and HMW SLP 
subunits. The LMW SLP subunit has previously been described as the 
immunodominant antigen of the S-Layer (Fagan et al. 2009). While it was not 
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surprising to find evidence of positive selection here, due to high sequence 
variability, the majority of ribotypes exhibiting positive selection in this subunit 
have been previously reported as “hypervirulent”, for example ribotypes 017, 
027 and 078 (Arvand et al. 2009; Goorhuis et al. 2008; Marsh et al. 2012). Our in 
vitro studies determined that the SLPs from RT 027 and 078 (where selection on 
the LMW SLP was detected) induced high levels of proinflammatory cytokine 
production, while SLPs from RT 001 and 014 (where no positive selection was 
detected) produced much lower levels. It is therefore possible that amino acid 
altering mutations in the SLPs from these ribotypes are contributing to 
hypervirulence, specifically by interacting with TLR4 to modulate the host 
immune response to the advantage of the pathogen.  
 
Of particular interest is the relationship between the SLPs of ribotypes 001 and 
027. The slpA sequences from these ribotypes exhibit high sequence similarity, 
and are sister taxa on our phylogenetic tree. Therefore, a similar immune 
response to both SLPs might be expected. Positive selection on the branch 
leading to 027 suggests that the small sequence variations that do exist are 
important. RT 027 is described as hypervirulent in many studies, being 
associated with more severe colitis and recurrent disease (Marsh et al. 2012; 
Valiente et al. 2014; Dawson et al. 2011). It was initially hypothesised that the 
variations observed in SLP of RT 027 may shield the bacteria from the immune 
system. Sequence variation may result in a loss of recognition by the immune 
system and the SLPs will therefore act as a molecular “cloak”. The observed 
increased inflammation may contribute to disease severity in addition to the 
increased toxin production preciously described in RT 027 (Carter et al. 2011). 
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Positive selection has previously been associated with functional shift, where 
positively selected mutations alter the structure and function of a protein. 
Loughran et al have shown protein functional shift by positive selection in 
human myeloperoxidase (MPO) (Loughran et al. 2012). Using site directed 
mutagenesis on the amino acid residues under positive selection, they were able 
to show a complete loss in the novel chlorination function of MPO. The methods 
used for the detection of positive selection in MPO are identical to those used in 
this thesis (Loughran et al. 2012). This link between positive selection and 
protein functional shift has also been shown in other studies. Mutation of 
positively selected sites in the lipase/feruloyl esterase A family of proteins 
resulted in loss of function in fungi (Levasseur et al. 2006), and similar results 
were found for Potato Virus Y (Moury & Simon 2011). These functional studies 
of positively selected residues corroborate our findings of positive selection on 
the SLPs of C. difficile, and strongly suggest a role for protein functional shift in 
severe CDI. 
 
In addition to showing the link between positive selection and protein functional 
shift, phylogenetic analysis have been used to directly determine the role of 
positive selection in other infections. Positive selection has previously been 
detected on the pilus adhesion, FimH, of uropathogenic Escherichia coli (UPEC) 
(Chen et al. 2009). The receptor binding domain of FimH contains a mannose-
specific binding pocket, yet positive selection was detected in residues away 
from this area. Despite maintaining binding to mannosylated receptors on the 
uroepithelium, mutation of two residues under positive selection resulted in a 
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10,000-fold reduction in colonisation of UPEC. This mutation also resulted in 
UPEC being unable to form intracellular bacterial communities (Chen et al. 
2009). The PorB surface protein of Neisseria meningitidis has also been shown 
to exhibit signatures of positive selection, the residues under positive selection 
are predicted to be exposed to the host immune response with implications for 
pathogenesis (Urwin et al. 2002). Urwin et al. postulated that these positively 
selected sites were under strong immune selection (Urwin et al. 2002). These 
studies show a direct link between positive selection and pathogenicity, and 
highlight the importance of understanding these links in infections like CDI. 
 
SLPs from ribotypes 027 and 078 consistently induced higher levels of cytokine 
production in macrophages and dendritic cells than SLPs of RT 001 and 014. 
This strongly suggests that the positively selected amino acid substitutions in 
slpA facilitate the production a more severe inflammatory response. The SLPs 
may therefore be contributing to the inflammatory state in the gut through 
interaction with the host immune system. As the SLPs are only a single 
component of the bacteria however, we used an animal model to see if these 
results directly translate to infection and disease. 
 
The antibiotic cocktail mouse model for CDI (Chen et al. 2008) was used to 
determine if this trend of increased inflammation by positive selection on SLPs 
was evident in infection with the whole bacteria. Again, we observed high levels 
of pro-inflammatory cytokines in response to RT 027, with increased tissue 
damage and bacterial load in the gut relative to RT 001. Animals cleared 
infection of RT 001 after seven days, but it appears the immune response could 
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not mount an appropriate response against 027. This more severe infection in 
response to RT 027 agrees with our in vitro findings. The cytokine environment 
of the gut is a crucial determinate in how the adaptive immune system responds 
to pathogens, and may be the key to how C. difficile modulates the host to evade 
clearance while causing severe inflammation. RT 001 induces IL-6, IL-23 and 
TGF-β, all indicative of a Th17 response, and many studies have shown the 
protective role Th17 cells play in clearing extracellular pathogens, particularly in 
the gut (Khader et al. 2009; Zhang et al. 2009b; Blaschitz & Raffatellu 2010; 
Ishigame et al. 2009).  
 
Positive selection acting on the SLPs of RT 027 may be altering the sequence 
motif responsible for activating TLR4 and mounting an immune response. High 
levels of TNFα in particular may be driving disease, having been associated with 
severe colitis in many studies (Plevy et al. 1997; Braegger et al. 1992), and anti-
TNFα therapies being utilised as a viable treatment for inflammatory bowel 
disease (Lv et al. 2014; Su et al. 2002). High levels of IL-10 may be working to 
suppress components of the immune system necessary for clearance. IL-10 has 
been shown to inhibit Th17 development (Maynard & Weaver 2008), and the 
lack of Th17 specific cytokines, along with RORγ in the gut of 027-infected 
animals suggests that this is the case. Other pathogens are known to manipulate 
the immune system with IL-10 to avoid clearance (O’Leary et al. 2011), and C. 
difficile may use a similar mechanism. IFNγ has been shown to play a role in 
phagosome maturation (O’Leary et al. 2011; Hostetter et al. 2002), so its 
downregulation by 027 may prevent macrophages from destroying phagocytosed 
bacteria. Low IFNγ levels, in addition to high levels of IL-10 and TNFα all may 
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contribute to more severe and persistent disease. Activation of the MyD88-
independent pathway leads to downstream activation of IRF3, and activation of 
both MyD88-dependent and -independent pathways results in higher levels of 
IL-10 (Boonstra et al. 2006; Chang et al. 2007). We found that SLPs from RT 
027 induced expression of IRF3. The motif present in the SLPs of 027 likely 
modulates TLR4 signalling, increasing IL-10 production. 
 
While the specific sequence motifs that TLR4 binds to on the SLPs are unknown, 
likely candidates are the areas under positive selection. As the SLPs from 
ribotypes 001 and 027 are the most closely related sequences in our dataset, only 
027 SLPs can activate the MyD88-independent pathway, it appears that the small 
sequence differences under positive selection are playing a significant role in 
how the host mounts an immune response. It is also important to note that the 
responses observed in vivo cannot be attributed to SLPs alone. The production of 
toxins, along with the role of other adhesions plays a role in the pathology of C. 
difficile.  However, our results in vitro showing high IL-17 induced by RT 001 
SLPs and high IL-10 by 027 SLPs are consistent with the infection studies in 
vivo, and it is likely that SLP sequence is a crucial determinate in driving 
adaptive T cell responses to clear infection. Positive selection on SLPs from 027 
appears to play a role in inhibiting the protective Th17 response observed in 001-
infection, specifically by activating the MyD88-independent pathway 
downstream of TLR4, and increasing IL-10 expression. This shows us a link 
between positive selection of the SLPs and severity of infection. 
 
Future studies on site-directed mutagenesis of the positively selected regions, and 
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the use of recombinant SLPs may help to further confirm the role of positively 
selected residues on the slpA gene in modulating the immune response. Such 
studies could also contribute to determining the amino acid motif by which 
TLR4 recognises C. difficile and mounts a response, thereby unmasking a 
potential therapeutic target.  
 
The continued prevalence of antibiotic-resistant strains, along with the 
emergence of new hypervirulent strains, reveals the need for new forms of 
treatment against CDI. If a sequence motif with signatures of positive selection is 
responsible for modulating TLR4 to increase IL-10 production, then blocking 
this interaction may be a key therapeutic strategy. However, it is important to 
consider that a complete loss of recognition by TLR4 could have detrimental 
effects on infection. TLR5 also plays a role in mounting a response to C. difficile 
infection, specifically by recognising bacterial flagella (Yoshino et al. 2013). 
TLR5 stimulation has also been shown to have protective effects against C. 
difficile –induced colitis in mice (Jarchum et al. 2011), therefore in the case of 
strains undergoing positive selection on slpA, blocking TLR4-SLP interaction 
may help ameliorate severe symptoms of disease, while enhanced TLR5 
activation could provide improved protective effects.  
 
Antibody therapies against SLPs could potentially be a viable treatment for CDI, 
indeed anti-SLP antibody has previously been detected in human sera (Drudy et 
al. 2004). However, due to the high sequence variation between strains, a 
universal treatment targeting all variations of SLPs may prove difficult. 
Inhibiting the activity of the protease Cwp84 could potentially reduce severity of 
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CDI. As this cell wall protein is responsible for cleaving SlpA in the mature 
LMW and HMW subunits of the S-Layer (de la Riva et al. 2011), blocking the 
protease activity would result in the accumulation of immature SLP precursors at 
the cell wall. This would alter the conformation of the S-Layer, potentially 
inhibiting adherence of the gastrointestinal tract (Merrigan et al. 2013), and 
blocking SLP-TLR4 interaction. 
 
Another potential therapy is the blocking of IL-10 to ensure an appropriate 
immune response is initiated. As this cytokine suppresses adaptive immune 
responses, anti-IL-10 antibody could reverse this immune suppression and help 
clear disease. Neutralisation of IL-10 has been shown to be beneficial in both 
bacterial and viral infections. Blocking of IL-10 has been shown to increase 
survival in mice infected with Klebsiella pneumonia (Greenberger et al. 1995), 
and administration of anti-IL-10 antibody effectively enhances resistance to 
Mycobacterium avium in mice (Bermudez & Champsi 1993). Similar results are 
seen in viral infections, with IL-10-/- mice exhibiting less severe disease in 
response to West Nile Virus, along with anti-IL-10 antibody providing protective 
effects (Bai et al. 2009). Blocking of IL-10 has even been shown to be effective 
in the treatment of parasitic infections, specifically in human visceral 
leishmaniasis (Gautam et al. 2011). These studies together highlight the potential 
importance of anti-IL-10 therapy in the treatment of severe CDI. 
 
The idea that ribotype can be a reliable indicator of disease severity has been 
controversial, and conflicting positions are debated heavily in the literature 
(Walk et al. 2012; A Sarah Walker, Eyre, Crook, et al. 2013; A Sarah Walker, 
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Eyre, Wyllie, et al. 2013). However, we have shown a direct link between RT 
027 and increased inflammation leading to severe disease. Specifically, we 
suggest that positive selection on the SLPs of RT 027 contributes significantly to 
increased severity of disease. We must exercise caution in comparing these 
results to global infections as recent studies have shown potential for 
recombination and horizontal gene transfer between the SLPs of different 
ribotypes (Dingle et al. 2013). This means that individual isolates of a particular 
ribotype may possess unique SLP sequences. We confirmed by sequencing that 
all SLPs analysed in this thesis correspond directly to the sequences from our 
bioinformatics analysis. We can therefore directly correlate positive selection 
analysis with our in vitro and in vivo findings. While these finding may not be 
true for all strains designated RT 027, they provide an important insight into the 
role of SLPs in infection, along with the mechanisms by which they modulate the 
immune response.  
 
In conclusion, positive selection on the slpA sequences of C. difficile appears to 
induce a protein functional shift, and modulate TLR4 signalling. In the case of 
hypervirulent RT 027, this manipulation activates IRF3, increasing IL-10 
production in the gut, and suppressing adaptive responses such as a protective 
Th17 response. In the absence of this functional shift, infection appears less 
severe, with successful clearance by the host immune system. Identification of 
these positively selected regions of slpA gives us greater insight into the 
molecular mechanisms of CDI, and reveals novel potential therapeutic targets for 
future treatment of the disease. A diagram summarising this process can be seen 
in Figure 6.1. 
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Figure 6.1 
 
Figure 6.1 Summary of immune modulation by SLPs 
SLPs from RT 001 activate NF-kB via TLR4 activation to stimulate proinflammatory cytokine 
production. High levels of IL-6, IL-23 and TGF-β may help drive an IL-17-heavy response, 
which, along with phagocytosis, aids bacterial clearance and tissue repair. Positive selection on 
the SLPs of RT 027 modulates TLR4 signalling to induce IRF3 activation, inducing high levels 
of IL-10, which can block adaptive immune responses. Later induction of proinflammatory 
cytokines exacerbates tissue damage, while IL-10 suppresses clearance, leading to persistent 
disease.   
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APPENDIX A – MEDIA AND BUFFERS 
 
5x Loading Buffer 
Glycerol 15mL 
10% SDS 10mL 
Tris pH6.8 (0.5M) 6.25mL 
dH2O 18.75mL 
Bromoblue tipful 
250μL of DTT was added to 1mL of Loading Buffer to make final buffer. 3μL of 
this 5x loading buffer was added to 12μL of each sample. 
 
10% Separating Gel 
dH2O 10mL 
Bis-acrylamide 8.38mL 
Tris pH 8.8 (1.5M) 6.25mL 
10% SDS 250μL 
10% APS 250μL 
TEMED 30μL 
Components required for four 10% separating gels. 
 
10% Stacking Gel 
dH2O 3.5mL 
Bis-acrylamide 1.062mL 
Tris pH 6.8 (0.5M) 1.56mL 
10% SDS 62.5μL 
10% APS 62.5μL 
TEMED 4μL 
Components required for four 10% stacking gels. 
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10x Running Buffer 
Tris base 15g 
Glycine 72g 
SDS 5g 
dH2O 500mL 
Components required for 10x Running Buffer. 
 
Coomassie Stain 
0.2% Brilliant Blue 0.2g 
45% Methanol 45mL 
45% dH2O 45mL 
10% Acetic Acid 10mL 
Components required for 100mL of Coomassie Blue Stain. 
 
Destain Solution 
25% Methanol 50mL 
65% dH2O 130mL 
10% Acetic Acid 20mL 
Components required for 200mL Destain solution. 
 
10X PBS 
NaCl 160g 
Na2HPO4 23.2g 
KH2PO4 4g 
KCl 4g 
dH2O 2L 
List of salts required for 2L of 10x PBS. 
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Wash Buffer 
10X PBS 500mL 
dH2O 4,500mL 
0.05% Tween 2.5mL 
List of components required for 5L of 1x Wash Buffer. 
 
TBS Reagent Diluent 
Trizma 6.1g 
NaCl 1.74g 
BSA 0.2g 
Tween 0.1mL 
dH2O 200mL 
List of components required for 200mL of TBS Reagent Diluent. 
 
cDNA Master Mix 
Component Amount 
10X RT buffer 2µL 
10X RT Random Primers 2µL 
25X dNTP Mix (100µM) 0.8µL 
MultiScribe™Reverse Transcriptase 1µL 
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APPENDIX B – SLP CHARACTERISATION 
 
A Bicinchoninic acid (BCA) assay was performed on all samples to determine 
the protein concentration for each batch of SLPs. This was of great importance as 
a standard volume of each SLP was required for cell stimulation.  The standard 
curve is given in Figure 7.1. Sample Concentrations calculated using equation of 
line are given in Table 4.2.3 below. 
 
 
Figure 7.1 
 
Figure 7.1 
Plot of standard concentration vs. absorbance at 562nm. Equation of the line and 
R2 value are also given. 
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Concentration of SLPs from different ribotypes of C. difficile.  
Ribotype Conc (mg/mL) 
001 3.640 
014 3.3315 
078 7.243 
027 8.365 
 
 
 
LAL Endotoxin Assay 
To ensure that any observed immune response was indeed due to the SLP and 
not due to potential contaminating endotoxins. The assay results are in Figure 7.2 
given below. LPS is used as a positive control. All samples tested negative for 
endotoxin, showing no contamination. 
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Figure 7.2 
 
Figure 7.2 
LAL assay results showing Endotoxin activity in samples. LPS (10ng/mL) was 
used as a positive control. SLPs were tested at a concentration of 20µg/mL. 
Results show that no Endotoxin is present in the SLP samples, and observed 
responses are due to activation with SLP. 
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APPENDIX C – PRIMER EFFICIENCY CURVES 
 
Efficiency = 97%  Dynamic Range = 16-29 Cq 
 
 
Efficiency = 98%  Dynamic Range = 18-28 Cq 
 
Efficiency = 100%  Dynamic Range = 21-32 Cq 
y = -3.4037x + 32.888
R² = 0.9991
0
5
10
15
20
25
30
35
0.0001 0.001 0.01 0.1 1
C
t
Quantity
s18 Standard Curve Plot
y = -3.3643x + 32.419
R² = 0.9945
0
5
10
15
20
25
30
35
0.001 0.01 0.1 1
C
t
Quantity
Gusb Standard Curve Plot
y = -3.247x + 33.42
R² = 0.9998
0
5
10
15
20
25
30
35
0.001 0.01 0.1 1
C
t
Quantity
TGFb Standard Curve Plot
257 
 
 
Efficiency = 99%  Dynamic Range = 24-34 Cq 
 
Efficiency = 99%  Dynamic Range = 26-35 Cq 
 
Efficiency = 100%  Dynamic Range = 17-26 Cq 
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Efficiency = 99%  Dynamic Range = 20-33 Cq 
 
Efficiency = 100%  Dynamic Range = 19-30 Cq 
 
Efficiency = 100%  Dynamic Range = 20-34 Cq 
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Efficiency = 97%  Dynamic Range = 26-36 Cq 
 
 
Efficiency = 104%  Dynamic Range = 28-35 Cq 
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APPENDIX D – PRIMER SEQUENCES 
Gusb 
Primer 1 5’- CCA ATG AGC CTT CCT CTG C-3’ 
Primer 2 5’- ATC ATA TTT GGC GTT GCT CAC-3’ 
 
Rps18 
Primer 1 5’- CCT GAG AAG TTC CAG CAC AT-3’ 
Primer 2 5’- ACA CCA CAT GAG CAT ATC TCC-3’ 
 
IL-6 
Primer 1 5’- AGC CAG AGT CCT TCA GAG A-3’ 
Primer 2 5’- TCC TTA GCC ACT CCT TCT GT-3’ 
 
IL-10 
Primer 1 5’- GGC ATC ACT TCT ACC AGG TAA-3’ 
Primer 2 5’- TCA GCC AGG TGA AGA CTT TC-3’ 
 
IL-12b (p40) 
Primer 1 5’- TGT CCT CAG AAG CTA ACC ATC-3’ 
Primer 2 5’- TCC AGT CCA CCT CTA CAA CA-3’ 
 
IL-17a 
Primer 1 5’- AGA CTA CCT CAA CCG TTC CA-3’ 
Primer 2 5’- GAG CTT CCC AGA TCA CAG AG-3’ 
 
IL-23 
Primer 1 5’- ACC AGC GGG ACA TAT GAA TC-3’ 
Primer 2 5’- GAT CCT TTG CAA GCA GAA CTG-3’ 
 
IFNγ 
Primer 1 5’- ATG AAC GCT ACA CAC TGC ATC-3’ 
Primer 2 5’- CCA TCC TTT TGC CAG TTC CTC -3’ 
 
TGFb1 
Primer 1 5’- GCG GAC TAC TAT GCT AAA GAG G-3’ 
Primer 2 5’- CCG AAT GTC TGA CGT ATT GAA GA-3’ 
 
TNFa 
Primer 1 5’- AGA CCC TCA CAC TCA GAT CA-3’ 
Primer 2 5’- TCT TTG AGA TCC ATG CCG TTG-3’ 
 
RORg 
Primer 1 5’- TCT GCA AGA CTC ATC GAC AAG-3’ 
Primer 2 5’- GAG GTG CTG GAA GAT CTG C-3’ 
